[{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"449102301756932096"}],"id":"449137112722710529","entities":{"hashtags":[{"start":14,"end":19,"tag":"News"}],"mentions":[{"start":3,"end":12,"username":"EASDnews","id":"79702114"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-27T10:53:26.000Z","text":"RT @EASDnews: #News - direct evidence that response of unborn children to glucose is associated with mother's insulin sensitivity http://t.…","lang":"en","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"449137112722710529","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"449105626787229696"}],"id":"449137014445989888","entities":{"hashtags":[{"start":80,"end":98,"tag":"multiplesclerosis"}],"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"urls":[{"start":116,"end":138,"url":"http://t.co/ZzWhhAC1CH","expanded_url":"http://bit.ly/1lo1Xmt","display_url":"bit.ly/1lo1Xmt"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-27T10:53:03.000Z","text":"RT @IMI_JU: Study by IMI project ABIRISK: could patients’ genes affect how well #multiplesclerosis treatment works? http://t.co/ZzWhhAC1CH …","lang":"en","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"449137014445989888","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":{},"id":"449133698462781440","entities":{"hashtags":{},"mentions":{},"urls":[{"start":72,"end":94,"url":"http://t.co/q987RFusP6","expanded_url":"http://svy.mk/OcE6HP","display_url":"svy.mk/OcE6HP"}],"annotations":[{"start":20,"end":26,"probability":0.6741,"type":"Product","normalized_text":"Twitter"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-27T10:39:52.000Z","text":"Help us improve our Twitter feed  further by completing a quick survey: http://t.co/q987RFusP6","lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"449133698462781440","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":{},"id":"449133423777841152","entities":{"hashtags":{},"mentions":{},"urls":[{"start":118,"end":140,"url":"http://t.co/lCRwSD3Zeo","expanded_url":"http://bit.ly/18SjN71","display_url":"bit.ly/18SjN71"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-27T10:38:47.000Z","text":"We published a tender for monitoring scientific and medical literature for adverse reaction reports. Apply by 13 May: http://t.co/lCRwSD3Zeo","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"449133423777841152","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":{},"id":"449131532822003712","entities":{"hashtags":[{"start":84,"end":92,"tag":"thyroid"}],"mentions":{},"urls":[{"start":101,"end":123,"url":"http://t.co/RsNJdV8cXL","expanded_url":"http://bit.ly/1fjWUvV","display_url":"bit.ly/1fjWUvV"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-27T10:31:16.000Z","text":"We've published the EPAR for Cometriq (cabozantinib), a medicine to treat medullary #thyroid cancer: http://t.co/RsNJdV8cXL","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"449131532822003712","attachments":{"media_keys":{}}},{"source":"bitly bitlink","referenced_tweets":{},"id":"448883112706318336","entities":{"hashtags":[{"start":97,"end":105,"tag":"thyroid"}],"mentions":{},"urls":[{"start":114,"end":136,"url":"http://t.co/RsNJdV8cXL","expanded_url":"http://bit.ly/1fjWUvV","display_url":"bit.ly/1fjWUvV"}],"annotations":[{"start":42,"end":49,"probability":0.2746,"type":"Person","normalized_text":"Cometriq"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-26T18:04:08.000Z","text":"We've published the assessment report for Cometriq (cabozantinib), a medicine to treat medullary #thyroid cancer: http://t.co/RsNJdV8cXL","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"448883112706318336","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":{},"id":"448881179077664768","entities":{"hashtags":{},"mentions":{},"urls":[{"start":76,"end":98,"url":"http://t.co/q987RFusP6","expanded_url":"http://svy.mk/OcE6HP","display_url":"svy.mk/OcE6HP"}],"annotations":[{"start":30,"end":36,"probability":0.7631,"type":"Product","normalized_text":"Twitter"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-26T17:56:27.000Z","text":"Tell us what you think of our Twitter feed by completing this short survey: http://t.co/q987RFusP6","lang":"en","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"448881179077664768","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":{},"id":"448881052007034880","entities":{"hashtags":{},"mentions":{},"urls":[{"start":106,"end":128,"url":"http://t.co/79UhJzvnOx","expanded_url":"http://bit.ly/1p52XLh","display_url":"bit.ly/1p52XLh"}],"annotations":[{"start":27,"end":65,"probability":0.4774,"type":"Other","normalized_text":"European Network of Paediatric Research"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-26T17:55:57.000Z","text":"The annual workshop of the European Network of Paediatric Research at the EMA will be held on 26-27 June: http://t.co/79UhJzvnOx","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"448881052007034880","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":{},"id":"448880802500456449","entities":{"hashtags":{},"mentions":{},"urls":[{"start":77,"end":99,"url":"http://t.co/vbfIC29R9M","expanded_url":"http://bit.ly/NSH83G","display_url":"bit.ly/NSH83G"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-26T17:54:57.000Z","text":"We're changing the way we handle certain evaluation procedures from 1 April: http://t.co/vbfIC29R9M","lang":"en","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"448880802500456449","attachments":{"media_keys":{}}},{"source":"bitly bitlink","referenced_tweets":{},"id":"448879297269600256","entities":{"hashtags":{},"mentions":{},"urls":[{"start":112,"end":134,"url":"http://t.co/lCRwSD3Zeo","expanded_url":"http://bit.ly/18SjN71","display_url":"bit.ly/18SjN71"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-26T17:48:58.000Z","text":"We've pubished a call for tender for monitoring scientific and medical literature for adverse reaction reports: http://t.co/lCRwSD3Zeo","lang":"en","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":4,"quote_count":0},"conversation_id":"448879297269600256","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"448775226873372673"}],"id":"448805487933673472","entities":{"hashtags":[{"start":116,"end":123,"tag":"Pharma"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":92,"end":114,"url":"http://t.co/TVpovVZOxA","expanded_url":"http://bit.ly/1h8GMkQ","display_url":"bit.ly/1h8GMkQ"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-26T12:55:41.000Z","text":"RT @EFPIA: EFPIA PR- UPDATE: Clinical Data Sharing – progress made against 2013 commitments http://t.co/TVpovVZOxA  #Pharma #ClinicalDataSh…","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"448805487933673472","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"448777090423611392"}],"id":"448805429959999488","entities":{"hashtags":{},"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-26T12:55:27.000Z","text":"RT @IMI_JU: IMI project SAFE-T identifies &amp; validates biomarkers for drug-induced injury of liver, kidneys &amp; vascular system-T Joos #EuroMe…","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"448805429959999488","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"448785500661633024"}],"id":"448805230294351873","entities":{"hashtags":[{"start":31,"end":38,"tag":"cancer"}],"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"urls":[{"start":111,"end":133,"url":"http://t.co/B0263zahKA","expanded_url":"http://bit.ly/HLasers","display_url":"bit.ly/HLasers"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-26T12:54:39.000Z","text":"RT @innovationunion: Detecting #cancer at the speed of light thanks to new – and cheaper – optical technology: http://t.co/B0263zahKA #Hori…","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"448805230294351873","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"448798907364286464"}],"id":"448804797186342912","entities":{"hashtags":[{"start":105,"end":109,"tag":"UHC"}],"mentions":[{"start":3,"end":14,"username":"IAPOtweets","id":"14682411"},{"start":25,"end":36,"username":"IAPOtweets","id":"14682411"}],"urls":[{"start":110,"end":132,"url":"http://t.co/ahRZfvhHrA","expanded_url":"http://goo.gl/jEvyU5","display_url":"goo.gl/jEvyU5"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-26T12:52:56.000Z","text":"RT @IAPOtweets: Ahead of @IAPOtweets 6th Congress this weekend, we have developed important resources on #UHC http://t.co/ahRZfvhHrA #GPC20…","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"448804797186342912","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":{},"id":"448786185234939904","entities":{"hashtags":{},"mentions":{},"urls":[{"start":61,"end":83,"url":"http://t.co/q987RFusP6","expanded_url":"http://svy.mk/OcE6HP","display_url":"svy.mk/OcE6HP"}],"annotations":[{"start":29,"end":35,"probability":0.7446,"type":"Product","normalized_text":"Twitter"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-26T11:38:59.000Z","text":"Give us your feedback on our Twitter feed in a short survey: http://t.co/q987RFusP6","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"448786185234939904","attachments":{"media_keys":{}}},{"source":"bitly bitlink","referenced_tweets":{},"id":"448779627809746944","entities":{"hashtags":{},"mentions":{},"urls":[{"start":110,"end":132,"url":"http://t.co/79UhJzvnOx","expanded_url":"http://bit.ly/1p52XLh","display_url":"bit.ly/1p52XLh"}],"annotations":[{"start":41,"end":79,"probability":0.6321,"type":"Other","normalized_text":"European Network of Paediatric Research"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-26T11:12:55.000Z","text":"We're holding the annual workshop of the European Network of Paediatric Research at the EMA on on 26-27 June: http://t.co/79UhJzvnOx","lang":"en","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"448779627809746944","attachments":{"media_keys":{}}},{"source":"bitly bitlink","referenced_tweets":{},"id":"448764187951788032","entities":{"hashtags":{},"mentions":{},"urls":[{"start":84,"end":106,"url":"http://t.co/vbfIC29R9M","expanded_url":"http://bit.ly/NSH83G","display_url":"bit.ly/NSH83G"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-26T10:11:34.000Z","text":"We're making changes to the handling of certain evaluation procedures from 1 April: http://t.co/vbfIC29R9M","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"448764187951788032","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"448439213092917249"}],"id":"448464990182600704","entities":{"hashtags":[{"start":72,"end":86,"tag":"antimicrobial"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"},{"start":35,"end":43,"username":"EFSA_EU","id":"84582815"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-25T14:22:40.000Z","text":"RT @ECDC_EU: Infographic: ECDC and @EFSA_EU coordinate efforts to fight #antimicrobial resistance in humans, animals and food http://t.co/u…","lang":"en","public_metrics":{"retweet_count":44,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"448464990182600704","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"448455178606624768"}],"id":"448464628591624192","entities":{"hashtags":[{"start":15,"end":25,"tag":"EU4Health"},{"start":54,"end":70,"tag":"chronicdiseases"},{"start":85,"end":88,"tag":"EU"},{"start":101,"end":104,"tag":"EU"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-25T14:21:14.000Z","text":"RT @EU_Health: #EU4Health How to reduce the burden of #chronicdiseases &amp; what is #EU action? 1st #EU summit on the topic 3-4/04/14 http://t…","lang":"en","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"448464628591624192","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"448458354009317376"}],"id":"448464522643529728","entities":{"hashtags":[{"start":109,"end":121,"tag":"RareDisease"}],"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"urls":{},"annotations":[{"start":87,"end":92,"probability":0.6806,"type":"Place","normalized_text":"Europe"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-25T14:20:48.000Z","text":"RT @eurordis: Available in 7 languages, EURORDIS eNews reports on workshop:  Unlocking Europe’s Potential in #RareDisease Therapies http://…","lang":"en","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"448464522643529728","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","referenced_tweets":{},"id":"448459520051003392","entities":{"hashtags":{},"mentions":{},"urls":[{"start":86,"end":108,"url":"http://t.co/CwmedYfhWH","expanded_url":"http://bit.ly/1prP2gE","display_url":"bit.ly/1prP2gE"}],"annotations":[{"start":45,"end":60,"probability":0.6127,"type":"Organization","normalized_text":"Management Board"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-25T14:00:56.000Z","text":"Yesterday we issued our press release on the Management Board meeting held last week: http://t.co/CwmedYfhWH","lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"448459520051003392","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"448402671725060097"}],"id":"448405692505133056","entities":{"hashtags":[{"start":98,"end":104,"tag":"ECE14"}],"mentions":[{"start":3,"end":19,"username":"ESEndocrinology","id":"221055586"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-25T10:27:02.000Z","text":"RT @ESEndocrinology: Learn more about the latest advances in thyroid ultrasound techniques at the #ECE14 Pre-congress postgraduate course  …","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"448405692505133056","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":{},"id":"448401336946950144","entities":{"hashtags":{},"mentions":{},"urls":[{"start":69,"end":91,"url":"http://t.co/q987RFusP6","expanded_url":"http://svy.mk/OcE6HP","display_url":"svy.mk/OcE6HP"}],"annotations":[{"start":35,"end":41,"probability":0.7426,"type":"Product","normalized_text":"Twitter"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-25T10:09:44.000Z","text":"Let us know what you think of this Twitter feed in our short survey: http://t.co/q987RFusP6","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"448401336946950144","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":{},"id":"448400855700873216","entities":{"hashtags":[{"start":92,"end":103,"tag":"veterinary"}],"mentions":{},"urls":[{"start":114,"end":136,"url":"http://t.co/DMb3rzKtAp","expanded_url":"http://bit.ly/1jmvhK2","display_url":"bit.ly/1jmvhK2"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-25T10:07:49.000Z","text":"We've published a draft concept paper on a user safety guideline for topically administered #veterinary products: http://t.co/DMb3rzKtAp","lang":"en","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":1,"quote_count":0},"conversation_id":"448400855700873216","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"448124209625976832"}],"id":"448144194264367104","entities":{"hashtags":[{"start":13,"end":24,"tag":"WorldTBDay"},{"start":29,"end":33,"tag":"MDR"},{"start":34,"end":37,"tag":"TB"}],"mentions":[{"start":3,"end":11,"username":"ECDC_TB","id":"1282878908"}],"urls":{},"annotations":[{"start":68,"end":69,"probability":0.7469,"type":"Place","normalized_text":"EU"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-24T17:07:56.000Z","text":"RT @ECDC_TB: #WorldTBDay low #MDR #TB successful treatment rates in EU have been compared to the situation in pre-antibiotic era http://t.c…","lang":"en","public_metrics":{"retweet_count":17,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"448144194264367104","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"448129267885682688"}],"id":"448144087380942848","entities":{"hashtags":{},"mentions":[{"start":3,"end":14,"username":"IAPOtweets","id":"14682411"}],"urls":[{"start":116,"end":138,"url":"http://t.co/OOFDMD88oa","expanded_url":"http://goo.gl/Xvlyvm","display_url":"goo.gl/Xvlyvm"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-24T17:07:31.000Z","text":"RT @IAPOtweets: New online training programme to help patient advocates influence decisions on access to medicines: http://t.co/OOFDMD88oa …","lang":"en","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"448144087380942848","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"448143102528598016"}],"id":"448143676750200832","entities":{"hashtags":{},"mentions":[{"start":3,"end":17,"username":"WHO_Europe_TB","id":"920721606"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-24T17:05:53.000Z","text":"RT @WHO_Europe_TB: an estimated of around 1 mln. children developed TB disease in 2010, of whom 31 948 (25 594—38 663) had MDR http://t.co/…","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"448143676750200832","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":{},"id":"448142691113902081","entities":{"hashtags":{},"mentions":{},"urls":[{"start":59,"end":81,"url":"http://t.co/q987RFusP6","expanded_url":"http://svy.mk/OcE6HP","display_url":"svy.mk/OcE6HP"}],"annotations":[{"start":24,"end":30,"probability":0.7034,"type":"Product","normalized_text":"Twitter"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-24T17:01:58.000Z","text":"Give us feedback on our Twitter feed in this short survey: http://t.co/q987RFusP6","lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"448142691113902081","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":{},"id":"448142426323296256","entities":{"hashtags":[{"start":102,"end":115,"tag":"hypertension"}],"mentions":{},"urls":[{"start":117,"end":139,"url":"http://t.co/Gza4hT522i","expanded_url":"http://bit.ly/1kBnbdH","display_url":"bit.ly/1kBnbdH"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-24T17:00:55.000Z","text":"One week to comment on our paediatric addendum to guidance on clinical investigation of medicines for #hypertension: http://t.co/Gza4hT522i","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"448142426323296256","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":{},"id":"448142295922384897","entities":{"hashtags":[{"start":94,"end":98,"tag":"HIV"}],"mentions":{},"urls":[{"start":110,"end":132,"url":"http://t.co/9jX4i4VlnA","expanded_url":"http://bit.ly/1gEHx16","display_url":"bit.ly/1gEHx16"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-24T17:00:24.000Z","text":"One week left to comment on our draft guideline on clinical development of medicines to treat #HIV infection: http://t.co/9jX4i4VlnA","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"448142295922384897","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":{},"id":"448142148597452800","entities":{"hashtags":{},"mentions":{},"urls":[{"start":111,"end":133,"url":"http://t.co/KFfwjugdGi","expanded_url":"http://bit.ly/JO7XUv","display_url":"bit.ly/JO7XUv"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-24T16:59:48.000Z","text":"One more week to comment on our guideline on core SmPC for plasma-derived fibrin sealant/haemostatic products: http://t.co/KFfwjugdGi","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"448142148597452800","attachments":{"media_keys":{}}},{"source":"bitly bitlink","referenced_tweets":{},"id":"448096587680841728","entities":{"hashtags":[{"start":89,"end":100,"tag":"veterinary"}],"mentions":{},"urls":[{"start":111,"end":133,"url":"http://t.co/DMb3rzKtAp","expanded_url":"http://bit.ly/1jmvhK2","display_url":"bit.ly/1jmvhK2"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-24T13:58:46.000Z","text":"Comment on our draft concept paper on a user safety guideline for topically administered #veterinary products: http://t.co/DMb3rzKtAp","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"448096587680841728","attachments":{"media_keys":{}}},{"source":"bitly bitlink","referenced_tweets":{},"id":"448071539142184960","entities":{"hashtags":{},"mentions":{},"urls":[{"start":84,"end":106,"url":"http://t.co/CwmedYfhWH","expanded_url":"http://bit.ly/1prP2gE","display_url":"bit.ly/1prP2gE"}],"annotations":[{"start":43,"end":58,"probability":0.5886,"type":"Organization","normalized_text":"Management Board"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-24T12:19:14.000Z","text":"We've just issued our press release on the Management Board meeting held last week: http://t.co/CwmedYfhWH","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"448071539142184960","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","referenced_tweets":{},"id":"448057865291714560","entities":{"hashtags":[{"start":53,"end":63,"tag":"diacerein"}],"mentions":{},"urls":[{"start":86,"end":108,"url":"http://t.co/lqlvQF8pmj","expanded_url":"http://bit.ly/1r4R2iz","display_url":"bit.ly/1r4R2iz"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-24T11:24:54.000Z","text":"CMDh endorsed recommendations to restrict the use of #diacerein-containing medicines: http://t.co/lqlvQF8pmj","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"448057865291714560","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","referenced_tweets":{},"id":"448057619396431872","entities":{"hashtags":[{"start":43,"end":51,"tag":"Entyvio"},{"start":61,"end":72,"tag":"ulcerative"},{"start":85,"end":91,"tag":"Crohn"}],"mentions":{},"urls":[{"start":105,"end":127,"url":"http://t.co/f0fAzjpbEi","expanded_url":"http://bit.ly/1phIrp2","display_url":"bit.ly/1phIrp2"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-24T11:23:55.000Z","text":"We recommended marketing authorisation for #Entyvio to treat #ulcerative colitis and #Crohn's disease: http://t.co/f0fAzjpbEi","lang":"en","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"448057619396431872","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","referenced_tweets":{},"id":"448057419663691776","entities":{"hashtags":[{"start":43,"end":51,"tag":"Sylvant"},{"start":72,"end":82,"tag":"Castleman"}],"mentions":{},"urls":[{"start":94,"end":116,"url":"http://t.co/hkCONEpH7c","expanded_url":"http://bit.ly/1ghWfAi","display_url":"bit.ly/1ghWfAi"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-24T11:23:08.000Z","text":"We recommended marketing authorisation for #Sylvant, first medicine for #Castleman's disease: http://t.co/hkCONEpH7c","lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"448057419663691776","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","referenced_tweets":{},"id":"448057200754573312","entities":{"hashtags":{},"mentions":{},"urls":[{"start":115,"end":137,"url":"http://t.co/QI4PQxHTxZ","expanded_url":"http://bit.ly/1fM0Tkb","display_url":"bit.ly/1fM0Tkb"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-24T11:22:15.000Z","text":"We recommended approval of new treatment for platinum-resistant ovarian cancer together with companion diagnostic: http://t.co/QI4PQxHTxZ","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"448057200754573312","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","referenced_tweets":{},"id":"448056823925710848","entities":{"hashtags":[{"start":29,"end":34,"tag":"CHMP"}],"mentions":{},"urls":[{"start":55,"end":77,"url":"http://t.co/efxOhpYALj","expanded_url":"http://bit.ly/PXhEE7","display_url":"bit.ly/PXhEE7"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-24T11:20:45.000Z","text":"Last Friday we published the #CHMP meeting highlights: http://t.co/efxOhpYALj","lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"448056823925710848","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":{},"id":"448038411941994496","entities":{"hashtags":{},"mentions":{},"urls":[{"start":73,"end":95,"url":"http://t.co/q987RFusP6","expanded_url":"http://svy.mk/OcE6HP","display_url":"svy.mk/OcE6HP"}],"annotations":[{"start":38,"end":44,"probability":0.5782,"type":"Product","normalized_text":"Twitter"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-24T10:07:36.000Z","text":"Help us offer you the best service on Twitter by doing our quick survey: http://t.co/q987RFusP6","lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"448038411941994496","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"448037928862625792"}],"id":"448038008487706624","entities":{"hashtags":[{"start":53,"end":63,"tag":"medicines"},{"start":64,"end":74,"tag":"shortages"}],"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"},{"start":88,"end":97,"username":"EMA_News","id":"116716199"}],"urls":[{"start":112,"end":134,"url":"http://t.co/BdiTOjXnZ8","expanded_url":"http://bit.ly/1dhAxvP","display_url":"bit.ly/1dhAxvP"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-24T10:06:00.000Z","text":"RT @EAHPtweet: Latest EAHP EU Monitor looks at a new #medicines #shortages survey &amp; @EMA_News 2014 workplan http://t.co/BdiTOjXnZ8 http://t…","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"448038008487706624","attachments":{"media_keys":{}}},{"source":"bitly bitlink","referenced_tweets":{},"id":"448037549014274048","entities":{"hashtags":[{"start":103,"end":116,"tag":"hypertension"}],"mentions":{},"urls":[{"start":118,"end":140,"url":"http://t.co/Gza4hT522i","expanded_url":"http://bit.ly/1kBnbdH","display_url":"bit.ly/1kBnbdH"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-24T10:04:10.000Z","text":"One more week to comment on paediatric addendum to guidance on clinical investigation of medicines for #hypertension: http://t.co/Gza4hT522i","lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"448037549014274048","attachments":{"media_keys":{}}},{"source":"bitly bitlink","referenced_tweets":{},"id":"448037047337746432","entities":{"hashtags":[{"start":94,"end":98,"tag":"HIV"}],"mentions":{},"urls":[{"start":110,"end":132,"url":"http://t.co/9jX4i4VlnA","expanded_url":"http://bit.ly/1gEHx16","display_url":"bit.ly/1gEHx16"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-24T10:02:10.000Z","text":"One more week to comment on our draft guideline on clinical development of medicines to treat #HIV infection: http://t.co/9jX4i4VlnA","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"448037047337746432","attachments":{"media_keys":{}}},{"source":"bitly bitlink","referenced_tweets":{},"id":"448036576627798016","entities":{"hashtags":{},"mentions":{},"urls":[{"start":117,"end":139,"url":"http://t.co/KFfwjugdGi","expanded_url":"http://bit.ly/JO7XUv","display_url":"bit.ly/JO7XUv"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-24T10:00:18.000Z","text":"One week left to comment on our draft guideline on core SmPC for plasma-derived fibrin sealant/haemostatic products: http://t.co/KFfwjugdGi","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"448036576627798016","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"448014895661871104"}],"id":"448035779097665536","entities":{"hashtags":[{"start":21,"end":39,"tag":"ResearchHeadlines"},{"start":51,"end":58,"tag":"Cancer"}],"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-24T09:57:08.000Z","text":"RT @innovationunion: #ResearchHeadlines - Fighting #Cancer by attacking its support network: When we think of cancer we often think of... h…","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"448035779097665536","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"448021269402107904"}],"id":"448035600810377216","entities":{"hashtags":[{"start":29,"end":32,"tag":"EU"},{"start":45,"end":52,"tag":"health"},{"start":82,"end":89,"tag":"Health"},{"start":90,"end":100,"tag":"Programme"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"urls":{},"annotations":[{"start":114,"end":121,"probability":0.9852,"type":"Place","normalized_text":"Brussels"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-24T09:56:26.000Z","text":"RT @EU_Health: Interested in #EU funding for #health? Attend the info day for 3rd #Health #Programme 2014-2020 in Brussels, 11.04, http://t…","lang":"en","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"448035600810377216","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"448023899784364032"}],"id":"448035371977555968","entities":{"hashtags":[{"start":27,"end":36,"tag":"WTBD2014"},{"start":117,"end":124,"tag":"TBchat"}],"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"urls":[{"start":54,"end":76,"url":"http://t.co/N19WVTU7Ql","expanded_url":"http://streaming.uncity.dk/who/","display_url":"streaming.uncity.dk/who/"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-24T09:55:31.000Z","text":"RT @WHO_Europe: Follow the #WTBD2014 discussions live http://t.co/N19WVTU7Ql  and send questions / comments to us at #TBchat","lang":"en","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"448035371977555968","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"448025342494912512"}],"id":"448035137285283840","entities":{"hashtags":[{"start":120,"end":123,"tag":"TB"},{"start":124,"end":135,"tag":"WorldTBDay"}],"mentions":[{"start":3,"end":16,"username":"EuropeanLung","id":"121759520"},{"start":53,"end":69,"username":"ERSpublications","id":"424241621"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-24T09:54:35.000Z","text":"RT @EuropeanLung: Read the latest press release from @erspublications on new consensus statements for the management of #TB #WorldTBDay htt…","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"448035137285283840","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","referenced_tweets":{},"id":"448034702306590720","entities":{"hashtags":[{"start":17,"end":28,"tag":"WorldTBDay"}],"mentions":{},"urls":[{"start":36,"end":58,"url":"http://t.co/OesphItQbR","expanded_url":"http://bit.ly/1r5DjIi","display_url":"bit.ly/1r5DjIi"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-24T09:52:51.000Z","text":"We're supporting #WorldTBDay today: http://t.co/OesphItQbR","lang":"en","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":4,"quote_count":0},"conversation_id":"448034702306590720","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"447055782958206976"}],"id":"447066546574458880","entities":{"hashtags":[{"start":43,"end":46,"tag":"TB"},{"start":55,"end":58,"tag":"TB"},{"start":84,"end":95,"tag":"WorldTBDay"}],"mentions":[{"start":3,"end":11,"username":"ECDC_TB","id":"1282878908"}],"urls":[{"start":96,"end":118,"url":"http://t.co/pE400SXHYw","expanded_url":"https://twitter.com/ECDC_TB/status/447055782958206976/photo/1","display_url":"pic.twitter.com/pE400SXHYw"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-21T17:45:45.000Z","text":"RT @ECDC_TB: 5 facts you should know about #TB and MDR #TB. Don't forget, Monday is #WorldTBDay http://t.co/pE400SXHYw","lang":"en","public_metrics":{"retweet_count":57,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"447066546574458880","attachments":{"media_keys":["3_447055782735908864"]}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"447065005792714752"}],"id":"447065737832988672","entities":{"hashtags":{},"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-21T17:42:32.000Z","text":"RT @US_FDA: Innovative project identifying “fingerprints” of disease-causing bacteria like E coli, Salmonella &amp; Listeria in foods http://t.…","lang":"en","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"447065737832988672","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":{},"id":"447065616072327168","entities":{"hashtags":[{"start":52,"end":56,"tag":"flu"}],"mentions":{},"urls":[{"start":81,"end":103,"url":"http://t.co/YybwSTfTky","expanded_url":"http://bit.ly/1g7Z5qu","display_url":"bit.ly/1g7Z5qu"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-21T17:42:03.000Z","text":"We've issued recommendations for the composition of #flu vaccines for 2014/2015: http://t.co/YybwSTfTky","lang":"en","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"447065616072327168","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":{},"id":"447064743380279296","entities":{"hashtags":{},"mentions":{},"urls":[{"start":44,"end":66,"url":"http://t.co/q987RFusP6","expanded_url":"http://svy.mk/OcE6HP","display_url":"svy.mk/OcE6HP"}],"annotations":[{"start":30,"end":36,"probability":0.8186,"type":"Product","normalized_text":"Twitter"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-21T17:38:35.000Z","text":"Tell us what you think of our Twitter feed: http://t.co/q987RFusP6","lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"447064743380279296","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":{},"id":"447024067372404737","entities":{"hashtags":[{"start":64,"end":77,"tag":"tuberculosis"}],"mentions":{},"urls":[{"start":41,"end":63,"url":"http://t.co/OesphItQbR","expanded_url":"http://bit.ly/1r5DjIi","display_url":"bit.ly/1r5DjIi"}],"annotations":[{"start":17,"end":28,"probability":0.5595,"type":"Other","normalized_text":"World TB Day"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-21T14:56:57.000Z","text":"We're supporting World TB Day on Monday: http://t.co/OesphItQbR #tuberculosis","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"447024067372404737","attachments":{"media_keys":{}}},{"source":"bitly bitlink","referenced_tweets":{},"id":"446990865974968321","entities":{"hashtags":[{"start":53,"end":63,"tag":"diacerein"}],"mentions":{},"urls":[{"start":86,"end":108,"url":"http://t.co/lqlvQF8pmj","expanded_url":"http://bit.ly/1r4R2iz","display_url":"bit.ly/1r4R2iz"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-21T12:45:01.000Z","text":"CMDh endorsed recommendations to restrict the use of #diacerein-containing medicines: http://t.co/lqlvQF8pmj","lang":"en","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"446990865974968321","attachments":{"media_keys":{}}},{"source":"bitly bitlink","referenced_tweets":{},"id":"446990395759931392","entities":{"hashtags":[{"start":46,"end":54,"tag":"Entyvio"},{"start":64,"end":75,"tag":"ulcerative"},{"start":88,"end":94,"tag":"Crohn"}],"mentions":{},"urls":[{"start":108,"end":130,"url":"http://t.co/f0fAzjpbEi","expanded_url":"http://bit.ly/1phIrp2","display_url":"bit.ly/1phIrp2"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-21T12:43:09.000Z","text":"We've recommended marketing authorisation for #Entyvio to treat #ulcerative colitis and #Crohn's disease: http://t.co/f0fAzjpbEi","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"446990395759931392","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":{},"id":"446989759161061376","entities":{"hashtags":{},"mentions":{},"urls":[{"start":64,"end":86,"url":"http://t.co/q987RFusP6","expanded_url":"http://svy.mk/OcE6HP","display_url":"svy.mk/OcE6HP"}],"annotations":[{"start":21,"end":27,"probability":0.7341,"type":"Product","normalized_text":"Twitter"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-21T12:40:37.000Z","text":"Help us optimise our Twitter feed by filling in a quick survey: http://t.co/q987RFusP6","lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"446989759161061376","attachments":{"media_keys":{}}},{"source":"bitly bitlink","referenced_tweets":{},"id":"446988884971638784","entities":{"hashtags":[{"start":46,"end":54,"tag":"Sylvant"},{"start":75,"end":85,"tag":"Castleman"}],"mentions":{},"urls":[{"start":96,"end":118,"url":"http://t.co/hkCONEpH7c","expanded_url":"http://bit.ly/1ghWfAi","display_url":"bit.ly/1ghWfAi"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-21T12:37:09.000Z","text":"We've recommended marketing authorisation for #Sylvant, first medicine for #Castleman's disease http://t.co/hkCONEpH7c","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"446988884971638784","attachments":{"media_keys":{}}},{"source":"bitly bitlink","referenced_tweets":{},"id":"446987512662466560","entities":{"hashtags":[{"start":52,"end":56,"tag":"flu"}],"mentions":{},"urls":[{"start":89,"end":111,"url":"http://t.co/YybwSTfTky","expanded_url":"http://bit.ly/1g7Z5qu","display_url":"bit.ly/1g7Z5qu"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-21T12:31:42.000Z","text":"We've issued recommendations for the composition of #flu vaccines for the coming season: http://t.co/YybwSTfTky","lang":"en","public_metrics":{"retweet_count":6,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"446987512662466560","attachments":{"media_keys":{}}},{"source":"bitly bitlink","referenced_tweets":{},"id":"446987283871576064","entities":{"hashtags":{},"mentions":{},"urls":[{"start":118,"end":140,"url":"http://t.co/QI4PQxHTxZ","expanded_url":"http://bit.ly/1fM0Tkb","display_url":"bit.ly/1fM0Tkb"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-21T12:30:47.000Z","text":"We've recommended approval of new treatment for platinum-resistant ovarian cancer together with companion diagnostic: http://t.co/QI4PQxHTxZ","lang":"en","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"446987283871576064","attachments":{"media_keys":{}}},{"source":"bitly bitlink","referenced_tweets":{},"id":"446986862897680384","entities":{"hashtags":[{"start":25,"end":30,"tag":"CHMP"}],"mentions":{},"urls":[{"start":51,"end":73,"url":"http://t.co/efxOhpYALj","expanded_url":"http://bit.ly/PXhEE7","display_url":"bit.ly/PXhEE7"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-21T12:29:07.000Z","text":"We've just published the #CHMP meeting highlights: http://t.co/efxOhpYALj","lang":"en","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"446986862897680384","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"446941524589166592"}],"id":"446983866499497984","entities":{"hashtags":{},"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"}],"urls":[{"start":106,"end":128,"url":"http://t.co/7zOJdUsqNP","expanded_url":"http://www.pjonline.com/news/european_agency_takes_flexible_approach_to_new_drugs_to_improve_patient_access?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+pjonline%2Fnews+%28PJ+Online+news+feed%29#.UywGWQcxBG0.twitter","display_url":"pjonline.com/news/european_…"}],"annotations":[{"start":96,"end":104,"probability":0.4991,"type":"Organization","normalized_text":"PJ Online"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-21T12:17:13.000Z","text":"RT @EAHPtweet: European agency takes flexible approach to new drugs to improve patient access | PJ Online http://t.co/7zOJdUsqNP","lang":"en","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"446983866499497984","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"446952654057795584"}],"id":"446983495479746560","entities":{"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":95,"end":117,"url":"http://t.co/YlTdWxuFMB","expanded_url":"http://bit.ly/1oDW6In","display_url":"bit.ly/1oDW6In"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-21T12:15:44.000Z","text":"RT @EFPIA: Huge disparities in antibiotic consumption across European region, new report shows http://t.co/YlTdWxuFMB","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"446983495479746560","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"446688745690247169"}],"id":"446688808416075776","entities":{"hashtags":{},"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"}],"urls":{},"annotations":[{"start":44,"end":96,"probability":0.4496,"type":"Organization","normalized_text":"12thEGA International Biosimilar Medicines Conference"},{"start":114,"end":119,"probability":0.8079,"type":"Place","normalized_text":"London"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-20T16:44:45.000Z","text":"RT @egagenerics: LAST CALL FOR REGISTRATION:12thEGA International Biosimilar Medicines Conference(3-4 April 2014)-London http://t.co/d9fqdR…","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"446688808416075776","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"446687129377439744"}],"id":"446687435079290880","entities":{"hashtags":[{"start":44,"end":57,"tag":"tuberculosis"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"},{"start":85,"end":101,"username":"Eurosurveillanc","id":"455839750"}],"urls":[{"start":112,"end":134,"url":"http://t.co/GPEtzVZLBY","expanded_url":"http://bit.ly/1eVVMyg","display_url":"bit.ly/1eVVMyg"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-20T16:39:18.000Z","text":"RT @ECDC_EU: Drug-resistance: challenge for #tuberculosis control in the EU/EEA, new @Eurosurveillanc editorial http://t.co/GPEtzVZLBY #Wor…","lang":"ro","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"446687435079290880","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"446686190281162752"}],"id":"446687397489938432","entities":{"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":82,"end":104,"url":"http://t.co/tLtYekBtpp","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/03/news_detail_002046.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"annotations":[{"start":13,"end":37,"probability":0.7668,"type":"Organization","normalized_text":"European Medicines Agency"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-20T16:39:09.000Z","text":"RT @GCessak: European Medicines Agency launches adaptive licensing pilot project: http://t.co/tLtYekBtpp","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"446687397489938432","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"446684780827254784"}],"id":"446685537710395392","entities":{"hashtags":{},"mentions":[{"start":3,"end":14,"username":"BushbyKate","id":"1216228962"},{"start":16,"end":27,"username":"empoweratm","id":"711407584436101120"},{"start":28,"end":37,"username":"EMA_News","id":"116716199"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-20T16:31:45.000Z","text":"RT @BushbyKate: @empoweratm @EMA_News agree this is a very interesting development and offers hope of a more responsive system for #raredis…","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"446685537710395392","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"446328993885982720"}],"id":"446685503904284672","entities":{"hashtags":[{"start":106,"end":118,"tag":"raredisease"}],"mentions":[{"start":3,"end":14,"username":"BushbyKate","id":"1216228962"},{"start":36,"end":45,"username":"EMA_News","id":"116716199"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-20T16:31:37.000Z","text":"RT @BushbyKate: New initiative from @EMA_News to allow adaptive licensing: calls for companies to try it. #raredisease exemplars? http://t.…","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"446685503904284672","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":{},"id":"446671122340524032","entities":{"hashtags":{},"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"urls":[{"start":117,"end":139,"url":"http://t.co/J1q61r38el","expanded_url":"http://bit.ly/1iGPnvE","display_url":"bit.ly/1iGPnvE"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-20T15:34:28.000Z","text":"RT @AEMPSGOB: Lonseren 25 mg/ml solution for injection, 1 ampoule 4 ml: note regarding pharmaceutical alert R15/2014 http://t.co/J1q61r38el","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"446671122340524032","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":{},"id":"446662010072469505","entities":{"hashtags":[{"start":14,"end":19,"tag":"EFSA"}],"mentions":[{"start":3,"end":12,"username":"agesnews","id":"223456379"},{"start":63,"end":71,"username":"EFSA_EU","id":"84582815"}],"urls":[{"start":97,"end":119,"url":"http://t.co/SY0m2pemFI","expanded_url":"http://bit.ly/1ijj0lZ","display_url":"bit.ly/1ijj0lZ"}],"annotations":[{"start":47,"end":58,"probability":0.6512,"type":"Person","normalized_text":"Bernhard Url"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-20T14:58:16.000Z","text":"RT @agesnews: #EFSA Management Board nominates Bernhard Url as @EFSA_EU's new Executive Director http://t.co/SY0m2pemFI","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"446662010072469505","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"446657983234441216"}],"id":"446659393820827648","entities":{"hashtags":{},"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"urls":[{"start":110,"end":132,"url":"http://t.co/sVPhVtoUEa","expanded_url":"http://go.usa.gov/KyqY","display_url":"go.usa.gov/KyqY"}],"annotations":[{"start":19,"end":21,"probability":0.7296,"type":"Organization","normalized_text":"FDA"},{"start":25,"end":32,"probability":0.4741,"type":"Organization","normalized_text":"Medscape"},{"start":45,"end":47,"probability":0.7427,"type":"Organization","normalized_text":"FDA"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-20T14:47:52.000Z","text":"RT @US_FDA: Latest FDA &amp; Medscape interview: FDA's Rare Disease Program - A Rare Opportunity to Help Kids http://t.co/sVPhVtoUEa","lang":"en","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"446659393820827648","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"446654660657811457"}],"id":"446659063078989824","entities":{"hashtags":[{"start":55,"end":66,"tag":"antibiotic"}],"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"urls":[{"start":71,"end":93,"url":"http://t.co/gNLE08Jodi","expanded_url":"http://bit.ly/1peV8kv","display_url":"bit.ly/1peV8kv"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-20T14:46:33.000Z","text":"RT @WHO_Europe: Video: the 5 things you should know on #antibiotic use http://t.co/gNLE08Jodi","lang":"en","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"446659063078989824","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"446653238734249984"}],"id":"446658676930379777","entities":{"hashtags":{},"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-20T14:45:01.000Z","text":"RT @WHO_Europe: Particular antibiotic brands are overused &amp; misused, due to pharma marketing &amp; poor knowledge by prescribers &amp; public http:…","lang":"en","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"446658676930379777","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"446652417720205312"}],"id":"446658602666045440","entities":{"hashtags":{},"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-20T14:44:44.000Z","text":"RT @WHO_Europe: Seasonal fluctuations in antibiotic consumption indicate they are improperly used to treat seasonal viral infections (eg. #…","lang":"en","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"446658602666045440","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"446651868270579712"}],"id":"446658575545675776","entities":{"hashtags":{},"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-20T14:44:37.000Z","text":"RT @WHO_Europe: Total antibiotic consumption is too high. Antibiotics are overprescribed &amp; people have easy over-the-counter access http://…","lang":"en","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"446658575545675776","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"446650384451657728"}],"id":"446658510592684032","entities":{"hashtags":{},"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"},{"start":78,"end":94,"username":"TheLancetInfDis","id":"2375643853"}],"urls":[{"start":95,"end":117,"url":"http://t.co/tjYrhQUy2h","expanded_url":"http://bit.ly/Nx5Ne0","display_url":"bit.ly/Nx5Ne0"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-20T14:44:22.000Z","text":"RT @WHO_Europe: See full report on antibiotic consumption in non-EU countries @TheLancetInfDis http://t.co/tjYrhQUy2h","lang":"en","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"446658510592684032","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"446647622020132864"}],"id":"446648373870084096","entities":{"hashtags":[{"start":86,"end":90,"tag":"EMA"},{"start":91,"end":102,"tag":"regulatory"}],"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"}],"urls":[{"start":106,"end":128,"url":"http://t.co/U6x5bNq2VR","expanded_url":"http://fb.me/2lWiedwCv","display_url":"fb.me/2lWiedwCv"}],"annotations":[{"start":18,"end":42,"probability":0.7362,"type":"Organization","normalized_text":"European Medicines Agency"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-20T14:04:05.000Z","text":"RT @DrugInfoAssn: European Medicines Agency launches adaptive licensing pilot project #EMA #regulatory... http://t.co/U6x5bNq2VR","lang":"en","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"446648373870084096","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"446647466365292544"}],"id":"446648292790009856","entities":{"hashtags":{},"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"urls":[{"start":112,"end":134,"url":"http://t.co/uLcQkrGi2h","expanded_url":"http://bit.ly/1fJJadc","display_url":"bit.ly/1fJJadc"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-20T14:03:45.000Z","text":"RT @WHO_Europe: Zsuzsanna Jakab: Mapping antibiotic consumption is first step in tackling antibiotic resistance http://t.co/uLcQkrGi2h","lang":"en","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"446648292790009856","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"446647397309890560"}],"id":"446648208320892930","entities":{"hashtags":{},"mentions":[{"start":3,"end":17,"username":"MHRAmedicines","id":"960436586"}],"urls":[{"start":93,"end":115,"url":"http://t.co/ClGjtUjBdR","expanded_url":"http://tinyurl.com/pnqpebx","display_url":"tinyurl.com/pnqpebx"}],"annotations":[{"start":28,"end":38,"probability":0.6222,"type":"Organization","normalized_text":"NHS England"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-20T14:03:25.000Z","text":"RT @MHRAmedicines: MHRA and NHS England in initiative to simplify adverse incident reporting http://t.co/ClGjtUjBdR","lang":"en","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"446648208320892930","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"446646522441396224"}],"id":"446646591928410112","entities":{"hashtags":{},"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"urls":[{"start":108,"end":130,"url":"http://t.co/uLcQkrGi2h","expanded_url":"http://bit.ly/1fJJadc","display_url":"bit.ly/1fJJadc"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-20T13:57:00.000Z","text":"RT @WHO_Europe: Four-fold difference in antibiotic consumption across the European Region – new WHO report  http://t.co/uLcQkrGi2h","lang":"en","public_metrics":{"retweet_count":16,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"446646591928410112","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"446646271567478784"}],"id":"446646513742385152","entities":{"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":59,"end":81,"url":"http://t.co/gckn7cO1rh","expanded_url":"http://bit.ly/1ijaNyf","display_url":"bit.ly/1ijaNyf"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-20T13:56:41.000Z","text":"RT @EFPIA: Statins could treat advanced MS, study suggests http://t.co/gckn7cO1rh","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"446646513742385152","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"446641510118088704"}],"id":"446641824749596672","entities":{"hashtags":[{"start":72,"end":81,"tag":"Medicine"},{"start":101,"end":113,"tag":"antibiotics"}],"mentions":[{"start":3,"end":11,"username":"EPHA_EU","id":"184756856"}],"urls":{},"annotations":[{"start":24,"end":27,"probability":0.4519,"type":"Place","normalized_text":"MEPs"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-20T13:38:03.000Z","text":"RT @EPHA_EU: Meeting of MEPs (Group for Complementary &amp; Alternative #Medicine) Reducing need for #antibiotics- 1 April: http://t.co/UAHLrkF…","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"446641824749596672","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"446640603833458688"}],"id":"446640711094771712","entities":{"hashtags":[{"start":31,"end":34,"tag":"TB"},{"start":39,"end":43,"tag":"MDR"},{"start":95,"end":102,"tag":"TBChat"}],"mentions":[{"start":3,"end":17,"username":"WHO_Europe_TB","id":"920721606"}],"urls":[{"start":103,"end":125,"url":"http://t.co/54ZLrVzdRX","expanded_url":"http://www.euro.who.int/en/health-topics/communicable-diseases/tuberculosis/news/news/2014/03/outcomes-of-pharmacovigilance-training-workshop","display_url":"euro.who.int/en/health-topi…"}],"annotations":[{"start":86,"end":91,"probability":0.9925,"type":"Place","normalized_text":"Europe"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-20T13:33:38.000Z","text":"RT @WHO_Europe_TB: Outcomes of #TB and #MDR-TB pharmacovigilance training workshop in Europe | #TBChat http://t.co/54ZLrVzdRX","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"446640711094771712","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"446640371209347072"}],"id":"446640452532727809","entities":{"hashtags":{},"mentions":[{"start":3,"end":11,"username":"FDACBER","id":"303777686"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-20T13:32:36.000Z","text":"RT @FDACBER: Guidance for Industry: Allowable Excess Volume &amp; Labeled Vial Fill Size in Injectable Drug &amp; Biological Products   http://t.co…","lang":"en","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"446640452532727809","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"446638007093694464"}],"id":"446638080133718016","entities":{"hashtags":[{"start":54,"end":64,"tag":"medicines"}],"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"}],"urls":[{"start":108,"end":130,"url":"http://t.co/7MSp9XbFXp","expanded_url":"http://bit.ly/1g4miKd","display_url":"bit.ly/1g4miKd"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-20T13:23:11.000Z","text":"RT @EAHPtweet: EAHP's 2014 survey of the pan-European #medicines shortage situation now open! Closes 7 May. http://t.co/7MSp9XbFXp http://t…","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"446638080133718016","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"446637296071081985"}],"id":"446638055144058880","entities":{"hashtags":[{"start":80,"end":90,"tag":"Parkinson"}],"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-20T13:23:05.000Z","text":"RT @euparkinsons: Cerebrospinal fluid α-synuclein predicts cognitive decline in #Parkinson's disease progression in the datatop cohort: htt…","lang":"ro","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"446638055144058880","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"446631793178181632"}],"id":"446633748222988288","entities":{"hashtags":[{"start":13,"end":18,"tag":"EFSA"},{"start":46,"end":55,"tag":"Bernhard"},{"start":63,"end":68,"tag":"EFSA"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":[{"start":94,"end":116,"url":"http://t.co/oZigluNmW1","expanded_url":"http://bit.ly/1eVgM8y","display_url":"bit.ly/1eVgM8y"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-20T13:05:58.000Z","text":"RT @EFSA_EU: #EFSA Management Board nominates #Bernhard Url as #EFSA's new Executive Director http://t.co/oZigluNmW1","lang":"en","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"446633748222988288","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"446628508593188866"}],"id":"446629290256662528","entities":{"hashtags":{},"mentions":[{"start":3,"end":19,"username":"ESEndocrinology","id":"221055586"}],"urls":[{"start":111,"end":133,"url":"http://t.co/h8apfk4WqY","expanded_url":"http://ow.ly/uMoqk","display_url":"ow.ly/uMoqk"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-20T12:48:15.000Z","text":"RT @ESEndocrinology: Genetic testing may help select women with ER+ breast cancer for extended hormone therapy http://t.co/h8apfk4WqY","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"446629290256662528","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"446626024714149888"}],"id":"446629080868585472","entities":{"hashtags":[{"start":117,"end":126,"tag":"FDAvoice"}],"mentions":[{"start":3,"end":12,"username":"FDA_MCMi","id":"1606025952"}],"urls":[{"start":94,"end":116,"url":"http://t.co/bAUxKQOjLI","expanded_url":"http://ht.ly/uL1En","display_url":"ht.ly/uL1En"}],"annotations":[{"start":14,"end":16,"probability":0.9291,"type":"Organization","normalized_text":"FDA"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-20T12:47:25.000Z","text":"RT @FDA_MCMi: FDA’s new acting chief scientist talks about his role, and regulatory science \n http://t.co/bAUxKQOjLI #FDAvoice","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"446629080868585472","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","referenced_tweets":{},"id":"446623424228900864","entities":{"hashtags":{},"mentions":{},"urls":[{"start":70,"end":92,"url":"http://t.co/q987RFusP6","expanded_url":"http://svy.mk/OcE6HP","display_url":"svy.mk/OcE6HP"}],"annotations":[{"start":30,"end":36,"probability":0.7138,"type":"Product","normalized_text":"Twitter"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-20T12:24:56.000Z","text":"Give us your thoughts on this Twitter feed. Fill in our short survey: http://t.co/q987RFusP6","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"446623424228900864","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"446622803857780736"}],"id":"446623001455640576","entities":{"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":55,"end":77,"url":"http://t.co/Hctu9KzaIl","expanded_url":"http://bit.ly/1qZ2Bry","display_url":"bit.ly/1qZ2Bry"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-20T12:23:16.000Z","text":"RT @EFPIA: Resistant superbugs on the rise in children http://t.co/Hctu9KzaIl","lang":"en","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"446623001455640576","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"446622423497334785"}],"id":"446622583237390336","entities":{"hashtags":{},"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":[{"start":117,"end":139,"url":"http://t.co/Uej1Jk2PjD","expanded_url":"http://goo.gl/5TdsxD","display_url":"goo.gl/5TdsxD"}],"annotations":[{"start":26,"end":34,"probability":0.335,"type":"Organization","normalized_text":"EXPAND-TB"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-20T12:21:36.000Z","text":"RT @WHO: A project called EXPAND-TB helped to triple the number of MDR-TB cases diagnosed in participating countries http://t.co/Uej1Jk2PjD","lang":"en","public_metrics":{"retweet_count":44,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"446622583237390336","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"446622025121947648"}],"id":"446622467705286656","entities":{"hashtags":{},"mentions":[{"start":3,"end":14,"username":"Berlaymont","id":"19003991"}],"urls":[{"start":47,"end":69,"url":"http://t.co/9qvRuwS1Zz","expanded_url":"http://bit.ly/1oyZww0","display_url":"bit.ly/1oyZww0"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-20T12:21:08.000Z","text":"RT @Berlaymont: Human Brain project got bigger http://t.co/9qvRuwS1Zz","lang":"en","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"446622467705286656","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"446617746403774464"}],"id":"446620591697956864","entities":{"hashtags":[{"start":95,"end":113,"tag":"pharmacovigilance"},{"start":114,"end":124,"tag":"alltrials"}],"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"},{"start":19,"end":28,"username":"EMA_News","id":"116716199"}],"urls":[{"start":71,"end":93,"url":"http://t.co/SpDQij4Rvf","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages%2Fnews_and_events%2Fnews%2F2014%2F03%2Fnews_detail_002045.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-20T12:13:41.000Z","text":"RT @EAHPtweet: The @EMA_News has published its work programme for 2014 http://t.co/SpDQij4Rvf  #pharmacovigilance #alltrials #falsifiedmedi…","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"446620591697956864","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"446610027517050880"}],"id":"446618986495877120","entities":{"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":51,"end":65,"username":"EU_Commission","id":"157981564"}],"urls":[{"start":66,"end":88,"url":"http://t.co/BxqSxDr8Mn","expanded_url":"http://bit.ly/NwM0vd","display_url":"bit.ly/NwM0vd"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-20T12:07:18.000Z","text":"RT @EFPIA: The Human Brain Project just got bigger @EU_Commission http://t.co/BxqSxDr8Mn","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"446618986495877120","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"446605270895304704"}],"id":"446618361464913920","entities":{"hashtags":[{"start":47,"end":60,"tag":"tuberculosis"},{"start":80,"end":83,"tag":"TB"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":[{"start":110,"end":132,"url":"http://t.co/VHugBv7PJI","expanded_url":"http://goo.gl/8SaQpg","display_url":"goo.gl/8SaQpg"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-20T12:04:49.000Z","text":"RT @WHO: New technologies can rapidly diagnose #tuberculosis and drug-resistant #TB in as little as two hours http://t.co/VHugBv7PJI","lang":"en","public_metrics":{"retweet_count":92,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"446618361464913920","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"446604455891701760"}],"id":"446618258872213504","entities":{"hashtags":[{"start":42,"end":59,"tag":"Trypanosomatidic"}],"mentions":[{"start":3,"end":12,"username":"myCORDIS","id":"818505470608572416"},{"start":95,"end":108,"username":"UNIMORE_univ","id":"166888600"}],"urls":[{"start":71,"end":93,"url":"http://t.co/OrtRRyvXVt","expanded_url":"http://cordis.europa.eu/news/rcn/36486_en.html","display_url":"cordis.europa.eu/news/rcn/36486…"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-20T12:04:25.000Z","text":"RT @myCORDIS: Drugs improvement to combat #Trypanosomatidic infections http://t.co/OrtRRyvXVt \n@UNIMORE_univ","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"446618258872213504","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"446599806451212288"}],"id":"446618024574205952","entities":{"hashtags":[{"start":83,"end":92,"tag":"research"},{"start":93,"end":107,"tag":"digitalagenda"}],"mentions":[{"start":3,"end":17,"username":"EU_Commission","id":"157981564"},{"start":108,"end":122,"username":"NeelieKroesEU","id":"159950527"}],"urls":[{"start":60,"end":82,"url":"http://t.co/jNiy7PAn3p","expanded_url":"http://europa.eu/!kd34td","display_url":"europa.eu/!kd34td"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-20T12:03:29.000Z","text":"RT @EU_Commission: The Human Brain Project just got bigger! http://t.co/jNiy7PAn3p #research #digitalagenda @NeelieKroesEU","lang":"en","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"446618024574205952","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","referenced_tweets":{},"id":"446602434979586048","entities":{"hashtags":[{"start":60,"end":78,"tag":"adaptivelicensing"}],"mentions":{},"urls":[{"start":80,"end":102,"url":"http://t.co/1Xwzb9QxYp","expanded_url":"http://bit.ly/1fHHbWC","display_url":"bit.ly/1fHHbWC"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-20T11:01:32.000Z","text":"We're inviting companies to take part in a pilot project on #adaptivelicensing: http://t.co/1Xwzb9QxYp","lang":"en","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"446602434979586048","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"446589491545772032"}],"id":"446596155515084800","entities":{"hashtags":{},"mentions":[{"start":3,"end":19,"username":"ESEndocrinology","id":"221055586"}],"urls":[{"start":90,"end":112,"url":"http://t.co/aThCZlWc0v","expanded_url":"http://ow.ly/uMok4","display_url":"ow.ly/uMok4"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-20T10:36:35.000Z","text":"RT @ESEndocrinology: In the news; Diabetes researchers track cells' ability to regenerate http://t.co/aThCZlWc0v","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"446596155515084800","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"446589231096672256"}],"id":"446596060103081984","entities":{"hashtags":[{"start":17,"end":28,"tag":"DidYouKnow"},{"start":97,"end":112,"tag":"sustainability"},{"start":113,"end":124,"tag":"employment"}],"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"}],"urls":{},"annotations":[{"start":33,"end":34,"probability":0.8291,"type":"Organization","normalized_text":"EU"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-20T10:36:12.000Z","text":"RT @egagenerics: #DidYouKnow the EU has 1000 generics companies with more than 150,000 employees #sustainability #employment","lang":"en","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"446596060103081984","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"446588789431885825"}],"id":"446595974375694337","entities":{"hashtags":{},"mentions":[{"start":3,"end":14,"username":"Berlaymont","id":"19003991"}],"urls":[{"start":56,"end":78,"url":"http://t.co/MQgneddv6Z","expanded_url":"http://bit.ly/1oywxIN","display_url":"bit.ly/1oywxIN"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-20T10:35:52.000Z","text":"RT @Berlaymont: The Human Brain Project just got bigger http://t.co/MQgneddv6Z","lang":"en","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"446595974375694337","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"446588263629746176"}],"id":"446595847779024896","entities":{"hashtags":{},"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-20T10:35:22.000Z","text":"RT @WHO: Almost half a million people fell ill w/ multidrug-resistant TB in 2012 - less than 1 in 4 of these ppl was diagnosed http://t.co/…","lang":"en","public_metrics":{"retweet_count":201,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"446595847779024896","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":{},"id":"446595689599221760","entities":{"hashtags":{},"mentions":[{"start":3,"end":12,"username":"agesnews","id":"223456379"},{"start":113,"end":127,"username":"VPH_Institute","id":"718101349"},{"start":128,"end":139,"username":"EU_eHealth","id":"931560712484343810"}],"urls":[{"start":90,"end":112,"url":"http://t.co/mNgGQrrHQT","expanded_url":"http://bit.ly/OzR8zO","display_url":"bit.ly/OzR8zO"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-20T10:34:44.000Z","text":"RT @agesnews: EU project: carrying out clinical trials without tests on animals or humans http://t.co/mNgGQrrHQT @VPH_Institute @EU_eHealth","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":3,"quote_count":0},"conversation_id":"446595689599221760","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":{},"id":"446594917490769920","entities":{"hashtags":{},"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"urls":[{"start":39,"end":61,"url":"http://t.co/I6I3OUFfKg","expanded_url":"http://bit.ly/OzQHWj","display_url":"bit.ly/OzQHWj"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-20T10:31:40.000Z","text":"RT @LV_MPA: 2014 Pharmacovigilance Day http://t.co/I6I3OUFfKg","lang":"en","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"446594917490769920","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":{},"id":"446594636019412992","entities":{"hashtags":[{"start":45,"end":57,"tag":"sideeffects"}],"mentions":[{"start":3,"end":12,"username":"agesnews","id":"223456379"}],"urls":[{"start":118,"end":140,"url":"http://t.co/yym5AWPL0X","expanded_url":"http://bit.ly/1kL87tZ","display_url":"bit.ly/1kL87tZ"}],"annotations":[{"start":17,"end":23,"probability":0.9909,"type":"Place","normalized_text":"Austria"},{"start":78,"end":91,"probability":0.4758,"type":"Organization","normalized_text":"Federal Office"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-20T10:30:33.000Z","text":"RT @agesnews: In Austria patients can report #sideeffects to medicines to the Federal Office for Safety in Healthcare http://t.co/yym5AWPL0X","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"446594636019412992","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":{},"id":"446594128877735936","entities":{"hashtags":{},"mentions":[{"start":3,"end":12,"username":"agesnews","id":"223456379"}],"urls":[{"start":84,"end":106,"url":"http://t.co/F8VHxZd8t9","expanded_url":"http://bit.ly/OzQfqM","display_url":"bit.ly/OzQfqM"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-20T10:28:32.000Z","text":"RT @agesnews: The meaning of the black triangle on the package leaflet of medicines http://t.co/F8VHxZd8t9","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"446594128877735936","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":{},"id":"446593875394977792","entities":{"hashtags":{},"mentions":[{"start":3,"end":12,"username":"agesnews","id":"223456379"}],"urls":[{"start":86,"end":108,"url":"http://t.co/PsGju40ttr","expanded_url":"http://bit.ly/1kL7Bwc","display_url":"bit.ly/1kL7Bwc"},{"start":109,"end":131,"url":"http://t.co/nEeuXfLyIp","expanded_url":"http://bit.ly/OzQ3YK","display_url":"bit.ly/OzQ3YK"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-20T10:27:31.000Z","text":"RT @agesnews: New symbol on medicines under additional monitoring - ORF Heute Konkret http://t.co/PsGju40ttr http://t.co/nEeuXfLyIp","lang":"da","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"446593875394977792","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","referenced_tweets":{},"id":"446571798948499456","entities":{"hashtags":{},"mentions":{},"urls":[{"start":93,"end":115,"url":"http://t.co/q987RFusP6","expanded_url":"http://svy.mk/OcE6HP","display_url":"svy.mk/OcE6HP"}],"annotations":[{"start":18,"end":24,"probability":0.682,"type":"Product","normalized_text":"Twitter"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-20T08:59:48.000Z","text":"Help us make this Twitter feed better. Tell us what you need by completing our quick survey: http://t.co/q987RFusP6","lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"446571798948499456","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"446569606212513793"}],"id":"446571401106165760","entities":{"hashtags":[{"start":99,"end":110,"tag":"PharmaJobs"},{"start":111,"end":118,"tag":"Pharma"},{"start":119,"end":129,"tag":"Vacancies"},{"start":130,"end":133,"tag":"EU"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":76,"end":98,"url":"http://t.co/2VHBhFfPoU","expanded_url":"http://bit.ly/1j4VAQo","display_url":"bit.ly/1j4VAQo"}],"annotations":[{"start":51,"end":74,"probability":0.6719,"type":"Organization","normalized_text":"EFPIA Government Affairs"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-20T08:58:13.000Z","text":"RT @EFPIA: EFPIA is Recruiting! Assistant Manager, EFPIA Government Affairs http://t.co/2VHBhFfPoU #PharmaJobs #Pharma #Vacancies #EU","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"446571401106165760","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"446565642616176640"}],"id":"446571291190243328","entities":{"hashtags":[{"start":32,"end":47,"tag":"clinicaltrials"},{"start":88,"end":96,"tag":"eHealth"},{"start":130,"end":139,"tag":"Avicenna"}],"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"}],"urls":[{"start":106,"end":129,"url":"https://t.co/y6kmAnka5A","expanded_url":"https://ec.europa.eu/digital-agenda/news-redirect/15098","display_url":"ec.europa.eu/digital-agenda…"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-20T08:57:47.000Z","text":"RT @EU_eHealth: Revolutionising #clinicaltrials: No more tests on animals or humans but #eHealth instead- https://t.co/y6kmAnka5A #Avicenna…","lang":"en","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"446571291190243328","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"replied_to","id":"446427707447197698"}],"id":"446570997068873728","entities":{"hashtags":{},"mentions":{},"urls":[{"start":65,"end":87,"url":"http://t.co/1ZfEj0gY24","expanded_url":"http://bit.ly/X4lXwT","display_url":"bit.ly/X4lXwT"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-20T08:56:37.000Z","text":"@BayAreaBethany Please could you send us a follow-up message via http://t.co/1ZfEj0gY24 and we'll look into it.","lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"446427707447197698","attachments":{"media_keys":{}},"in_reply_to_user_id":"25438493"},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"446343322517258240"}],"id":"446345108334837760","entities":{"hashtags":[{"start":63,"end":74,"tag":"hantavirus"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"urls":[{"start":102,"end":124,"url":"http://t.co/VEfBv4LzGE","expanded_url":"http://bit.ly/1eSuvNb","display_url":"bit.ly/1eSuvNb"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-19T17:59:01.000Z","text":"RT @ECDC_EU: How European countries prevent and communicate on #hantavirus infection? New ECDC study: http://t.co/VEfBv4LzGE","lang":"en","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"446345108334837760","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":{},"id":"446345019608547328","entities":{"hashtags":{},"mentions":{},"urls":[{"start":74,"end":96,"url":"http://t.co/q987RFusP6","expanded_url":"http://svy.mk/OcE6HP","display_url":"svy.mk/OcE6HP"}],"annotations":[{"start":29,"end":35,"probability":0.747,"type":"Product","normalized_text":"Twitter"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-19T17:58:40.000Z","text":"Give us your feedback on our Twitter feed by completing our quick survey: http://t.co/q987RFusP6","lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"446345019608547328","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":{},"id":"446341608154222592","entities":{"hashtags":{},"mentions":{},"urls":[{"start":45,"end":67,"url":"http://t.co/eUnmdmAlMF","expanded_url":"http://bit.ly/1eRjL1K","display_url":"bit.ly/1eRjL1K"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-19T17:45:06.000Z","text":"We've published our work programme for 2014: http://t.co/eUnmdmAlMF","lang":"en","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":5,"quote_count":0},"conversation_id":"446341608154222592","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","referenced_tweets":{},"id":"446328001979248641","entities":{"hashtags":[{"start":60,"end":78,"tag":"adaptivelicensing"}],"mentions":{},"urls":[{"start":80,"end":102,"url":"http://t.co/1Xwzb9QxYp","expanded_url":"http://bit.ly/1fHHbWC","display_url":"bit.ly/1fHHbWC"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-19T16:51:02.000Z","text":"We're inviting companies to take part in a pilot project on #adaptivelicensing: http://t.co/1Xwzb9QxYp","lang":"en","public_metrics":{"retweet_count":8,"reply_count":2,"like_count":6,"quote_count":0},"conversation_id":"446328001979248641","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"446252764809932800"}],"id":"446253404953018368","entities":{"hashtags":[{"start":68,"end":75,"tag":"asthma"}],"mentions":[{"start":3,"end":16,"username":"EuropeanLung","id":"121759520"},{"start":114,"end":129,"username":"Reuters_Health","id":"25562183"}],"urls":[{"start":87,"end":109,"url":"http://t.co/OK9CWegsv2","expanded_url":"http://bit.ly/1j2Pjc9","display_url":"bit.ly/1j2Pjc9"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-19T11:54:37.000Z","text":"RT @EuropeanLung: Drugs companies are working to develop new severe #asthma treatments http://t.co/OK9CWegsv2 via @Reuters_Health","lang":"en","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"446253404953018368","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":{},"id":"446244263559712769","entities":{"hashtags":{},"mentions":{},"urls":[{"start":75,"end":97,"url":"http://t.co/q987RFusP6","expanded_url":"http://svy.mk/OcE6HP","display_url":"svy.mk/OcE6HP"}],"annotations":[{"start":38,"end":44,"probability":0.6187,"type":"Product","normalized_text":"Twitter"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-19T11:18:17.000Z","text":"Help us offer you the best service on Twitter by filling our quick survey: http://t.co/q987RFusP6","lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"446244263559712769","attachments":{"media_keys":{}}},{"source":"bitly bitlink","referenced_tweets":{},"id":"446241538155491328","entities":{"hashtags":{},"mentions":{},"urls":[{"start":92,"end":114,"url":"http://t.co/f8YBHubEVn","expanded_url":"http://bit.ly/1eRjL1K","display_url":"bit.ly/1eRjL1K"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-19T11:07:28.000Z","text":"We've published our work programme for this year. Read about our priorities and objectives: http://t.co/f8YBHubEVn","lang":"en","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"446241538155491328","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"446213388537167872"}],"id":"446237967599026177","entities":{"hashtags":[{"start":35,"end":38,"tag":"EU"}],"mentions":[{"start":3,"end":13,"username":"EUCouncil","id":"206717989"}],"urls":[{"start":94,"end":116,"url":"http://t.co/9GpK7qBUL9","expanded_url":"http://ow.ly/uHGDX","display_url":"ow.ly/uHGDX"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-19T10:53:16.000Z","text":"RT @EUCouncil: Do you know how new #EU laws are adopted? Visit the new section of our website http://t.co/9GpK7qBUL9  Feedback appreciated!…","lang":"en","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"446237967599026177","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"446220062437818368"}],"id":"446237486642372608","entities":{"hashtags":[{"start":28,"end":35,"tag":"eahp14"}],"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"}],"urls":[{"start":107,"end":129,"url":"http://t.co/aBwv0lKuXx","expanded_url":"http://bit.ly/1ek5UUT","display_url":"bit.ly/1ek5UUT"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-19T10:51:22.000Z","text":"RT @EAHPtweet: 7 days until #eahp14! Here's 7 key programme features to check out. Still time to register! http://t.co/aBwv0lKuXx http://t.…","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"446237486642372608","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"446220865819009024"}],"id":"446237404278837248","entities":{"hashtags":[{"start":49,"end":55,"tag":"ECE14"}],"mentions":[{"start":3,"end":19,"username":"ESEndocrinology","id":"221055586"}],"urls":[{"start":117,"end":139,"url":"http://t.co/f97OXbQgvB","expanded_url":"http://bit.ly/1f7PoFP","display_url":"bit.ly/1f7PoFP"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-19T10:51:02.000Z","text":"RT @ESEndocrinology: Are you an endocrine nurse? #ECE14 includes three sessions specifically for you - find out more http://t.co/f97OXbQgvB","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"446237404278837248","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"446227495009153024"}],"id":"446237212355887104","entities":{"hashtags":{},"mentions":[{"start":3,"end":13,"username":"TOPRANEWS","id":"26739900"}],"urls":[{"start":114,"end":136,"url":"http://t.co/GHoN17bx2Q","expanded_url":"http://bit.ly/1lNQg5s","display_url":"bit.ly/1lNQg5s"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-19T10:50:16.000Z","text":"RT @TOPRANEWS: New Regulatory Rapporteur examines initiatives for transparency in regulatory affairs. Read online http://t.co/GHoN17bx2Q #r…","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"446237212355887104","attachments":{"media_keys":{}}},{"source":"Twitter for iPhone","referenced_tweets":[{"type":"retweeted","id":"445982344047230976"}],"id":"445996347301568512","entities":{"hashtags":{},"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-18T18:53:10.000Z","text":"RT @FDAanimalhealth: Agency Information Collection: Designation of New Animal Drugs for Minor Use or Minor Species, Final Rule http://t.co/…","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"445996347301568512","attachments":{"media_keys":{}}},{"source":"Twitter for iPhone","referenced_tweets":[{"type":"retweeted","id":"445981003900026881"}],"id":"445996159652601857","entities":{"hashtags":{},"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"urls":[{"start":89,"end":111,"url":"http://t.co/Y6m7QXAQII","expanded_url":"http://bit.ly/hN7hpR","display_url":"bit.ly/hN7hpR"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-18T18:52:25.000Z","text":"RT @FDAanimalhealth: Final Rules, Confidentiality of Data and Information in a NADA File http://t.co/Y6m7QXAQII","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"445996159652601857","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"445957664892538880"}],"id":"445958099833462785","entities":{"hashtags":{},"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"urls":[{"start":102,"end":124,"url":"http://t.co/06AvU65Cpv","expanded_url":"http://ow.ly/uId8T","display_url":"ow.ly/uId8T"}],"annotations":[{"start":38,"end":46,"probability":0.8161,"type":"Person","normalized_text":"J. Larkin"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-18T16:21:11.000Z","text":"RT @myESMO: ESMOChannel: Interview w/ J. Larkin. Inhibition of MEK to Treat Cancer: Focus on Melanoma http://t.co/06AvU65Cpv","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"445958099833462785","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"445952504959082497"}],"id":"445954527884492800","entities":{"hashtags":{},"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"urls":[{"start":102,"end":124,"url":"http://t.co/lytI1los2c","expanded_url":"http://go.usa.gov/KQyz","display_url":"go.usa.gov/KQyz","images":[{"url":"https://pbs.twimg.com/news_img/1482023485236924418/_GtmjTJA?format=png&name=orig","width":1200,"height":675},{"url":"https://pbs.twimg.com/news_img/1482023485236924418/_GtmjTJA?format=png&name=150x150","width":150,"height":150}],"status":200,"title":"FDA Voices: Perspectives From FDA Leadership and Experts","description":"Insights from FDA leadership and experts into the agency's work in the following topic areas.","unwound_url":"https://www.fda.gov/news-events/fda-newsroom/fda-voices"}],"annotations":[{"start":24,"end":36,"probability":0.3283,"type":"Organization","normalized_text":"FDAVoice Blog"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-18T16:06:59.000Z","text":"RT @US_FDA: Latest from FDAVoice Blog: Harnessing the power of databases to evaluate medical products http://t.co/lytI1los2c","lang":"en","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"445954527884492800","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"445951297116598272"}],"id":"445951719730855936","entities":{"hashtags":[{"start":19,"end":32,"tag":"Tuberculosis"},{"start":64,"end":71,"tag":"Europe"},{"start":113,"end":120,"tag":"TBChat"}],"mentions":[{"start":3,"end":17,"username":"WHO_Europe_TB","id":"920721606"}],"urls":[{"start":89,"end":111,"url":"http://t.co/8ZV0Qq2ad7","expanded_url":"http://www.euro.who.int/en/health-topics/communicable-diseases/tuberculosis/publications/2014/tuberculosis-surveillance-and-monitoring-in-europe-2014","display_url":"euro.who.int/en/health-topi…"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-18T15:55:50.000Z","text":"RT @WHO_Europe_TB: #Tuberculosis surveillance and monitoring in #Europe 2014 is out now  http://t.co/8ZV0Qq2ad7 |#TBChat","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"445951719730855936","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"445951123598622721"}],"id":"445951623580614656","entities":{"hashtags":[{"start":15,"end":25,"tag":"EU4Health"},{"start":45,"end":53,"tag":"HIVAIDS"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"urls":{},"annotations":[{"start":27,"end":30,"probability":0.8394,"type":"Person","normalized_text":"Rapp"},{"start":33,"end":43,"probability":0.9719,"type":"Person","normalized_text":"J. Lundgren"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-18T15:55:27.000Z","text":"RT @EU_Health: #EU4Health: Rapp, J. Lundgren #HIVAIDS session: discrimination key issue, co-morbidities problematic, treatment is public #h…","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"445951623580614656","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"445950913359122433"}],"id":"445951564038295552","entities":{"hashtags":[{"start":32,"end":45,"tag":"tuberculosis"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-18T15:55:12.000Z","text":"RT @ECDC_EU: How to improve MDR #tuberculosis treatment outcomes? Case studies in 4 EU countries lists key health system factors http://t.c…","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"445951564038295552","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"445947930608824321"}],"id":"445948953612541952","entities":{"hashtags":[{"start":17,"end":20,"tag":"TB"}],"mentions":[{"start":3,"end":11,"username":"ECDC_TB","id":"1282878908"}],"urls":{},"annotations":[{"start":50,"end":51,"probability":0.8778,"type":"Place","normalized_text":"EU"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-18T15:44:50.000Z","text":"RT @ECDC_TB: New #TB report: notification rate in EU is now 13.5 per 100000 population, target of average 5yr decline is achieved http://t.…","lang":"en","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"445948953612541952","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"445947785188089857"}],"id":"445948861337841664","entities":{"hashtags":[{"start":32,"end":45,"tag":"Tuberculosis"},{"start":98,"end":105,"tag":"TBChat"}],"mentions":[{"start":3,"end":17,"username":"WHO_Europe_TB","id":"920721606"}],"urls":[{"start":73,"end":95,"url":"http://t.co/IYKvf7ODTj","expanded_url":"http://www.euro.who.int/en/media-centre/sections/fact-sheets/2014/fact-sheet-tuberculosis-in-the-who-european-region","display_url":"euro.who.int/en/media-centr…"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-18T15:44:28.000Z","text":"RT @WHO_Europe_TB: Fact sheet - #Tuberculosis in the WHO European Region http://t.co/IYKvf7ODTj | #TBChat","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"445948861337841664","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"445947493365215232"}],"id":"445948791330721792","entities":{"hashtags":[{"start":48,"end":61,"tag":"Tuberculosis"},{"start":71,"end":78,"tag":"WTBD14"},{"start":120,"end":127,"tag":"TBChat"}],"mentions":[{"start":3,"end":17,"username":"WHO_Europe_TB","id":"920721606"},{"start":28,"end":39,"username":"WHO_Europe","id":"125403342"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-18T15:44:11.000Z","text":"RT @WHO_Europe_TB: Event at @WHO_Europe - World #Tuberculosis Day 2014 #WTBD14: boost efforts to eliminate TB by 2050 | #TBChat http://t.co…","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"445948791330721792","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"445939717734170624"}],"id":"445940257612398594","entities":{"hashtags":[{"start":40,"end":44,"tag":"HIV"},{"start":47,"end":52,"tag":"Aids"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":65,"end":87,"url":"http://t.co/yNVXkhFHxL","expanded_url":"http://bit.ly/1egBTFs","display_url":"bit.ly/1egBTFs"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-18T15:10:17.000Z","text":"RT @EFPIA: European Commission sets out #HIV / #Aids action plan http://t.co/yNVXkhFHxL","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"445940257612398594","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"445921157997658112"}],"id":"445933737424207872","entities":{"hashtags":[{"start":16,"end":19,"tag":"TB"},{"start":126,"end":135,"tag":"WTBD2014"}],"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"urls":[{"start":103,"end":125,"url":"http://t.co/g7uvhNw5Tg","expanded_url":"http://bit.ly/OszDRV","display_url":"bit.ly/OszDRV"}],"annotations":[{"start":46,"end":51,"probability":0.965,"type":"Place","normalized_text":"Europe"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-18T14:44:22.000Z","text":"RT @WHO_Europe: #TB cases down 5% each yr but Europe failing to cure most multidrug-resistant patients http://t.co/g7uvhNw5Tg #WTBD2014","lang":"en","public_metrics":{"retweet_count":16,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"445933737424207872","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":{},"id":"445933553747251200","entities":{"hashtags":[{"start":32,"end":38,"tag":"foods"},{"start":43,"end":54,"tag":"mediciness"}],"mentions":[{"start":3,"end":16,"username":"FDAenEspanol","id":"570148387"}],"urls":[{"start":91,"end":113,"url":"http://t.co/yJcS2WoQiG","expanded_url":"http://bit.ly/1fF4Nes","display_url":"bit.ly/1fF4Nes"},{"start":114,"end":136,"url":"http://t.co/fZU51qh7wy","expanded_url":"http://bit.ly/1iZ98RO","display_url":"bit.ly/1iZ98RO"}],"annotations":[{"start":84,"end":89,"probability":0.5338,"type":"Organization","normalized_text":"Flickr"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-18T14:43:38.000Z","text":"RT @FDAenEspanol: See photos of #foods and #mediciness withdrawn from the market on Flickr http://t.co/yJcS2WoQiG http://t.co/fZU51qh7wy","lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"445933553747251200","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":{},"id":"445932927139213312","entities":{"hashtags":[{"start":37,"end":45,"tag":"Doribax"}],"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"urls":[{"start":118,"end":140,"url":"http://t.co/NWL7PVe6T1","expanded_url":"http://1.usa.gov/1icPmyw","display_url":"1.usa.gov/1icPmyw"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-18T14:41:09.000Z","text":"RT @FDA_Drug_Info: Label changes for #Doribax / doripenem, increased risk of death patients w pneumonia on respirator http://t.co/NWL7PVe6T1","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"445932927139213312","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"445917052231237632"}],"id":"445932087854788608","entities":{"hashtags":[{"start":63,"end":67,"tag":"FDA"}],"mentions":[{"start":3,"end":12,"username":"FDA_MCMi","id":"1606025952"}],"urls":[{"start":79,"end":101,"url":"http://t.co/EN6pMEN4sE","expanded_url":"http://ht.ly/uHLA2","display_url":"ht.ly/uHLA2"}],"annotations":[{"start":71,"end":76,"probability":0.416,"type":"Organization","normalized_text":"Flickr"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-18T14:37:49.000Z","text":"RT @FDA_MCMi: Need a quick way to check for recalled products? #FDA on Flickr: http://t.co/EN6pMEN4sE","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"445932087854788608","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":{},"id":"445904925856636929","entities":{"hashtags":{},"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"urls":[{"start":105,"end":127,"url":"http://t.co/GwLqGk67ap","expanded_url":"http://bit.ly/1fVPins","display_url":"bit.ly/1fVPins"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-18T12:49:53.000Z","text":"RT @INFARMED_IP: Prior assessment of medicinal products for human use for use in a hospital environment. http://t.co/GwLqGk67ap","lang":"en","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"445904925856636929","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"445899025783730176"}],"id":"445899115969671168","entities":{"hashtags":[{"start":13,"end":26,"tag":"Tuberculosis"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"urls":[{"start":114,"end":136,"url":"http://t.co/dHsUVxJToR","expanded_url":"http://bit.ly/1kZTohl","display_url":"bit.ly/1kZTohl"}],"annotations":[{"start":47,"end":48,"probability":0.8799,"type":"Place","normalized_text":"EU"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-18T12:26:48.000Z","text":"RT @ECDC_EU: #Tuberculosis cases going down in EU but only 1 in 3 MDR TB patients finishes treatment successfully http://t.co/dHsUVxJToR #W…","lang":"en","public_metrics":{"retweet_count":17,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"445899115969671168","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","referenced_tweets":{},"id":"445895915279495168","entities":{"hashtags":{},"mentions":{},"urls":[{"start":88,"end":110,"url":"http://t.co/q987RFusP6","expanded_url":"http://svy.mk/OcE6HP","display_url":"svy.mk/OcE6HP"}],"annotations":[{"start":18,"end":24,"probability":0.6458,"type":"Product","normalized_text":"Twitter"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-18T12:14:05.000Z","text":"Help us make this Twitter feed meet your needs better. Complete our five-minute survey: http://t.co/q987RFusP6","lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"445895915279495168","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","referenced_tweets":{},"id":"445895612379430912","entities":{"hashtags":[{"start":35,"end":43,"tag":"vacancy"},{"start":89,"end":101,"tag":"recruitment"}],"mentions":{},"urls":[{"start":65,"end":87,"url":"http://t.co/gRheJ2j2uB","expanded_url":"http://bit.ly/1fxYYQt","display_url":"bit.ly/1fxYYQt"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-18T12:12:52.000Z","text":"Just one day left to apply for our #vacancy for a Legal Officer: http://t.co/gRheJ2j2uB  #recruitment","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"445895612379430912","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"445889131709992960"}],"id":"445891132648865792","entities":{"hashtags":[{"start":37,"end":50,"tag":"tuberculosis"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-18T11:55:05.000Z","text":"RT @ECDC_EU: In 2012, 68423 cases of #tuberculosis were reported in the EU, a 6% decrease compared to 2011, shows new report http://t.co/Ap…","lang":"en","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"445891132648865792","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","referenced_tweets":{},"id":"445872958704476160","entities":{"hashtags":{},"mentions":{},"urls":[{"start":77,"end":99,"url":"http://t.co/q987RFusP6","expanded_url":"http://svy.mk/OcE6HP","display_url":"svy.mk/OcE6HP"}],"annotations":[{"start":37,"end":43,"probability":0.7697,"type":"Product","normalized_text":"Twitter"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-18T10:42:51.000Z","text":"Do you have any suggestions for this Twitter feed? Fill in our quick survey: http://t.co/q987RFusP6","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"445872958704476160","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","referenced_tweets":{},"id":"445872701497151488","entities":{"hashtags":[{"start":29,"end":37,"tag":"vacancy"},{"start":83,"end":95,"tag":"recruitment"}],"mentions":{},"urls":[{"start":59,"end":81,"url":"http://t.co/gRheJ2j2uB","expanded_url":"http://bit.ly/1fxYYQt","display_url":"bit.ly/1fxYYQt"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-18T10:41:50.000Z","text":"Last chance to apply for our #vacancy for a Legal Officer: http://t.co/gRheJ2j2uB  #recruitment","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"445872701497151488","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":{},"id":"445871824807940096","entities":{"hashtags":{},"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"urls":[{"start":115,"end":137,"url":"http://t.co/8Px7Jd4RGB","expanded_url":"http://bit.ly/1nAp6nj","display_url":"bit.ly/1nAp6nj"}],"annotations":[{"start":90,"end":113,"probability":0.5453,"type":"Organization","normalized_text":"Italian Medicines Agency"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-18T10:38:21.000Z","text":"RT @Aifa_ufficiale: Avastin - Lucentis: Position of the Italian Society of Pharmacology | Italian Medicines Agency http://t.co/8Px7Jd4RGB","lang":"en","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":3,"quote_count":0},"conversation_id":"445871824807940096","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"445866828670439424"}],"id":"445871269389815808","entities":{"hashtags":[{"start":110,"end":122,"tag":"RegAwards14"},{"start":123,"end":134,"tag":"regaffairs"}],"mentions":[{"start":3,"end":13,"username":"TOPRANEWS","id":"26739900"}],"urls":[{"start":87,"end":109,"url":"http://t.co/ZhRSQSTxNR","expanded_url":"http://bit.ly/1iZCET3","display_url":"bit.ly/1iZCET3"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-18T10:36:09.000Z","text":"RT @TOPRANEWS: Nominations are now open for the 2014 Awards for Regulatory Excellence: http://t.co/ZhRSQSTxNR #RegAwards14 #regaffairs","lang":"en","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"445871269389815808","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"445861038958055424"}],"id":"445870692664631297","entities":{"hashtags":[{"start":42,"end":59,"tag":"pancreaticCancer"},{"start":70,"end":73,"tag":"EU"}],"mentions":[{"start":3,"end":12,"username":"cancereu","id":"140344419"},{"start":102,"end":117,"username":"HCPhealthindex","id":"110945817"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-18T10:33:51.000Z","text":"RT @cancereu: Want to know more about how #pancreaticCancer affecting #EU and what can be done? Check @HCPhealthindex latest report http://…","lang":"en","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"445870692664631297","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"445860270372818944"}],"id":"445870648490213377","entities":{"hashtags":{},"mentions":[{"start":3,"end":13,"username":"HAIEurope","id":"3314634701"}],"urls":{},"annotations":[{"start":38,"end":51,"probability":0.4885,"type":"Organization","normalized_text":"EU-US TradeAgr"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-18T10:33:41.000Z","text":"RT @HAIEurope: HAI raises concerns at EU-US TradeAgr' conference re.pharma wish for clinical trial data to be 'trade secret'. webcam:http:/…","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"445870648490213377","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"445859607161102336"}],"id":"445870491388362752","entities":{"hashtags":{},"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"urls":[{"start":59,"end":82,"url":"https://t.co/PdjcIx2ARg","expanded_url":"https://www.jobs.nhs.uk/xi/vacancy/02036524dd37cc5202c4b732f5f9cd31/?vac_ref=913336260","display_url":"jobs.nhs.uk/xi/vacancy/020…"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-18T10:33:03.000Z","text":"RT @NICEcomms: NICE is looking for a web editor. More info https://t.co/PdjcIx2ARg","lang":"en","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"445870491388362752","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"445858934042001408"}],"id":"445869345533853696","entities":{"hashtags":[{"start":23,"end":33,"tag":"Pinterest"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":72,"end":78,"username":"EFPIA","id":"52084584"}],"urls":[{"start":106,"end":128,"url":"http://t.co/MKghsORwgi","expanded_url":"http://bit.ly/1mf9vYF","display_url":"bit.ly/1mf9vYF"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-18T10:28:30.000Z","text":"RT @EFPIA: EFPIA's new #Pinterest board on Conferences / Events - Tweet @efpia and we'll add your photos! http://t.co/MKghsORwgi http://t.c…","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"445869345533853696","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"445858175213142016"}],"id":"445869190462058496","entities":{"hashtags":[{"start":52,"end":69,"tag":"pancreaticCancer"}],"mentions":[{"start":3,"end":12,"username":"cancereu","id":"140344419"},{"start":26,"end":41,"username":"HCPhealthindex","id":"110945817"}],"urls":[{"start":71,"end":93,"url":"http://t.co/frvfTU5aTS","expanded_url":"http://ow.ly/uHgIB","display_url":"ow.ly/uHgIB"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-18T10:27:53.000Z","text":"RT @cancereu: Here is the @HCPhealthindex report on #pancreaticCancer: http://t.co/frvfTU5aTS","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"445869190462058496","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"445855951820951552"}],"id":"445868920587943936","entities":{"hashtags":[{"start":97,"end":108,"tag":"pharmajobs"},{"start":109,"end":117,"tag":"vacancy"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":73,"end":95,"url":"http://t.co/6kkB8ZAJLx","expanded_url":"http://bit.ly/1i91KQ6","display_url":"bit.ly/1i91KQ6"}],"annotations":[{"start":40,"end":63,"probability":0.5539,"type":"Organization","normalized_text":"EFPIA Government Affairs"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-18T10:26:49.000Z","text":"RT @EFPIA: ** EFPIA IS RECRUITING **  - EFPIA Government Affairs vacancy http://t.co/6kkB8ZAJLx  #pharmajobs #vacancy","lang":"en","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"445868920587943936","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"445851761543503872"}],"id":"445867758514102272","entities":{"hashtags":[{"start":69,"end":90,"tag":"EMAIFAHEuropeInfoDay"}],"mentions":[{"start":16,"end":25,"username":"EMA_News","id":"116716199"},{"start":26,"end":36,"username":"EU_Health","id":"606325697"},{"start":37,"end":49,"username":"animalpharm","id":"15904344"}],"urls":[{"start":111,"end":133,"url":"http://t.co/wpaU1XBr2C","expanded_url":"http://bit.ly/1fr65LR","display_url":"bit.ly/1fr65LR"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-18T10:22:12.000Z","text":"RT @IFAHEurope: @EMA_News @EU_Health @animalpharm Presentations from #EMAIFAHEuropeInfoDay are available here: http://t.co/wpaU1XBr2C","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"445867758514102272","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"445839884209885184"}],"id":"445853554180628480","entities":{"hashtags":[{"start":15,"end":18,"tag":"EU"},{"start":19,"end":26,"tag":"Health"},{"start":72,"end":91,"tag":"healthinequalities"},{"start":112,"end":115,"tag":"EU"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":32,"end":40,"username":"borgton","id":"1605512862"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-18T09:25:45.000Z","text":"RT @EU_Health: #EU #Health Cssr @borgton: We have made the reduction of #healthinequalities a key objective for #EU regional development fu…","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"445853554180628480","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"445839815280697344"}],"id":"445853536929468417","entities":{"hashtags":[{"start":67,"end":86,"tag":"healthinequalities"},{"start":114,"end":124,"tag":"EH4Health"}],"mentions":[{"start":3,"end":16,"username":"EFA_Patients","id":"1299643704"},{"start":23,"end":31,"username":"borgton","id":"1605512862"}],"urls":{},"annotations":[{"start":90,"end":91,"probability":0.7904,"type":"Place","normalized_text":"EU"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-18T09:25:41.000Z","text":"RT @EFA_Patients: Cmsr @borgton: even though the gap has narrowed, #healthinequalities in EU are still too high @ #EH4Health","lang":"en","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"445853536929468417","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":{},"id":"445615752448847872","entities":{"hashtags":[{"start":96,"end":109,"tag":"hypertension"}],"mentions":{},"urls":[{"start":111,"end":133,"url":"http://t.co/Gza4hT522i","expanded_url":"http://bit.ly/1kBnbdH","display_url":"bit.ly/1kBnbdH"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-17T17:40:49.000Z","text":"Two weeks to comment on a paediatric addendum to guidance on the investigation of medicines for #hypertension: http://t.co/Gza4hT522i","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"445615752448847872","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":{},"id":"445615279289413632","entities":{"hashtags":[{"start":90,"end":94,"tag":"HIV"}],"mentions":{},"urls":[{"start":106,"end":128,"url":"http://t.co/9jX4i4VlnA","expanded_url":"http://bit.ly/1gEHx16","display_url":"bit.ly/1gEHx16"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-17T17:38:56.000Z","text":"Two more weeks to comment on our draft guideline on clinical development of medicines for #HIV infection: http://t.co/9jX4i4VlnA","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"445615279289413632","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":{},"id":"445615118941179904","entities":{"hashtags":{},"mentions":{},"urls":[{"start":73,"end":95,"url":"http://t.co/q987RFusP6","expanded_url":"http://svy.mk/OcE6HP","display_url":"svy.mk/OcE6HP"}],"annotations":[{"start":30,"end":36,"probability":0.7679,"type":"Product","normalized_text":"Twitter"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-17T17:38:18.000Z","text":"Tell us what you think of our Twitter feed by completing a short survey: http://t.co/q987RFusP6","lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"445615118941179904","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"445534210582138880"}],"id":"445597227030163456","entities":{"hashtags":{},"mentions":[{"start":3,"end":8,"username":"PGEU","id":"459292439"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-17T16:27:12.000Z","text":"RT @PGEU: Check out our new  PGEU Annual Report for 2013 \"Community Pharmacy, the Accessible Local Healthcare Resource\"\nhttp://t.co/xWH6tme…","lang":"en","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"445597227030163456","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"445564655512346624"}],"id":"445596763245015040","entities":{"hashtags":[{"start":108,"end":116,"tag":"GPC2014"},{"start":117,"end":121,"tag":"UHC"}],"mentions":[{"start":3,"end":14,"username":"IAPOtweets","id":"14682411"},{"start":51,"end":62,"username":"IAPOtweets","id":"14682411"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-17T16:25:21.000Z","text":"RT @IAPOtweets: Read about what to expect from the @IAPOtweets 6th Global Patients Congress in the Handbook #GPC2014 #UHC http://t.co/S3UFN…","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"445596763245015040","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"445574363908427777"}],"id":"445596466770624512","entities":{"hashtags":[{"start":80,"end":93,"tag":"tuberculosis"},{"start":102,"end":106,"tag":"MDR"},{"start":119,"end":130,"tag":"WorldTBday"}],"mentions":[{"start":3,"end":11,"username":"ECDC_TB","id":"1282878908"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-17T16:24:11.000Z","text":"RT @ECDC_TB: Adequate treatment is essential to prevent drug-resistant forms of #tuberculosis such as #MDR and XDR TB. #WorldTBday coming i…","lang":"en","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"445596466770624512","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"replied_to","id":"445507124232462336"}],"id":"445561824713637888","entities":{"hashtags":{},"mentions":[{"start":0,"end":12,"username":"HJF29088181","id":"1007144522"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-17T14:06:31.000Z","text":"@HJF29088181 Thanks for spotting this, problem now fixed.","lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"445507124232462336","attachments":{"media_keys":{}},"in_reply_to_user_id":"1007144522"},{"source":"TweetDeck","referenced_tweets":{},"id":"445509850764947456","entities":{"hashtags":{},"mentions":{},"urls":[{"start":72,"end":94,"url":"http://t.co/q987RFusP6","expanded_url":"http://svy.mk/OcE6HP","display_url":"svy.mk/OcE6HP"}],"annotations":[{"start":29,"end":35,"probability":0.7476,"type":"Product","normalized_text":"Twitter"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-17T10:40:00.000Z","text":"Give us your feedback on our Twitter feed by completing a short survey: http://t.co/q987RFusP6","lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"445509850764947456","attachments":{"media_keys":{}}},{"source":"bitly bitlink","referenced_tweets":{},"id":"445509567720747008","entities":{"hashtags":[{"start":101,"end":114,"tag":"hypertension"}],"mentions":{},"urls":[{"start":116,"end":138,"url":"http://t.co/Gza4hT522i","expanded_url":"http://bit.ly/1kBnbdH","display_url":"bit.ly/1kBnbdH"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-17T10:38:52.000Z","text":"Two weeks to comment on a paediatric addendum to guidance on clinical investigation of medicines for #hypertension: http://t.co/Gza4hT522i","lang":"en","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":1,"quote_count":0},"conversation_id":"445509567720747008","attachments":{"media_keys":{}}},{"source":"bitly bitlink","referenced_tweets":{},"id":"445508802352525312","entities":{"hashtags":[{"start":99,"end":103,"tag":"HIV"}],"mentions":{},"urls":[{"start":115,"end":137,"url":"http://t.co/9jX4i4VlnA","expanded_url":"http://bit.ly/1gEHx16","display_url":"bit.ly/1gEHx16"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-17T10:35:50.000Z","text":"Two weeks left to comment on our draft guideline on clinical development of medicines for treating #HIV infection: http://t.co/9jX4i4VlnA","lang":"en","public_metrics":{"retweet_count":1,"reply_count":2,"like_count":0,"quote_count":0},"conversation_id":"445508802352525312","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","referenced_tweets":{},"id":"445508250256297984","entities":{"hashtags":[{"start":38,"end":50,"tag":"brimonidine"},{"start":84,"end":93,"tag":"erythema"},{"start":97,"end":105,"tag":"rosacea"}],"mentions":{},"urls":[{"start":107,"end":129,"url":"http://t.co/Hx0h2n9CXA","expanded_url":"http://bit.ly/1fXrGjg","display_url":"bit.ly/1fXrGjg"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-17T10:33:38.000Z","text":"We've published the EPAR for Mirvaso (#brimonidine), a medicine for treating facial #erythema in #rosacea: http://t.co/Hx0h2n9CXA","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"445508250256297984","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","referenced_tweets":{},"id":"445507720616345600","entities":{"hashtags":[{"start":57,"end":65,"tag":"vaccine"}],"mentions":{},"urls":[{"start":111,"end":133,"url":"http://t.co/zqMUke83uH","expanded_url":"http://bit.ly/1npFMOt","display_url":"bit.ly/1npFMOt"}],"annotations":[{"start":42,"end":52,"probability":0.3319,"type":"Person","normalized_text":"TritanrixHB"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-17T10:31:32.000Z","text":"We've published the assessment report for TritanrixHB, a #vaccine intended for use outside the European Union: http://t.co/zqMUke83uH","lang":"en","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"445507720616345600","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","referenced_tweets":{},"id":"445506200848052224","entities":{"hashtags":[{"start":93,"end":98,"tag":"CVMP"}],"mentions":{},"urls":[{"start":101,"end":123,"url":"http://t.co/4plvQm9POY","expanded_url":"http://bit.ly/1ilCSFM","display_url":"bit.ly/1ilCSFM"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-17T10:25:30.000Z","text":"We've published highlights of last week's meeting of our committee for veterinary medicines (#CVMP): http://t.co/4plvQm9POY","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"445506200848052224","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","referenced_tweets":{},"id":"445505444057198592","entities":{"hashtags":[{"start":98,"end":107,"tag":"Knotweed"}],"mentions":{},"urls":[{"start":115,"end":137,"url":"http://t.co/2BNOLbBSz8","expanded_url":"http://bit.ly/1cFIryJ","display_url":"bit.ly/1cFIryJ"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-17T10:22:29.000Z","text":"We've published a call for data to be used in scientific assessment of Polygoni avicularis herba (#Knotweed herb): http://t.co/2BNOLbBSz8","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"445505444057198592","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","referenced_tweets":{},"id":"445504753188229120","entities":{"hashtags":[{"start":65,"end":74,"tag":"Meliloti"},{"start":116,"end":123,"tag":"herbal"},{"start":124,"end":133,"tag":"medicine"}],"mentions":{},"urls":[{"start":92,"end":114,"url":"http://t.co/7wm33B5Fzq","expanded_url":"http://bit.ly/Oqgtfa","display_url":"bit.ly/Oqgtfa"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-17T10:19:44.000Z","text":"We've opened a call for data for the review of the monograph for #Meliloti herba (Melilot): http://t.co/7wm33B5Fzq  #herbal #medicine","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"445504753188229120","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","referenced_tweets":{},"id":"445504022553034752","entities":{"hashtags":[{"start":29,"end":37,"tag":"Sirturo"},{"start":39,"end":51,"tag":"bedaquiline"},{"start":90,"end":103,"tag":"tuberculosis"}],"mentions":{},"urls":[{"start":105,"end":127,"url":"http://t.co/1eEaKCRAgB","expanded_url":"http://bit.ly/PAQ0MZ","display_url":"bit.ly/PAQ0MZ"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-17T10:16:50.000Z","text":"We've published the EPAR for #Sirturo (#bedaquiline), a medicine for multi-drug-resistant #tuberculosis: http://t.co/1eEaKCRAgB","lang":"en","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"445504022553034752","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"445470916970311680"}],"id":"445501848385228800","entities":{"hashtags":[{"start":62,"end":70,"tag":"eHealth"},{"start":71,"end":88,"tag":"interoperability"}],"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"}],"urls":[{"start":91,"end":114,"url":"https://t.co/tjimAHLBa4","expanded_url":"https://ec.europa.eu/digital-agenda/news-redirect/15101","display_url":"ec.europa.eu/digital-agenda…"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-17T10:08:12.000Z","text":"RT @EU_eHealth: Register for free webinar and workshops on EU #eHealth #interoperability - https://t.co/tjimAHLBa4 @Antilope_EU","lang":"en","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"445501848385228800","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"replied_to","id":"444583515603365888"}],"id":"445501083923021824","entities":{"hashtags":{},"mentions":[{"start":0,"end":8,"username":"kerfors","id":"144624330"}],"urls":[{"start":60,"end":82,"url":"http://t.co/5zznJo3X2a","expanded_url":"http://bit.ly/Ywugka","display_url":"bit.ly/Ywugka"},{"start":118,"end":140,"url":"http://t.co/dvLFzsUwhW","expanded_url":"http://bit.ly/1dZDjE7","display_url":"bit.ly/1dZDjE7"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-17T10:05:10.000Z","text":"@kerfors We're finalising a policy on access to trial data: http://t.co/5zznJo3X2a. Our board will discuss this week: http://t.co/dvLFzsUwhW","lang":"en","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":1,"quote_count":0},"conversation_id":"444583515603365888","attachments":{"media_keys":{}},"in_reply_to_user_id":"144624330"},{"source":"bitly bitlink","referenced_tweets":{},"id":"444517927531065344","entities":{"hashtags":[{"start":42,"end":50,"tag":"Sirturo"},{"start":52,"end":64,"tag":"bedaquiline"},{"start":103,"end":116,"tag":"tuberculosis"}],"mentions":{},"urls":[{"start":118,"end":140,"url":"http://t.co/1eEaKCRAgB","expanded_url":"http://bit.ly/PAQ0MZ","display_url":"bit.ly/PAQ0MZ"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-14T16:58:27.000Z","text":"We've published the assessment report for #Sirturo (#bedaquiline), a medicine for multi-drug-resistant #tuberculosis: http://t.co/1eEaKCRAgB","lang":"en","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"444517927531065344","attachments":{"media_keys":{}}},{"source":"bitly bitlink","referenced_tweets":{},"id":"444510380354985984","entities":{"hashtags":[{"start":77,"end":86,"tag":"Meliloti"},{"start":117,"end":124,"tag":"herbal"},{"start":125,"end":134,"tag":"medicine"}],"mentions":{},"urls":[{"start":94,"end":116,"url":"http://t.co/7wm33B5Fzq","expanded_url":"http://bit.ly/Oqgtfa","display_url":"bit.ly/Oqgtfa"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-14T16:28:27.000Z","text":"We've launched a call for data for the systematic review of the monograph on #Meliloti herba: http://t.co/7wm33B5Fzq #herbal #medicine","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444510380354985984","attachments":{"media_keys":{}}},{"source":"bitly bitlink","referenced_tweets":{},"id":"444509549098459136","entities":{"hashtags":[{"start":72,"end":81,"tag":"Polygoni"},{"start":123,"end":130,"tag":"herbal"},{"start":131,"end":140,"tag":"medicine"}],"mentions":{},"urls":[{"start":100,"end":122,"url":"http://t.co/2BNOLbBSz8","expanded_url":"http://bit.ly/1cFIryJ","display_url":"bit.ly/1cFIryJ"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-14T16:25:09.000Z","text":"We've launched a call for scientific data for use in assessment work on #Polygoni avicularis herba: http://t.co/2BNOLbBSz8 #herbal #medicine","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444509549098459136","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"444507226284507138"}],"id":"444507287856873472","entities":{"hashtags":[{"start":27,"end":30,"tag":"TB"}],"mentions":[{"start":3,"end":11,"username":"ECDC_TB","id":"1282878908"},{"start":112,"end":128,"username":"Eurosurveillanc","id":"455839750"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-14T16:16:10.000Z","text":"RT @ECDC_TB: Monitoring of #TB drug resistance should be continued to support identification of risk groups, in @Eurosurveillanc http://t.c…","lang":"en","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444507287856873472","attachments":{"media_keys":{}}},{"source":"bitly bitlink","referenced_tweets":{},"id":"444506469728522240","entities":{"hashtags":[{"start":57,"end":62,"tag":"CVMP"},{"start":99,"end":103,"tag":"dog"},{"start":104,"end":113,"tag":"vaccines"}],"mentions":{},"urls":[{"start":115,"end":137,"url":"http://t.co/4plvQm9POY","expanded_url":"http://bit.ly/1ilCSFM","display_url":"bit.ly/1ilCSFM"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-14T16:12:55.000Z","text":"Our Committee for Medicinal Products for Veterinary Use (#CVMP) has recommended authorisation of 2 #dog #vaccines: http://t.co/4plvQm9POY","lang":"en","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"444506469728522240","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"444499325755084801"}],"id":"444499392582520832","entities":{"hashtags":{},"mentions":[{"start":3,"end":18,"username":"laurentlouette","id":"207525510"},{"start":50,"end":59,"username":"EMA_News","id":"116716199"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-14T15:44:48.000Z","text":"RT @laurentlouette: Step into the right direction @EMA_News publishes first summary of a risk-management plan for a medicine http://t.co/hg…","lang":"en","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444499392582520832","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"444499058238181376"}],"id":"444499289717624833","entities":{"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":49,"end":71,"url":"http://t.co/phXBXxUxr4","expanded_url":"http://bit.ly/1kRdtqf","display_url":"bit.ly/1kRdtqf"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-14T15:44:23.000Z","text":"RT @GCessak: The agenda of MB (EMA) is live now: http://t.co/phXBXxUxr4. Publication of and access to clinical-trial data is point B.11.","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444499289717624833","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"444498267335057408"}],"id":"444498588673277952","entities":{"hashtags":[{"start":81,"end":92,"tag":"pharmajobs"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":58,"end":80,"url":"http://t.co/6kkB8ZAJLx","expanded_url":"http://bit.ly/1i91KQ6","display_url":"bit.ly/1i91KQ6"}],"annotations":[{"start":25,"end":48,"probability":0.6228,"type":"Organization","normalized_text":"EFPIA Government Affairs"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-14T15:41:36.000Z","text":"RT @EFPIA: Recruitment - EFPIA Government Affairs vacancy http://t.co/6kkB8ZAJLx #pharmajobs","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444498588673277952","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"444498143301083137"}],"id":"444498571057197056","entities":{"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":81,"end":103,"url":"http://t.co/QD8fUfn9Ee","expanded_url":"http://bit.ly/1fDH0Au","display_url":"bit.ly/1fDH0Au"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-14T15:41:32.000Z","text":"RT @EFPIA: It's FRIDAY!!! That means... A FRESH EFPIA NEWSLETTER!! Happy Friday! http://t.co/QD8fUfn9Ee","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444498571057197056","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"replied_to","id":"444492928732631041"}],"id":"444498352374554624","entities":{"hashtags":{},"mentions":[{"start":0,"end":10,"username":"EAHPtweet","id":"203357203"},{"start":11,"end":19,"username":"GCessak","id":"556859372"}],"urls":[{"start":44,"end":66,"url":"http://t.co/ZgJnRABg6f","expanded_url":"http://bit.ly/1kRdtqf","display_url":"bit.ly/1kRdtqf"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-14T15:40:40.000Z","text":"@EAHPtweet @GCessak The agenda is live now: http://t.co/ZgJnRABg6f. Publication of and access to clinical-trial data is point B.11.","lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444445442563383296","attachments":{"media_keys":{}},"in_reply_to_user_id":"203357203"},{"source":"bitly bitlink","referenced_tweets":{},"id":"444496754483146753","entities":{"hashtags":[{"start":42,"end":54,"tag":"TritanrixHB"},{"start":58,"end":66,"tag":"vaccine"}],"mentions":{},"urls":[{"start":103,"end":125,"url":"http://t.co/zqMUke83uH","expanded_url":"http://bit.ly/1npFMOt","display_url":"bit.ly/1npFMOt"}],"annotations":[{"start":87,"end":100,"probability":0.2784,"type":"Organization","normalized_text":"European Union"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-14T15:34:19.000Z","text":"We've published the assessment report for #TritanrixHB, a #vaccine for use outside the European Union: http://t.co/zqMUke83uH","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444496754483146753","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"444495686965665792"}],"id":"444495722466246656","entities":{"hashtags":{},"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"urls":[{"start":109,"end":131,"url":"http://t.co/c2Af1I6JmE","expanded_url":"http://en.urpl.gov.pl/general-information/%3Cspan-style=-colol-red-information-of-the-office-from-14-march-2014-regarding-the-move-to-new-premises-of-the-office-for-registration-of-medicinal-pro","display_url":"en.urpl.gov.pl/general-inform…"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-14T15:30:13.000Z","text":"RT @URPLWMiPB: Information of the Office from 14 March 2014 Regarding the move to new premises of The Office http://t.co/c2Af1I6JmE","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444495722466246656","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"444495499933286401"}],"id":"444495600403611648","entities":{"hashtags":{},"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"},{"start":15,"end":24,"username":"EMA_News","id":"116716199"}],"urls":[{"start":42,"end":64,"url":"http://t.co/c2Af1I6JmE","expanded_url":"http://en.urpl.gov.pl/general-information/%3Cspan-style=-colol-red-information-of-the-office-from-14-march-2014-regarding-the-move-to-new-premises-of-the-office-for-registration-of-medicinal-pro","display_url":"en.urpl.gov.pl/general-inform…"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-14T15:29:44.000Z","text":"RT @URPLWMiPB: @EMA_News English version: http://t.co/c2Af1I6JmE","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444495600403611648","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":{},"id":"444494960516403200","entities":{"hashtags":{},"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"urls":[{"start":82,"end":104,"url":"http://t.co/K8al9iibcL","expanded_url":"http://bit.ly/1eAeLhC","display_url":"bit.ly/1eAeLhC"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-14T15:27:11.000Z","text":"RT @URPLWMiPB: Information on the new headquarters of the Polish medicines agency http://t.co/K8al9iibcL","lang":"en","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"444494960516403200","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"444490360644198400"}],"id":"444494510706679808","entities":{"hashtags":[{"start":17,"end":20,"tag":"TB"}],"mentions":[{"start":3,"end":11,"username":"ECDC_TB","id":"1282878908"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-14T15:25:24.000Z","text":"RT @ECDC_TB: MDR #TB patient characteristics according to surv data: most often male, native origin, had previous TB treatment http://t.co/…","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444494510706679808","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"444489355931815936"}],"id":"444494431023292418","entities":{"hashtags":[{"start":95,"end":102,"tag":"pharma"},{"start":103,"end":115,"tag":"earlyaccess"}],"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"}],"urls":[{"start":72,"end":94,"url":"http://t.co/rFW7CyQyPy","expanded_url":"http://www.reuters.com/article/2014/03/14/us-britain-pharmaceuticals-idUSBREA2D00H20140314","display_url":"reuters.com/article/2014/0…"}],"annotations":[{"start":18,"end":19,"probability":0.9486,"type":"Place","normalized_text":"UK"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-14T15:25:05.000Z","text":"RT @DrugInfoAssn: UK to fast-track some drugs under early access scheme http://t.co/rFW7CyQyPy #pharma #earlyaccess","lang":"en","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444494431023292418","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":{},"id":"444494262408065024","entities":{"hashtags":{},"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"urls":[{"start":116,"end":138,"url":"http://t.co/8mEFsQwM9a","expanded_url":"http://bit.ly/PAzaOq","display_url":"bit.ly/PAzaOq"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-14T15:24:25.000Z","text":"RT @INFARMED_IP: Voluntary recall of batches of Soliris (eculizumab), concentrate for solution for infusion, 300 mg http://t.co/8mEFsQwM9a","lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444494262408065024","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"444487014269079552"}],"id":"444494128580403200","entities":{"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":117,"end":139,"url":"http://t.co/kEJknRglZv","expanded_url":"http://bit.ly/1o0LxPq","display_url":"bit.ly/1o0LxPq"}],"annotations":[{"start":26,"end":28,"probability":0.6779,"type":"Other","normalized_text":"HIV"},{"start":70,"end":71,"probability":0.834,"type":"Place","normalized_text":"EU"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-14T15:23:53.000Z","text":"RT @EFPIA: \"Fight against HIV/AIDS: launch of enhanced Action plan in EU and neighbouring countries for 2014-2016\" - http://t.co/kEJknRglZv","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444494128580403200","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":{},"id":"444493110996115456","entities":{"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":112,"end":134,"url":"http://t.co/td3IcMflqI","expanded_url":"http://bit.ly/1eAcqDv","display_url":"bit.ly/1eAcqDv"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-14T15:19:50.000Z","text":"RT @GCessak: Communication on the content of Supplement 8.1 to the eighth edition of the European Pharmacopoeia http://t.co/td3IcMflqI","lang":"en","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":2,"quote_count":0},"conversation_id":"444493110996115456","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":{},"id":"444492956285009921","entities":{"hashtags":{},"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"urls":[{"start":114,"end":136,"url":"http://t.co/NyvUomK6mW","expanded_url":"http://bit.ly/PAy2KH","display_url":"bit.ly/PAy2KH"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-14T15:19:13.000Z","text":"RT @URPLWMiPB: Communication on the content of Supplement 8.1 to the eighth edition of the European Pharmacopoeia http://t.co/NyvUomK6mW","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444492956285009921","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"444473407233458177"}],"id":"444492784687271937","entities":{"hashtags":[{"start":14,"end":18,"tag":"Flu"}],"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"}],"urls":[{"start":103,"end":125,"url":"http://t.co/FCTg8HAPhk","expanded_url":"http://bit.ly/1qCE0Zf","display_url":"bit.ly/1qCE0Zf"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-14T15:18:32.000Z","text":"RT @ECDC_Flu: #Flu season's gradual decline continues; 32% of sentinel samples were positive last week http://t.co/FCTg8HAPhk http://t.co/n…","lang":"en","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444492784687271937","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"444472792126603264"}],"id":"444492665217118208","entities":{"hashtags":{},"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"urls":{},"annotations":[{"start":13,"end":16,"probability":0.5908,"type":"Organization","normalized_text":"ECHA"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-14T15:18:04.000Z","text":"RT @EU_ECHA: ECHA is recruiting a senior scientific officer in the field of ecotoxicology/environmental fate. Apply now! http://t.co/bEcJi4…","lang":"en","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444492665217118208","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"replied_to","id":"444468155050901504"}],"id":"444491978269810688","entities":{"hashtags":{},"mentions":[{"start":0,"end":10,"username":"EAHPtweet","id":"203357203"},{"start":11,"end":19,"username":"GCessak","id":"556859372"}],"urls":[{"start":73,"end":95,"url":"http://t.co/dvLFzsUwhW","expanded_url":"http://bit.ly/1dZDjE7","display_url":"bit.ly/1dZDjE7"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-14T15:15:20.000Z","text":"@EAHPtweet @GCessak We'll be publishing the agenda on this page shortly: http://t.co/dvLFzsUwhW","lang":"en","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":1,"quote_count":0},"conversation_id":"444445442563383296","attachments":{"media_keys":{}},"in_reply_to_user_id":"203357203"},{"source":"bitly bitlink","referenced_tweets":{},"id":"444466005277151232","entities":{"hashtags":[{"start":42,"end":50,"tag":"Mirvaso"},{"start":52,"end":64,"tag":"brimonidine"},{"start":93,"end":102,"tag":"erythema"},{"start":106,"end":114,"tag":"rosacea"}],"mentions":{},"urls":[{"start":116,"end":138,"url":"http://t.co/Hx0h2n9CXA","expanded_url":"http://bit.ly/1fXrGjg","display_url":"bit.ly/1fXrGjg"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-14T13:32:08.000Z","text":"We've published the assessment report for #Mirvaso (#brimonidine), a new medicine for facial #erythema in #rosacea: http://t.co/Hx0h2n9CXA","lang":"en","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444466005277151232","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"444465026251096064"}],"id":"444465522131107840","entities":{"hashtags":{},"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"urls":{},"annotations":[{"start":19,"end":21,"probability":0.7933,"type":"Organization","normalized_text":"FDA"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-14T13:30:12.000Z","text":"RT @FDA_Drug_Info: FDA: public hearing on issues and challenges associated with demographic subgroup data in applications. http://t.co/DvLo…","lang":"en","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444465522131107840","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"444464563288043520"}],"id":"444465445589241856","entities":{"hashtags":[{"start":66,"end":73,"tag":"Animal"}],"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"urls":{},"annotations":[{"start":21,"end":23,"probability":0.799,"type":"Organization","normalized_text":"FDA"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-14T13:29:54.000Z","text":"RT @FDAanimalhealth: FDA Amends Regulations for Disclosure of New #Animal Drug Approvals to Improve Timeliness of Public Disclosure – http:…","lang":"en","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444465445589241856","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"444462895716634624"}],"id":"444465363032760320","entities":{"hashtags":[{"start":38,"end":50,"tag":"raredisease"}],"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-14T13:29:34.000Z","text":"RT @eurordis: Read about the EURORDIS #raredisease day policy event on improving access to rare disease care. Video available too! http://t…","lang":"en","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444465363032760320","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"444461657755254784"}],"id":"444461692257599488","entities":{"hashtags":[{"start":15,"end":34,"tag":"pharmaceuticalcare"}],"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-14T13:14:59.000Z","text":"RT @edqm_news: #pharmaceuticalcare New project debutes for a pan-European formulary for non-licensed medicines for children  http://t.co/fl…","lang":"en","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444461692257599488","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"444457968398921728"}],"id":"444461527756972032","entities":{"hashtags":[{"start":35,"end":56,"tag":"EMAIFAHEuropeInfoDay"}],"mentions":{},"urls":[{"start":111,"end":133,"url":"http://t.co/7emkqBNAho","expanded_url":"http://bit.ly/1fr65LR","display_url":"bit.ly/1fr65LR"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-14T13:14:20.000Z","text":"RT @IFAHEurope: Finishing our 20th #EMAIFAHEuropeInfoDay. Presentations &amp; videos, etc will be posted here: http://t.co/7emkqBNAho http://t.…","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444461527756972032","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"444450039889690624"}],"id":"444451869826764801","entities":{"hashtags":[{"start":111,"end":131,"tag":"veterinarymedicines"}],"mentions":[{"start":16,"end":25,"username":"EMA_News","id":"116716199"}],"urls":{},"annotations":[{"start":26,"end":31,"probability":0.3779,"type":"Person","normalized_text":"Mackay"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-14T12:35:57.000Z","text":"RT @IFAHEurope: @EMA_News Mackay: New legislation to be published in 2014 should create true single market for #veterinarymedicines #EMAIFA…","lang":"en","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444451869826764801","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"444447777071050752"}],"id":"444447877944061953","entities":{"hashtags":[{"start":101,"end":121,"tag":"veterinarymedicines"}],"mentions":{},"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-14T12:20:06.000Z","text":"RT @IFAHEurope: Industry says there is still some way to go to reduce admin burden for variations to #veterinarymedicines #EMAIFAHEuropeInf…","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444447877944061953","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"444445442563383296"}],"id":"444447610439741441","entities":{"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":59,"end":81,"url":"http://t.co/Xlo1Vr4cdB","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/events/2013/08/event_detail_000739.jsp&mid=WC0b01ac058004d5c3","display_url":"ema.europa.eu/ema/index.jsp?…"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-14T12:19:02.000Z","text":"RT @GCessak: The Management Board of EMA meets next week:\n http://t.co/Xlo1Vr4cdB","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444447610439741441","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","referenced_tweets":{},"id":"444443370312962048","entities":{"hashtags":[{"start":52,"end":57,"tag":"CHMP"}],"mentions":{},"urls":[{"start":115,"end":137,"url":"http://t.co/NwsseHYijC","expanded_url":"http://bit.ly/1oSPZyi","display_url":"bit.ly/1oSPZyi"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-14T12:02:11.000Z","text":"The Committee for Medicinal Products for Human Use (#CHMP) meets next week. We're publishing highlights on Friday: http://t.co/NwsseHYijC","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"444443370312962048","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","referenced_tweets":{},"id":"444443196945600512","entities":{"hashtags":{},"mentions":{},"urls":[{"start":74,"end":96,"url":"http://t.co/q987RFusP6","expanded_url":"http://svy.mk/OcE6HP","display_url":"svy.mk/OcE6HP"}],"annotations":[{"start":34,"end":40,"probability":0.7121,"type":"Product","normalized_text":"Twitter"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-14T12:01:30.000Z","text":"Let us have your thoughts on this Twitter feed. Fill in our short survey: http://t.co/q987RFusP6","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444443196945600512","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"444438619898793984"}],"id":"444438928729579520","entities":{"hashtags":[{"start":17,"end":28,"tag":"DidYouKnow"}],"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"}],"urls":{},"annotations":[{"start":70,"end":71,"probability":0.6267,"type":"Organization","normalized_text":"EU"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-14T11:44:32.000Z","text":"RT @egagenerics: #DidYouKnow EGA work in close collaboration with the EU institutions, governments, patients groups, healthcare professiona…","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444438928729579520","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"444437519434645504"}],"id":"444438772193964032","entities":{"hashtags":[{"start":32,"end":35,"tag":"TB"}],"mentions":[{"start":3,"end":11,"username":"ECDC_TB","id":"1282878908"}],"urls":[{"start":101,"end":123,"url":"http://t.co/c7iyJVuTYL","expanded_url":"http://bit.ly/1cZTAoQ","display_url":"bit.ly/1cZTAoQ"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-14T11:43:55.000Z","text":"RT @ECDC_TB: Of all MDR and XDR #TB cases diagnosed 2007-2009, only 32.4% had a successful treatment http://t.co/c7iyJVuTYL http://t.co/231…","lang":"en","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444438772193964032","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"444437512975433728"}],"id":"444438739822325760","entities":{"hashtags":[{"start":29,"end":37,"tag":"vaccine"},{"start":87,"end":94,"tag":"Europe"}],"mentions":[{"start":3,"end":18,"username":"WHO_Europe_VPI","id":"561122363"}],"urls":[{"start":117,"end":139,"url":"http://t.co/C220OOe3KP","expanded_url":"http://bit.ly/1cyWA0T","display_url":"bit.ly/1cyWA0T"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-14T11:43:47.000Z","text":"RT @WHO_Europe_VPI: Tackling #vaccine hesitancy  and increasing demand for vaccines in #Europe on the agenda next wk http://t.co/C220OOe3KP…","lang":"en","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444438739822325760","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"444434635540295682"}],"id":"444435218632818689","entities":{"hashtags":[{"start":28,"end":31,"tag":"TB"}],"mentions":[{"start":3,"end":11,"username":"ECDC_TB","id":"1282878908"},{"start":54,"end":70,"username":"Eurosurveillanc","id":"455839750"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-14T11:29:48.000Z","text":"RT @ECDC_TB: Drug resistant #TB in EU/EEA: article in @Eurosurveillanc shows cases of drug-resistance are stable and not declining http://t…","lang":"en","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444435218632818689","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"444433887893389312"}],"id":"444435043831001088","entities":{"hashtags":{},"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"urls":{},"annotations":[{"start":50,"end":76,"probability":0.4012,"type":"Other","normalized_text":"NICE Annual Conference 2014"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-14T11:29:06.000Z","text":"RT @NICEcomms: Last chance to buy tickets for the NICE Annual Conference 2014 at the discounted early bird rate. Offer ends today: \nhttps:/…","lang":"en","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444435043831001088","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"444432005057740800"}],"id":"444432451700817920","entities":{"hashtags":[{"start":15,"end":18,"tag":"EU"},{"start":34,"end":38,"tag":"HIV"},{"start":39,"end":44,"tag":"AIDS"},{"start":113,"end":116,"tag":"EU"},{"start":117,"end":124,"tag":"health"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"urls":{},"annotations":[{"start":81,"end":88,"probability":0.3695,"type":"Other","normalized_text":"HIV/Aids"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-14T11:18:48.000Z","text":"RT @EU_Health: #EU Action plan on #HIV #AIDS extended to 2016: the fight against HIV/Aids remains a priority for #EU #health policy http://…","lang":"en","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444432451700817920","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"444431482627825664"}],"id":"444432390187134976","entities":{"hashtags":[{"start":33,"end":37,"tag":"HIV"},{"start":39,"end":44,"tag":"AIDS"},{"start":81,"end":84,"tag":"EU"}],"mentions":[{"start":3,"end":17,"username":"EU_Commission","id":"157981564"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-14T11:18:33.000Z","text":"RT @EU_Commission: Fight against #HIV/ #AIDS : launch of enhanced Action plan in #EU and neighbouring countries for 2014-2016 http://t.co/q…","lang":"en","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444432390187134976","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"444428920205881345"}],"id":"444432120610848768","entities":{"hashtags":[{"start":85,"end":106,"tag":"EMAIFAHEuropeInfoDay"}],"mentions":[{"start":23,"end":36,"username":"JHJournalist","id":"2382044864"},{"start":56,"end":68,"username":"animalpharm","id":"15904344"}],"urls":{},"annotations":[{"start":37,"end":49,"probability":0.9949,"type":"Person","normalized_text":"Joseph Harvey"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-14T11:17:29.000Z","text":"RT @IFAHEurope: VIDEO: @JHJournalist Joseph Harvey from @AnimalPharm on why he finds #EMAIFAHEuropeInfoDay interesting to attend http://t.c…","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444432120610848768","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"444424279632146432"}],"id":"444424336976658432","entities":{"hashtags":[{"start":34,"end":39,"tag":"VICH"}],"mentions":[{"start":16,"end":25,"username":"EMA_News","id":"116716199"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-14T10:46:33.000Z","text":"RT @IFAHEurope: @EMA_News Mackay: #VICH Outreach Forum 4 globally harmonised regulation important in developing regions #EMAIFAHEuropeInfoD…","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444424336976658432","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"444423189712887808"}],"id":"444423255068516352","entities":{"hashtags":[{"start":63,"end":83,"tag":"veterinarymedicines"}],"mentions":[{"start":16,"end":25,"username":"EMA_News","id":"116716199"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-14T10:42:15.000Z","text":"RT @IFAHEurope: @EMA_News Mackay on trends: Healthy pipeline 4 #veterinarymedicines development. Increased access 2 new technologies #EMAIF…","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444423255068516352","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"444418768404766720"}],"id":"444421440553881601","entities":{"hashtags":[{"start":60,"end":80,"tag":"veterinarymedicines"},{"start":103,"end":114,"tag":"innovation"},{"start":118,"end":131,"tag":"animalhealth"}],"mentions":[{"start":24,"end":33,"username":"EMA_News","id":"116716199"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-14T10:35:03.000Z","text":"RT @IFAHEurope: N Križ: @EMA_News Innovation TF now open to #veterinarymedicines. Provides a forum for #innovation in #animalhealth #EMAIFA…","lang":"cs","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444421440553881601","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"444418437251874816"}],"id":"444421374678147072","entities":{"hashtags":[{"start":102,"end":114,"tag":"EarlyAccess"}],"mentions":[{"start":3,"end":13,"username":"MHRApress","id":"330990243"}],"urls":[{"start":115,"end":137,"url":"http://t.co/RGFbrPSbWp","expanded_url":"http://www.mhra.gov.uk/NewsCentre/CON392899","display_url":"mhra.gov.uk/NewsCentre/CON…"}],"annotations":[{"start":31,"end":40,"probability":0.9826,"type":"Person","normalized_text":"Ian Hudson"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-14T10:34:47.000Z","text":"RT @MHRApress: MHRA chief exec Ian Hudson welcomes announcement of Earlier Access to Medicines Scheme #EarlyAccess http://t.co/RGFbrPSbWp","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444421374678147072","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"444417562198437891"}],"id":"444421325571252224","entities":{"hashtags":[{"start":106,"end":118,"tag":"EarlyAccess"}],"mentions":[{"start":3,"end":17,"username":"MHRAmedicines","id":"960436586"}],"urls":{},"annotations":[{"start":35,"end":44,"probability":0.982,"type":"Person","normalized_text":"Ian Hudson"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-14T10:34:35.000Z","text":"RT @MHRAmedicines: MHRA chief exec Ian Hudson welcomes announcement of Earlier Access to Medicines Scheme #EarlyAccess http://t.co/hrrah4nT…","lang":"en","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444421325571252224","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"444417485904039936"}],"id":"444421300812283904","entities":{"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":82,"end":104,"url":"http://t.co/QD8fUfn9Ee","expanded_url":"http://bit.ly/1fDH0Au","display_url":"bit.ly/1fDH0Au"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-14T10:34:29.000Z","text":"RT @EFPIA: It's FRIDAY!!! That means... A FRESH EFPIA NEWSLETTER!!! Happy Friday! http://t.co/QD8fUfn9Ee","lang":"en","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444421300812283904","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"444416917366116352"}],"id":"444421149062352896","entities":{"hashtags":[{"start":102,"end":114,"tag":"EarlyAccess"}],"mentions":[{"start":3,"end":13,"username":"MHRAgovuk","id":"330993102"}],"urls":[{"start":115,"end":137,"url":"http://t.co/NsfMhX5WG8","expanded_url":"http://www.mhra.gov.uk/NewsCentre/CON392899","display_url":"mhra.gov.uk/NewsCentre/CON…"}],"annotations":[{"start":31,"end":40,"probability":0.9826,"type":"Person","normalized_text":"Ian Hudson"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-14T10:33:53.000Z","text":"RT @MHRAgovuk: MHRA chief exec Ian Hudson welcomes announcement of Earlier Access to Medicines Scheme #EarlyAccess http://t.co/NsfMhX5WG8","lang":"en","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444421149062352896","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"444412631634706432"}],"id":"444421018963419136","entities":{"hashtags":[{"start":13,"end":27,"tag":"CallForTender"},{"start":83,"end":97,"tag":"FeedAdditives"},{"start":99,"end":104,"tag":"EFSA"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-14T10:33:22.000Z","text":"RT @EFSA_EU: #CallForTender: Review of immune stimulator substances/agents used as #FeedAdditives. #EFSA Deadline: 16 April 2014 http://t.c…","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444421018963419136","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"444409375332257792"}],"id":"444411648653393921","entities":{"hashtags":[{"start":82,"end":89,"tag":"Pharma"},{"start":90,"end":95,"tag":"Jobs"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":58,"end":80,"url":"http://t.co/6kkB8ZAJLx","expanded_url":"http://bit.ly/1i91KQ6","display_url":"bit.ly/1i91KQ6"}],"annotations":[{"start":25,"end":48,"probability":0.6062,"type":"Organization","normalized_text":"EFPIA Government Affairs"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-14T09:56:08.000Z","text":"RT @EFPIA: Recruitment - EFPIA Government Affairs vacancy http://t.co/6kkB8ZAJLx  #Pharma #Jobs","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444411648653393921","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"444407764790411265"}],"id":"444408034509717504","entities":{"hashtags":{},"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"}],"urls":{},"annotations":[{"start":41,"end":52,"probability":0.6766,"type":"Other","normalized_text":"World TB Day"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-14T09:41:46.000Z","text":"RT @EAHPtweet: The theme for this year's World TB Day on 24th March is \"Reach the 3 Million\". More information on the WHO website. http://t…","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444408034509717504","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"444405866952146945"}],"id":"444406036162969600","entities":{"hashtags":[{"start":30,"end":35,"tag":"MUMS"},{"start":89,"end":110,"tag":"EMAIFAHEuropeInfoDay"}],"mentions":{},"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-14T09:33:50.000Z","text":"RT @IFAHEurope: A Boettner on #MUMS: Insufficient data protection = \"innovation stopper\" #EMAIFAHEuropeInfoDay","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444406036162969600","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"444405261508558848"}],"id":"444405487413772288","entities":{"hashtags":[{"start":30,"end":35,"tag":"MUMS"},{"start":98,"end":112,"tag":"AnimalWelfare"}],"mentions":{},"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-14T09:31:39.000Z","text":"RT @IFAHEurope: A Boettner on #MUMS: Lack of suitable veterinary medicines can directly impact on #AnimalWelfare &amp; Consumer Safety #EMAIFAH…","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444405487413772288","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"444402704862154752"}],"id":"444402846302494720","entities":{"hashtags":[{"start":64,"end":85,"tag":"EMAIFAHEuropeInfoDay"}],"mentions":[{"start":23,"end":32,"username":"EMA_News","id":"116716199"}],"urls":[{"start":88,"end":110,"url":"http://t.co/qOBPC7k7gV","expanded_url":"http://bit.ly/1m2QcBK","display_url":"bit.ly/1m2QcBK"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-14T09:21:09.000Z","text":"RT @IFAHEurope: VIDEO: @EMA_News David Mackay talks on day 2 of #EMAIFAHEuropeInfoDay - http://t.co/qOBPC7k7gV","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444402846302494720","attachments":{"media_keys":{}}},{"source":"bitly bitlink","referenced_tweets":{},"id":"444400427338334208","entities":{"hashtags":[{"start":69,"end":74,"tag":"CHMP"}],"mentions":{},"urls":[{"start":116,"end":138,"url":"http://t.co/NwsseHYijC","expanded_url":"http://bit.ly/1oSPZyi","display_url":"bit.ly/1oSPZyi"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-14T09:11:33.000Z","text":"March meeting of the Committee for Medicinal Products for Human Use (#CHMP) is next week. Highlights out on Friday: http://t.co/NwsseHYijC","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444400427338334208","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","referenced_tweets":{},"id":"444399990916784128","entities":{"hashtags":{},"mentions":{},"urls":[{"start":87,"end":109,"url":"http://t.co/q987RFusP6","expanded_url":"http://svy.mk/OcE6HP","display_url":"svy.mk/OcE6HP"}],"annotations":[{"start":33,"end":39,"probability":0.6788,"type":"Product","normalized_text":"Twitter"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-14T09:09:49.000Z","text":"Do you have any comments on this Twitter feed? Tell us by completing our short survey: http://t.co/q987RFusP6","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444399990916784128","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"444398838779232256"}],"id":"444399303499739136","entities":{"hashtags":[{"start":43,"end":59,"tag":"pharmacogenetic"}],"mentions":[{"start":3,"end":8,"username":"Eu2P","id":"420241833"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-14T09:07:05.000Z","text":"RT @Eu2P: One size does not fit all! Study #pharmacogenetic susceptibility to ADRs. Apply by March 30 for next course session. http://t.co/…","lang":"en","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444399303499739136","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"444390531976929280"}],"id":"444398886967603200","entities":{"hashtags":[{"start":14,"end":21,"tag":"Cancer"},{"start":122,"end":131,"tag":"Diabetes"}],"mentions":[{"start":3,"end":12,"username":"EASDnews","id":"79702114"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-14T09:05:25.000Z","text":"RT @EASDnews: #Cancer patients with insulin-treated diabetes have 4x higher mortality compared to cancer patients without #Diabetes http://…","lang":"en","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444398886967603200","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"444390066001952768"}],"id":"444398774707044352","entities":{"hashtags":[{"start":21,"end":39,"tag":"ResearchHeadlines"}],"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-14T09:04:59.000Z","text":"RT @innovationunion: #ResearchHeadlines - Tiny technology to tackle Alzheimer's: Today, some 24 million people worldwide are affected... ht…","lang":"en","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444398774707044352","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":{},"id":"444169472942047232","entities":{"hashtags":{},"mentions":{},"urls":[{"start":63,"end":85,"url":"http://t.co/q987RFusP6","expanded_url":"http://svy.mk/OcE6HP","display_url":"svy.mk/OcE6HP"}],"annotations":[{"start":31,"end":37,"probability":0.752,"type":"Product","normalized_text":"Twitter"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-13T17:53:49.000Z","text":"Tell us what you think of this Twitter feed in a quick survey: http://t.co/q987RFusP6","lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444169472942047232","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"444151823763767296"}],"id":"444166580231237632","entities":{"hashtags":[{"start":79,"end":96,"tag":"bloodtransfusion"}],"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":[{"start":113,"end":135,"url":"http://t.co/iG7bxChbXD","expanded_url":"http://bit.ly/1kilRMC","display_url":"bit.ly/1kilRMC"}],"annotations":[{"start":106,"end":111,"probability":0.9882,"type":"Place","normalized_text":"Europe"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-13T17:42:19.000Z","text":"RT @edqm_news: Trend analysis report provides insight into developments in the #bloodtransfusion chain in Europe http://t.co/iG7bxChbXD #ED…","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444166580231237632","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"444074312866496512"}],"id":"444124142003294208","entities":{"hashtags":[{"start":14,"end":19,"tag":"ECDC"},{"start":22,"end":26,"tag":"WHO"}],"mentions":[{"start":3,"end":12,"username":"iTrainEU","id":"703909451439460356"}],"urls":{},"annotations":[{"start":110,"end":118,"probability":0.9895,"type":"Place","normalized_text":"Stockholm"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-13T14:53:41.000Z","text":"RT @iTrainEU: #ECDC / #WHO workshop on foodborne parasites; a pilot multidisciplinary training now ongoing in Stockholm. http://t.co/u3NuE8…","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444124142003294208","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"444079846587912192"}],"id":"444123914374250496","entities":{"hashtags":[{"start":67,"end":74,"tag":"asthma"},{"start":79,"end":88,"tag":"wheezing"}],"mentions":[{"start":3,"end":16,"username":"EuropeanLung","id":"121759520"}],"urls":[{"start":99,"end":121,"url":"http://t.co/ankLpmbeHv","expanded_url":"http://bit.ly/1i7VRmj","display_url":"bit.ly/1i7VRmj"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-13T14:52:47.000Z","text":"RT @EuropeanLung: Preterm birth may increase the risk of childhood #asthma and #wheezing disorders http://t.co/ankLpmbeHv","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444123914374250496","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"444107193236062208"}],"id":"444123127732523008","entities":{"hashtags":{},"mentions":[{"start":3,"end":17,"username":"MHRAmedicines","id":"960436586"}],"urls":[{"start":114,"end":136,"url":"http://t.co/LC2XQVnfk5","expanded_url":"http://www.mhra.gov.uk/NewsCentre/Pressreleases/CON392891","display_url":"mhra.gov.uk/NewsCentre/Pre…"}],"annotations":[{"start":45,"end":112,"probability":0.4007,"type":"Product","normalized_text":"FreeStyle Blood Glucose Meter and FreeStyle Mini Blood Glucose Meter"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-13T14:49:39.000Z","text":"RT @MHRAmedicines: MHRA issues warning about FreeStyle Blood Glucose Meter and FreeStyle Mini Blood Glucose Meter http://t.co/LC2XQVnfk5","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444123127732523008","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":{},"id":"444076268028690432","entities":{"hashtags":{},"mentions":{},"urls":[{"start":63,"end":85,"url":"http://t.co/q987RFusP6","expanded_url":"http://svy.mk/OcE6HP","display_url":"svy.mk/OcE6HP"}],"annotations":[{"start":20,"end":26,"probability":0.6968,"type":"Product","normalized_text":"Twitter"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-13T11:43:27.000Z","text":"Help us improve our Twitter feed by completing a quick survey: http://t.co/q987RFusP6","lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444076268028690432","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"444041667960922112"}],"id":"444075316341133312","entities":{"hashtags":[{"start":28,"end":33,"tag":"EFSA"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-13T11:39:40.000Z","text":"RT @EFSA_EU: Save the date: #EFSA launches call to renew EFSA's Scientific Committee and Panels membership early April: http://t.co/Tb102EY…","lang":"en","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444075316341133312","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"444055955005652992"}],"id":"444074394194051073","entities":{"hashtags":{},"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"urls":{},"annotations":[{"start":53,"end":74,"probability":0.3925,"type":"Other","normalized_text":"Antimicrobial Research"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-13T11:36:00.000Z","text":"RT @innovationunion: 3rd International Conference on Antimicrobial Research - ICAR2014 - 1-3 October 2014, Madrid: ICAR2014 will be a... ht…","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"444074394194051073","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"443786713261830145"}],"id":"443787328138788864","entities":{"hashtags":[{"start":71,"end":79,"tag":"measles"},{"start":80,"end":88,"tag":"rubella"},{"start":94,"end":101,"tag":"Europe"},{"start":125,"end":140,"tag":"immunizeEurope"}],"mentions":[{"start":3,"end":18,"username":"WHO_Europe_VPI","id":"561122363"}],"urls":[{"start":102,"end":124,"url":"http://t.co/C220OOe3KP","expanded_url":"http://bit.ly/1cyWA0T","display_url":"bit.ly/1cyWA0T"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-12T16:35:18.000Z","text":"RT @WHO_Europe_VPI: 53 Member States to review progress in eliminating #measles #rubella from #Europe http://t.co/C220OOe3KP #immunizeEurope","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"443787328138788864","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"443783648865964032"}],"id":"443787188166467584","entities":{"hashtags":[{"start":40,"end":53,"tag":"infographics"},{"start":131,"end":141,"tag":"HealthyEU"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":55,"end":77,"url":"http://t.co/07BgzQEaMX","expanded_url":"http://bit.ly/1d1DlLl","display_url":"bit.ly/1d1DlLl"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-12T16:34:45.000Z","text":"RT @EFPIA: Like our Health &amp; Growth #infographics? http://t.co/07BgzQEaMX Get in touch with us and we’ll send you our leaflet! #HealthyEU","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"443787188166467584","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"443782980503601152"}],"id":"443787098433548288","entities":{"hashtags":[{"start":16,"end":25,"tag":"Dementia"}],"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"},{"start":119,"end":133,"username":"VPH_Institute","id":"718101349"}],"urls":[{"start":94,"end":116,"url":"http://t.co/iZ87Ba6jXA","expanded_url":"http://www.vph-dare.eu/?utm_source=VPH-DARE%40IT+Newsletter&utm_campaign=00729facf8-VPH-DARE%40IT+Newsletter+Issue+1&utm_medium=email&utm_term=0_15155f99ca-00729facf8-&utm_source=VPH-DARE%40IT+Newsletter&utm_campaign=00729facf8-VPH-DARE%40IT+Newsletter+Issue+1&utm_medium=email&utm_term=0_15155f99ca-00729facf8-148363785","display_url":"vph-dare.eu/?utm_source=VP…"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-12T16:34:24.000Z","text":"RT @EU_eHealth: #Dementia Research enabled by IT (VPHDARE-IT project): the newsletter is out: http://t.co/iZ87Ba6jXA - @VPH_Institute #ehea…","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"443787098433548288","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","referenced_tweets":{},"id":"443762856363032577","entities":{"hashtags":{},"mentions":{},"urls":[{"start":65,"end":87,"url":"http://t.co/q987RFusP6","expanded_url":"http://svy.mk/OcE6HP","display_url":"svy.mk/OcE6HP"}],"annotations":[{"start":18,"end":24,"probability":0.6894,"type":"Product","normalized_text":"Twitter"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-12T14:58:04.000Z","text":"Help us make this Twitter feed better. Fill in our quick survey: http://t.co/q987RFusP6","lang":"en","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"443762856363032577","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","referenced_tweets":{},"id":"443762479047651328","entities":{"hashtags":[{"start":36,"end":44,"tag":"vacancy"},{"start":89,"end":101,"tag":"Recruitment"}],"mentions":{},"urls":[{"start":66,"end":88,"url":"http://t.co/gRheJ2j2uB","expanded_url":"http://bit.ly/1fxYYQt","display_url":"bit.ly/1fxYYQt"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-12T14:56:34.000Z","text":"Just one week left to apply for our #vacancy for a Legal Officer: http://t.co/gRheJ2j2uB #Recruitment","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"443762479047651328","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"443756822638247936"}],"id":"443761927530225664","entities":{"hashtags":[{"start":11,"end":24,"tag":"INFOGRAPHICS"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":89,"end":93,"username":"WHO","id":"14499829"}],"urls":[{"start":94,"end":116,"url":"http://t.co/hfHwGUPY5y","expanded_url":"https://twitter.com/EFPIA/status/443756822638247936/photo/1","display_url":"pic.twitter.com/hfHwGUPY5y"}],"annotations":[{"start":27,"end":42,"probability":0.7031,"type":"Other","normalized_text":"World Health Day"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-12T14:54:22.000Z","text":"RT @EFPIA: #INFOGRAPHICS - World Health Day: Protect yourself from vector-borne diseases @WHO http://t.co/hfHwGUPY5y","lang":"en","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"443761927530225664","attachments":{"media_keys":["3_443756822646636544"]}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"443755563839926272"}],"id":"443761030846775297","entities":{"hashtags":[{"start":53,"end":74,"tag":"EMAIFAHEuropeInfoDay"}],"mentions":{},"urls":[{"start":77,"end":99,"url":"http://t.co/wrF8gBd6e7","expanded_url":"http://bit.ly/1gkFhQe","display_url":"bit.ly/1gkFhQe"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-12T14:50:49.000Z","text":"RT @IFAHEurope: VIDEO: IFAH-Europe's Rick Clayton on #EMAIFAHEuropeInfoDay - http://t.co/wrF8gBd6e7","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"443761030846775297","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"443751376892739584"}],"id":"443759690670149632","entities":{"hashtags":[{"start":35,"end":46,"tag":"Veterinary"},{"start":117,"end":128,"tag":"employment"}],"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"urls":[{"start":94,"end":116,"url":"http://t.co/qkanLrBaBg","expanded_url":"http://1.usa.gov/O1mFKw","display_url":"1.usa.gov/O1mFKw"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-12T14:45:29.000Z","text":"RT @FDAanimalhealth: CVM Announces #Veterinary Medical Officer Staff Fellow 2-Year Internship http://t.co/qkanLrBaBg #employment","lang":"en","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"443759690670149632","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"443747241866448896"}],"id":"443758620992622592","entities":{"hashtags":{},"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"}],"urls":[{"start":97,"end":119,"url":"http://t.co/bDw8mEVDW1","expanded_url":"http://www.fiercediagnostics.com/story/three-alzheimers-biomarkers-build-over-time-decline-after-symptoms-appear/2014-03-10?utm_campaign=SocialMedia","display_url":"fiercediagnostics.com/story/three-al…"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-12T14:41:14.000Z","text":"RT @DrugInfoAssn: Three Alzheimer's biomarkers build over time but decline after symptoms appear http://t.co/bDw8mEVDW1","lang":"en","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"443758620992622592","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"443744466663649281"}],"id":"443758363739181056","entities":{"hashtags":{},"mentions":[{"start":3,"end":11,"username":"FDACBER","id":"303777686"}],"urls":[{"start":98,"end":120,"url":"http://t.co/RlMAbHCS2B","expanded_url":"http://1.usa.gov/1fTAqHb","display_url":"1.usa.gov/1fTAqHb"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-12T14:40:13.000Z","text":"RT @FDACBER: Vaccines: A Critical Tool in Protecting and Promoting Public Health----Learn more at http://t.co/RlMAbHCS2B","lang":"en","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"443758363739181056","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":{},"id":"443716401317314561","entities":{"hashtags":{},"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"urls":[{"start":57,"end":79,"url":"http://t.co/bk3ICLnbV2","expanded_url":"http://bit.ly/1njrlLQ","display_url":"bit.ly/1njrlLQ"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-12T11:53:28.000Z","text":"RT @LV_MPA: The use of ADHD medicines in 2013 identified http://t.co/bk3ICLnbV2","lang":"en","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"443716401317314561","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"443714121356541952"}],"id":"443715732208377856","entities":{"hashtags":{},"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-12T11:50:49.000Z","text":"RT @NICEcomms: Is NICE influenced by pharma? We take a closer look at media claims around our draft guidance on statins: \nhttp://t.co/Zd2PD…","lang":"en","public_metrics":{"retweet_count":22,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"443715732208377856","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":{},"id":"443713399852396544","entities":{"hashtags":{},"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"urls":[{"start":113,"end":135,"url":"http://t.co/Y8iXrblA9U","expanded_url":"http://bit.ly/1njq4nK","display_url":"bit.ly/1njq4nK"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-12T11:41:32.000Z","text":"RT @INFARMED_IP: Metoclopramida Medinfar, 2.6 mg/ml, oral drops, solution -revocation of marketing authorisation http://t.co/Y8iXrblA9U","lang":"en","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"443713399852396544","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"443707022538969088"}],"id":"443707356434927616","entities":{"hashtags":[{"start":104,"end":111,"tag":"Pharma"},{"start":112,"end":117,"tag":"Jobs"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":81,"end":103,"url":"http://t.co/GmWIl6YsSa","expanded_url":"http://bit.ly/1n0lSG0","display_url":"bit.ly/1n0lSG0"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-12T11:17:32.000Z","text":"RT @EFPIA: JOB OPENING! EFPIA is looking for a Planning &amp; Operations Manager http://t.co/GmWIl6YsSa #Pharma #Jobs","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"443707356434927616","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"443702278692691968"}],"id":"443704634897866752","entities":{"hashtags":{},"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"urls":[{"start":62,"end":84,"url":"http://t.co/8LPlAtFyFr","expanded_url":"https://twitter.com/EU_ECHA/status/443702278692691968/photo/1","display_url":"pic.twitter.com/8LPlAtFyFr"}],"annotations":[{"start":44,"end":51,"probability":0.6684,"type":"Product","normalized_text":"Facebook"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-12T11:06:43.000Z","text":"RT @EU_ECHA: On Friday we are launching our Facebook profile. http://t.co/8LPlAtFyFr","lang":"en","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"443704634897866752","attachments":{"media_keys":["3_443702278701080576"]}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"443698255936106496"}],"id":"443700271395651584","entities":{"hashtags":[{"start":16,"end":26,"tag":"Just1Bite"},{"start":82,"end":91,"tag":"mosquito"},{"start":92,"end":97,"tag":"tick"},{"start":98,"end":106,"tag":"sandfly"}],"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"urls":[{"start":107,"end":129,"url":"http://t.co/U4IOcpW4GX","expanded_url":"http://bit.ly/1hbHCuR","display_url":"bit.ly/1hbHCuR"}],"annotations":[{"start":29,"end":49,"probability":0.456,"type":"Other","normalized_text":"World Health Day 2014"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-12T10:49:22.000Z","text":"RT @WHO_Europe: #Just1Bite : World Health Day 2014 focuses on diseases carried by #mosquito #tick #sandfly http://t.co/U4IOcpW4GX","lang":"en","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"443700271395651584","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","referenced_tweets":{},"id":"443686090189570048","entities":{"hashtags":[{"start":122,"end":135,"tag":"transparency"}],"mentions":{},"urls":[{"start":99,"end":121,"url":"http://t.co/h8Hybr2YTs","expanded_url":"http://bit.ly/1cR952c","display_url":"bit.ly/1cR952c"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-12T09:53:01.000Z","text":"Yesterday we started publishing summaries of risk-management plans for authorised human medicines: http://t.co/h8Hybr2YTs #transparency","lang":"en","public_metrics":{"retweet_count":7,"reply_count":1,"like_count":1,"quote_count":0},"conversation_id":"443686090189570048","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","referenced_tweets":{},"id":"443684584996503552","entities":{"hashtags":{},"mentions":{},"urls":[{"start":58,"end":80,"url":"http://t.co/gRheJ2j2uB","expanded_url":"http://bit.ly/1fxYYQt","display_url":"bit.ly/1fxYYQt"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-12T09:47:02.000Z","text":"We're recruiting a Legal Officer. One week left to apply: http://t.co/gRheJ2j2uB","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"443684584996503552","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","referenced_tweets":{},"id":"443683899848544256","entities":{"hashtags":{},"mentions":{},"urls":[{"start":78,"end":100,"url":"http://t.co/q987RFusP6","expanded_url":"http://svy.mk/OcE6HP","display_url":"svy.mk/OcE6HP"}],"annotations":[{"start":35,"end":41,"probability":0.7598,"type":"Product","normalized_text":"Twitter"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-12T09:44:19.000Z","text":"Let us know what you think of this Twitter feed by filling in a quick survey: http://t.co/q987RFusP6","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"443683899848544256","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"443678798845063168"}],"id":"443683329947500544","entities":{"hashtags":[{"start":100,"end":106,"tag":"Brain"},{"start":107,"end":116,"tag":"Research"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":77,"end":99,"url":"http://t.co/sCg8yYDxaH","expanded_url":"http://bit.ly/1goYQTF","display_url":"bit.ly/1goYQTF"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-12T09:42:03.000Z","text":"RT @EFPIA: Researchers discover two new genetic regions for bipolar disorder http://t.co/sCg8yYDxaH #Brain #Research","lang":"en","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"443683329947500544","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"443677033261191168"}],"id":"443683138917916673","entities":{"hashtags":{},"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"},{"start":49,"end":57,"username":"EU_ECHA","id":"331604970"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-12T09:41:18.000Z","text":"RT @EU_ECHA: Are you interested in a traineeship @EU_ECHA? You have only two more days to apply for our two open positions http://t.co/N91W…","lang":"en","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"443683138917916673","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"443676929229848576"}],"id":"443683028385402880","entities":{"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":104,"end":126,"url":"http://t.co/xRGnf2ZZTt","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/03/news_detail_002041.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"annotations":[{"start":13,"end":37,"probability":0.5238,"type":"Organization","normalized_text":"European Medicines Agency"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-12T09:40:51.000Z","text":"RT @GCessak: European Medicines Agency published first summary of a risk-management plan for a medicine http://t.co/xRGnf2ZZTt","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"443683028385402880","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":{},"id":"443682656698781697","entities":{"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":102,"end":124,"url":"http://t.co/zbMbcJ5swW","expanded_url":"http://bit.ly/1fsHEAF","display_url":"bit.ly/1fsHEAF"}],"annotations":[{"start":58,"end":63,"probability":0.995,"type":"Place","normalized_text":"Poland"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-12T09:39:23.000Z","text":"RT @GCessak: Developing and suspected cases of the flu in Poland | Report - March 2014: 111,154 cases http://t.co/zbMbcJ5swW","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"443682656698781697","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"443668981791338496"}],"id":"443682348107042816","entities":{"hashtags":[{"start":56,"end":70,"tag":"Certification"},{"start":134,"end":138,"tag":"COS"}],"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":[{"start":111,"end":133,"url":"http://t.co/YECSh7TdDJ","expanded_url":"http://bit.ly/1cP9Qc6","display_url":"bit.ly/1cP9Qc6"}],"annotations":[{"start":74,"end":92,"probability":0.3456,"type":"Other","normalized_text":"Substances Division"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-12T09:38:09.000Z","text":"RT @edqm_news: The last monthly activity report for the #Certification of Substances Division is now available http://t.co/YECSh7TdDJ #COS …","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"443682348107042816","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":{},"id":"443439682811351040","entities":{"hashtags":{},"mentions":{},"urls":[{"start":79,"end":101,"url":"http://t.co/q987RFusP6","expanded_url":"http://svy.mk/OcE6HP","display_url":"svy.mk/OcE6HP"}],"annotations":[{"start":36,"end":42,"probability":0.7582,"type":"Product","normalized_text":"Twitter"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-11T17:33:53.000Z","text":"Please give us some feedback on our Twitter feed by filling in a quick survey: http://t.co/q987RFusP6","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"443439682811351040","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","referenced_tweets":{},"id":"443398793636356096","entities":{"hashtags":[{"start":120,"end":133,"tag":"transparency"}],"mentions":{},"urls":[{"start":97,"end":119,"url":"http://t.co/h8Hybr2YTs","expanded_url":"http://bit.ly/1cR952c","display_url":"bit.ly/1cR952c"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-11T14:51:25.000Z","text":"We've just published the first public-friendly summary of a risk-management plan for a medicine: http://t.co/h8Hybr2YTs #transparency","lang":"en","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":3,"quote_count":0},"conversation_id":"443398793636356096","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"443383855358418944"}],"id":"443396852051111936","entities":{"hashtags":[{"start":46,"end":55,"tag":"diabetes"}],"mentions":[{"start":3,"end":12,"username":"EASDnews","id":"79702114"}],"urls":[{"start":90,"end":112,"url":"http://t.co/XVa6rWHntX","expanded_url":"http://www.diabetologia-journal.org/","display_url":"diabetologia-journal.org"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-11T14:43:42.000Z","text":"RT @EASDnews: Study shows association between #diabetes and stroke in women but not men: \nhttp://t.co/XVa6rWHntX","lang":"en","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"443396852051111936","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"443396126969184256"}],"id":"443396481295597568","entities":{"hashtags":{},"mentions":[{"start":3,"end":19,"username":"AlzheimerEurope","id":"1536274003"}],"urls":[{"start":86,"end":108,"url":"http://t.co/E1zTPZChWC","expanded_url":"http://alzheimereurope.newsweaver.com/Newsletter/19zuqxerqq3","display_url":"alzheimereurope.newsweaver.com/Newsletter/19z…"}],"annotations":[{"start":25,"end":49,"probability":0.4323,"type":"Other","normalized_text":"Alzheimer Europe February"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-11T14:42:13.000Z","text":"RT @AlzheimerEurope: The Alzheimer Europe February newsletter is now available online http://t.co/E1zTPZChWC","lang":"en","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"443396481295597568","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","referenced_tweets":{},"id":"443384530238332928","entities":{"hashtags":{},"mentions":{},"urls":[{"start":66,"end":88,"url":"http://t.co/s06XDEpmyL","expanded_url":"http://svy.mk/OcE6HP","display_url":"svy.mk/OcE6HP"}],"annotations":[{"start":34,"end":40,"probability":0.776,"type":"Product","normalized_text":"Twitter"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-11T13:54:44.000Z","text":"Let us know what you think of our Twitter feed in a quick survey: http://t.co/s06XDEpmyL","lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"443384530238332928","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"443327213866217472"}],"id":"443368171782037504","entities":{"hashtags":{},"mentions":[{"start":3,"end":13,"username":"TOPRANEWS","id":"26739900"}],"urls":[{"start":69,"end":91,"url":"http://t.co/5piOpQC6F1","expanded_url":"http://bit.ly/1nEL5Gt","display_url":"bit.ly/1nEL5Gt"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-11T12:49:44.000Z","text":"RT @TOPRANEWS: Human medicines highlights - Issue 60 - February 2014 http://t.co/5piOpQC6F1","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"443368171782037504","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"443334372947943424"}],"id":"443367890646216705","entities":{"hashtags":[{"start":131,"end":135,"tag":"HTA"}],"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"urls":[{"start":108,"end":130,"url":"http://t.co/3NzeWudsCP","expanded_url":"http://bit.ly/1lRslFe","display_url":"bit.ly/1lRslFe"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-11T12:48:37.000Z","text":"RT @IMI_JU: Press release: New IMI project GETREAL to help incorporate real life data into drug development http://t.co/3NzeWudsCP #HTA","lang":"en","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"443367890646216705","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"443340851646062592"}],"id":"443367672219439104","entities":{"hashtags":[{"start":88,"end":101,"tag":"Microbiology"},{"start":102,"end":111,"tag":"Training"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-11T12:47:45.000Z","text":"RT @ECDC_EU: ECDC is looking for Head of EUPHEM or European Programme for Public Health #Microbiology #Training; deadline 14 April http://t…","lang":"en","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"443367672219439104","attachments":{"media_keys":{}}},{"source":"Twitter for iPhone","referenced_tweets":[{"type":"retweeted","id":"443077412050702336"}],"id":"443088877205864449","entities":{"hashtags":[{"start":48,"end":53,"tag":"Feed"}],"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"urls":[{"start":76,"end":98,"url":"http://t.co/M8iTfMVbig","expanded_url":"http://bit.ly/9h7CkO","display_url":"bit.ly/9h7CkO"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-10T18:19:55.000Z","text":"RT @FDAanimalhealth: List of Approved Medicated #Feed Mill Licenses Updated http://t.co/M8iTfMVbig","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"443088877205864449","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"443071365760163840"}],"id":"443072337379098624","entities":{"hashtags":[{"start":77,"end":99,"tag":"personalized_medicine"}],"mentions":[{"start":3,"end":12,"username":"cancereu","id":"140344419"}],"urls":[{"start":54,"end":76,"url":"http://t.co/RRA1qyc2cx","expanded_url":"http://nej.md/1nBiQZ0","display_url":"nej.md/1nBiQZ0"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-10T17:14:11.000Z","text":"RT @cancereu: Preparing for Precision Medicine — NEJM http://t.co/RRA1qyc2cx #personalized_medicine","lang":"ro","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"443072337379098624","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"443041832117600256"}],"id":"443044092294225920","entities":{"hashtags":{},"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"urls":[{"start":61,"end":83,"url":"http://t.co/u0rmpSPoaB","expanded_url":"http://j.mp/PjSGi3","display_url":"j.mp/PjSGi3"}],"annotations":[{"start":43,"end":45,"probability":0.4717,"type":"Organization","normalized_text":"EIW"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-10T15:21:57.000Z","text":"RT @ECDC_EU: Just added a new blog post on EIW campaign site http://t.co/u0rmpSPoaB","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"443044092294225920","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","referenced_tweets":{},"id":"443038356860321792","entities":{"hashtags":{},"mentions":{},"urls":[{"start":80,"end":102,"url":"http://t.co/q987RFusP6","expanded_url":"http://svy.mk/OcE6HP","display_url":"svy.mk/OcE6HP"}],"annotations":[{"start":26,"end":32,"probability":0.7242,"type":"Product","normalized_text":"Twitter"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-10T14:59:10.000Z","text":"What do you think of this Twitter feed? Tell us by completing our quick survey: http://t.co/q987RFusP6","lang":"en","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":3,"quote_count":0},"conversation_id":"443038356860321792","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","referenced_tweets":{},"id":"443038134612553728","entities":{"hashtags":[{"start":73,"end":78,"tag":"PMDA"},{"start":82,"end":89,"tag":"orphan"}],"mentions":[{"start":36,"end":43,"username":"US_FDA","id":"208120290"},{"start":58,"end":68,"username":"MHLWitter","id":"180585090"}],"urls":[{"start":113,"end":135,"url":"http://t.co/M4p16TCo9t","expanded_url":"http://bit.ly/N0nfao","display_url":"bit.ly/N0nfao"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-10T14:58:17.000Z","text":"Today we're hosting a workshop with @US_FDA, and Japanese @MHLWitter and #PMDA on #orphan medicines. Watch live: http://t.co/M4p16TCo9t","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"443038134612553728","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"443031818657607680"}],"id":"443037608109957121","entities":{"hashtags":{},"mentions":[{"start":3,"end":11,"username":"IlaeWeb","id":"611701745"}],"urls":[{"start":94,"end":116,"url":"http://t.co/w7pbRwXoCq","expanded_url":"http://epinet.co.nz/","display_url":"epinet.co.nz"}],"annotations":[{"start":13,"end":18,"probability":0.4597,"type":"Organization","normalized_text":"EpiNet"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-10T14:56:11.000Z","text":"RT @IlaeWeb: EpiNet seeks participation in study What is a Seizure - register, enter cases at http://t.co/w7pbRwXoCq to be eligible for NZ …","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"443037608109957121","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"443030156001550336"}],"id":"443037433014525952","entities":{"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":61,"end":83,"url":"http://t.co/mKsAYjdwna","expanded_url":"http://bit.ly/1malLpc","display_url":"bit.ly/1malLpc"},{"start":84,"end":106,"url":"http://t.co/Q6ktuaD9xP","expanded_url":"https://twitter.com/EFPIA/status/443030156001550336/photo/1","display_url":"pic.twitter.com/Q6ktuaD9xP"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-10T14:55:29.000Z","text":"RT @EFPIA: Scientific breakthroughs: look how far we’ve come http://t.co/mKsAYjdwna http://t.co/Q6ktuaD9xP","lang":"en","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"443037433014525952","attachments":{"media_keys":["3_443030156005744640"]}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"443024567557038080"}],"id":"443036871468535808","entities":{"hashtags":{},"mentions":[{"start":3,"end":14,"username":"Berlaymont","id":"19003991"}],"urls":[{"start":98,"end":120,"url":"http://t.co/n6BWlC7wUf","expanded_url":"http://bit.ly/1nAwHid","display_url":"bit.ly/1nAwHid"}],"annotations":[{"start":54,"end":55,"probability":0.6322,"type":"Organization","normalized_text":"EU"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-10T14:53:16.000Z","text":"RT @Berlaymont: German biopharmaceutical company wins EU's first ever innovation inducement prize http://t.co/n6BWlC7wUf","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"443036871468535808","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"443020480933810176"}],"id":"443036697916628992","entities":{"hashtags":{},"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"urls":{},"annotations":[{"start":26,"end":38,"probability":0.3504,"type":"Organization","normalized_text":"FDA Pinterest"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-10T14:52:34.000Z","text":"RT @US_FDA: Check out the FDA Pinterest page for a collection of infographics covering tobacco, generic drugs, cholesterol &amp; more http://t.…","lang":"en","public_metrics":{"retweet_count":16,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"443036697916628992","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"442999490971463680"}],"id":"443034871897001986","entities":{"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":63,"end":85,"url":"http://t.co/qsx04EjSwM","expanded_url":"http://europa.eu/rapid/press-release_MEMO-14-169_en.htm","display_url":"europa.eu/rapid/press-re…"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-10T14:45:19.000Z","text":"RT @GCessak: EU research and innovation on preventive vaccines http://t.co/qsx04EjSwM","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"443034871897001986","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"442993395850829824"}],"id":"443034790082916352","entities":{"hashtags":[{"start":39,"end":47,"tag":"eHealth"},{"start":52,"end":63,"tag":"depression"}],"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"},{"start":92,"end":108,"username":"JMedInternetRes","id":"768488439478038528"},{"start":109,"end":122,"username":"matic_meglic","id":"16153951"}],"urls":[{"start":65,"end":87,"url":"http://t.co/OCXr7s1FDR","expanded_url":"http://www.jmir.org/2014/2/e67/?utm_source=rss&utm_medium=rss&utm_campaign=routine-real-time-cost-effectiveness-monitoring-of-a-web-based-depression-intervention-a-risk-sharing-proposal","display_url":"jmir.org/2014/2/e67/?ut…"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-10T14:44:59.000Z","text":"RT @EU_eHealth: Study on effectiveness #eHealth and #depression: http://t.co/OCXr7s1FDR via @JMedInternetRes @matic_meglic","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"443034790082916352","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"442993072277045248"}],"id":"443034590069149696","entities":{"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":121,"end":136,"username":"VaccinesEurope","id":"1262320285"}],"urls":[{"start":98,"end":120,"url":"http://t.co/yfjMp6nGIe","expanded_url":"http://bit.ly/NQXhHi","display_url":"bit.ly/NQXhHi"}],"annotations":[{"start":31,"end":32,"probability":0.688,"type":"Organization","normalized_text":"EU"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-10T14:44:12.000Z","text":"RT @EFPIA: German company wins EU's €2 million inducement prize for innovative vaccine technology http://t.co/yfjMp6nGIe @VaccinesEurope","lang":"en","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"443034590069149696","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"replied_to","id":"443033688855834624"}],"id":"443033884650135552","entities":{"hashtags":{},"mentions":[{"start":0,"end":11,"username":"GeoMurariu","id":"1125798749727539202"},{"start":69,"end":83,"username":"EU_Commission","id":"157981564"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-10T14:41:23.000Z","text":"@GeoMurariu However please note that we don't approve medicines. The @EU_Commission approves after we've given an opinion.","lang":"en","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"443022598331719680","attachments":{"media_keys":{}},"in_reply_to_user_id":"116716199"},{"source":"TweetDeck","referenced_tweets":[{"type":"replied_to","id":"443022598331719680"}],"id":"443033688855834624","entities":{"hashtags":{},"mentions":[{"start":0,"end":11,"username":"GeoMurariu","id":"1125798749727539202"}],"urls":[{"start":46,"end":68,"url":"http://t.co/HKFvTyBOp8","expanded_url":"http://bit.ly/1oFjhQT","display_url":"bit.ly/1oFjhQT"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-10T14:40:37.000Z","text":"@GeoMurariu You can search human medicines at http://t.co/HKFvTyBOp8. We also have searches for veterinary and herbal medicines.","lang":"en","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"443022598331719680","attachments":{"media_keys":{}},"in_reply_to_user_id":"329999446"},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"442990689463582720"}],"id":"442991027737989120","entities":{"hashtags":[{"start":66,"end":79,"tag":"tuberculosis"}],"mentions":[{"start":3,"end":11,"username":"ECDC_TB","id":"1282878908"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-10T11:51:06.000Z","text":"RT @ECDC_TB: New Consensus Statement lists 32 recommendations for #tuberculosis control in big cities and urban risk groups in EU http://t.…","lang":"en","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"442991027737989120","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"442981982528868352"}],"id":"442983146523332608","entities":{"hashtags":[{"start":77,"end":86,"tag":"patients"},{"start":95,"end":105,"tag":"medicines"}],"mentions":[{"start":3,"end":16,"username":"EFA_Patients","id":"1299643704"},{"start":52,"end":63,"username":"eupatients","id":"465674067"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-10T11:19:47.000Z","text":"RT @EFA_Patients: Today the application process for @eupatients training for #patients opened! #medicines research &amp; more http://t.co/0AVGA…","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"442983146523332608","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"442980645581914112"}],"id":"442980790675046400","entities":{"hashtags":[{"start":30,"end":33,"tag":"EU"},{"start":34,"end":43,"tag":"research"},{"start":48,"end":59,"tag":"innovation"},{"start":74,"end":83,"tag":"vaccines"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":107,"end":123,"username":"ECspokesScience","id":"613378164"},{"start":124,"end":138,"username":"EU_Commission","id":"157981564"}],"urls":[{"start":84,"end":106,"url":"http://t.co/Q3UvJRI7C4","expanded_url":"http://europa.eu/!wU78VD","display_url":"europa.eu/!wU78VD"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-10T11:10:25.000Z","text":"RT @EU_Health: Read all about #EU #research and #innovation on preventive #vaccines http://t.co/Q3UvJRI7C4 @ECspokesScience @EU_Commission …","lang":"en","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"442980790675046400","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"442980216324247552"}],"id":"442980691538501632","entities":{"hashtags":[{"start":38,"end":41,"tag":"EU"},{"start":42,"end":51,"tag":"research"},{"start":56,"end":67,"tag":"innovation"},{"start":82,"end":91,"tag":"vaccines"}],"mentions":[{"start":3,"end":17,"username":"EU_Commission","id":"157981564"},{"start":120,"end":136,"username":"ECspokesScience","id":"613378164"}],"urls":[{"start":94,"end":116,"url":"http://t.co/y3jo6fFsJI","expanded_url":"http://europa.eu/!wU78VD","display_url":"europa.eu/!wU78VD"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-10T11:10:01.000Z","text":"RT @EU_Commission: To read further on #EU #research and #innovation on preventive #vaccines : http://t.co/y3jo6fFsJI cc @ECspokesScience","lang":"en","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"442980691538501632","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"442979945368010752"}],"id":"442980583342219264","entities":{"hashtags":[{"start":87,"end":96,"tag":"vaccines"}],"mentions":[{"start":3,"end":17,"username":"EU_Commission","id":"157981564"}],"urls":[{"start":109,"end":131,"url":"http://t.co/2PnMUFgS24","expanded_url":"http://europa.eu/!nw46fg","display_url":"europa.eu/!nw46fg"}],"annotations":[{"start":39,"end":40,"probability":0.6233,"type":"Organization","normalized_text":"EU"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-10T11:09:35.000Z","text":"RT @EU_Commission: German company wins EU's €2 million inducement prize for innovative #vaccines technology: http://t.co/2PnMUFgS24 cc @ECs…","lang":"en","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"442980583342219264","attachments":{"media_keys":{}}},{"source":"bitly bitlink","referenced_tweets":{},"id":"442977479574429696","entities":{"hashtags":{},"mentions":{},"urls":[{"start":79,"end":101,"url":"http://t.co/q987RFusP6","expanded_url":"http://svy.mk/OcE6HP","display_url":"svy.mk/OcE6HP"}],"annotations":[{"start":27,"end":33,"probability":0.7008,"type":"Product","normalized_text":"Twitter"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-10T10:57:15.000Z","text":"Please help us improve our Twitter feed by completing this five-minute survey: http://t.co/q987RFusP6","lang":"en","public_metrics":{"retweet_count":6,"reply_count":1,"like_count":1,"quote_count":0},"conversation_id":"442977479574429696","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","referenced_tweets":{},"id":"442974351961636864","entities":{"hashtags":[{"start":27,"end":36,"tag":"zolpidem"}],"mentions":{},"urls":[{"start":109,"end":131,"url":"http://t.co/U6HxyY7W39","expanded_url":"http://bit.ly/1gexY91","display_url":"bit.ly/1gexY91"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-10T10:44:50.000Z","text":"PRAC recommended update of #zolpidem to minimise risk of impaired driving and mental alertness next morning: http://t.co/U6HxyY7W39","lang":"en","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"442974351961636864","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","referenced_tweets":{},"id":"442974199930687488","entities":{"hashtags":[{"start":17,"end":27,"tag":"diacerein"}],"mentions":{},"urls":[{"start":88,"end":110,"url":"http://t.co/BdfMVR4bOa","expanded_url":"http://bit.ly/P843cU","display_url":"bit.ly/P843cU"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-10T10:44:13.000Z","text":"PRAC re-examined #diacerein and recommended that it remain available with restrictions: http://t.co/BdfMVR4bOa","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"442974199930687488","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","referenced_tweets":{},"id":"442974045601296385","entities":{"hashtags":[{"start":36,"end":48,"tag":"domperidone"}],"mentions":{},"urls":[{"start":50,"end":72,"url":"http://t.co/rN8fqXcDeY","expanded_url":"http://bit.ly/1dyDGp0","display_url":"bit.ly/1dyDGp0"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-10T10:43:37.000Z","text":"PRAC recommended restricting use of #domperidone: http://t.co/rN8fqXcDeY","lang":"en","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"442974045601296385","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","referenced_tweets":{},"id":"442973756794085376","entities":{"hashtags":[{"start":29,"end":34,"tag":"PRAC"}],"mentions":{},"urls":[{"start":55,"end":77,"url":"http://t.co/XXc3FcbXqn","expanded_url":"http://bit.ly/1igyvtu","display_url":"bit.ly/1igyvtu"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-10T10:42:28.000Z","text":"Last Friday we published the #PRAC meeting highlights: http://t.co/XXc3FcbXqn","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"442973756794085376","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"442971131562061824"}],"id":"442971180241141760","entities":{"hashtags":{},"mentions":[{"start":3,"end":11,"username":"ECDC_TB","id":"1282878908"}],"urls":[{"start":108,"end":130,"url":"http://t.co/hVYrCayV7N","expanded_url":"http://bit.ly/OcxRE2","display_url":"bit.ly/OcxRE2"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-10T10:32:14.000Z","text":"RT @ECDC_TB: In 15 big cities of low-incidence EU countries, TB rates were twice national notification rate http://t.co/hVYrCayV7N http://t…","lang":"en","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"442971180241141760","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"442969339567038464"}],"id":"442969583134048257","entities":{"hashtags":[{"start":29,"end":32,"tag":"TB"}],"mentions":[{"start":3,"end":11,"username":"ECDC_TB","id":"1282878908"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-10T10:25:53.000Z","text":"RT @ECDC_TB: New study shows #TB epidemiology transition in EU/EEA: disease concentrates in big cities as national incidence falls http://t…","lang":"en","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"442969583134048257","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"442961572139651072"}],"id":"442961779832811521","entities":{"hashtags":[{"start":44,"end":65,"tag":"EMAIFAHEuropeInfoDay"},{"start":91,"end":104,"tag":"AnimalHealth"}],"mentions":{},"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-10T09:54:52.000Z","text":"RT @IFAHEurope: 13-14/3:join discussions on #EMAIFAHEuropeInfoDay 4 latest developments in #AnimalHealth regulatory topics http://t.co/wpaU…","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"442961779832811521","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"442957145127280640"}],"id":"442959880966504448","entities":{"hashtags":[{"start":71,"end":81,"tag":"Alzheimer"}],"mentions":[{"start":3,"end":19,"username":"AlzheimerEurope","id":"1536274003"},{"start":113,"end":127,"username":"alzheimerssoc","id":"34267043"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-10T09:47:20.000Z","text":"RT @AlzheimerEurope: A lot of media attention on simple blood test for #Alzheimer. Worth checking out comment by @alzheimerssoc http://t.co…","lang":"en","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"442959880966504448","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"442954397513814016"}],"id":"442959683909742593","entities":{"hashtags":[{"start":98,"end":101,"tag":"TB"}],"mentions":[{"start":3,"end":17,"username":"WHO_Europe_TB","id":"920721606"},{"start":19,"end":30,"username":"WHO_Europe","id":"125403342"}],"urls":[{"start":110,"end":132,"url":"http://t.co/TXrxr2PVI1","expanded_url":"http://www.euro.who.int/en/media-centre/events/events/2014/03/world-tuberculosis-day-2014-boost-efforts-to-eliminate-tb-by-2050","display_url":"euro.who.int/en/media-centr…"}],"annotations":[{"start":42,"end":63,"probability":0.6924,"type":"Other","normalized_text":"World Tuberculosis Day"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-10T09:46:33.000Z","text":"RT @WHO_Europe_TB: @WHO_Europe | Events - World Tuberculosis Day 2014: boost efforts to eliminate #TB by 2050 http://t.co/TXrxr2PVI1 | #TBc…","lang":"en","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"442959683909742593","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":{},"id":"442950599806447616","entities":{"hashtags":{},"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"urls":[{"start":99,"end":121,"url":"http://t.co/OP8X0n2JWX","expanded_url":"http://bit.ly/1h66SCL","display_url":"bit.ly/1h66SCL"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-10T09:10:27.000Z","text":"RT @INFARMED_IP: Voluntary recall of various batches of the medicine Timoglobulina, 25 mg/5 ml,... http://t.co/OP8X0n2JWX","lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"442950599806447616","attachments":{"media_keys":{}}},{"source":"bitly bitlink","referenced_tweets":{},"id":"442950150760435712","entities":{"hashtags":[{"start":61,"end":66,"tag":"PMDA"},{"start":70,"end":77,"tag":"orphan"}],"mentions":[{"start":24,"end":31,"username":"US_FDA","id":"208120290"},{"start":46,"end":56,"username":"MHLWitter","id":"180585090"}],"urls":[{"start":107,"end":129,"url":"http://t.co/M4p16TCo9t","expanded_url":"http://bit.ly/N0nfao","display_url":"bit.ly/N0nfao"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-10T09:08:40.000Z","text":"Our joint workshop with @US_FDA, and Japanese @MHLWitter and #PMDA on #orphan medicines takes place today: http://t.co/M4p16TCo9t","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"442950150760435712","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"replied_to","id":"442026330289614848"}],"id":"442946254339723264","entities":{"hashtags":{},"mentions":[{"start":0,"end":16,"username":"tb_or_not_tb_uk","id":"1912237170"},{"start":17,"end":28,"username":"newtbdrugs","id":"267361250"},{"start":88,"end":98,"username":"NICEComms","id":"85555796"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-10T08:53:11.000Z","text":"@tb_or_not_tb_uk @newtbdrugs We do not deal with pricing issues. We suggest you contact @NICEcomms for more information.","lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"442018018961666050","attachments":{"media_keys":{}},"in_reply_to_user_id":"1912237170"},{"source":"Twitter Web Client","referenced_tweets":{},"id":"441978673051467776","entities":{"hashtags":[{"start":84,"end":88,"tag":"flu"}],"mentions":{},"urls":[{"start":109,"end":131,"url":"http://t.co/s4L6r9POZn","expanded_url":"http://bit.ly/1e8ZdBk","display_url":"bit.ly/1e8ZdBk"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-07T16:48:21.000Z","text":"We've published draft interim guidance on enhanced safety surveillance for seasonal #flu vaccines in the EU: http://t.co/s4L6r9POZn","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"441978673051467776","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","referenced_tweets":{},"id":"441978428070576128","entities":{"hashtags":[{"start":40,"end":45,"tag":"CVMP"}],"mentions":{},"urls":[{"start":106,"end":128,"url":"http://t.co/SVQ1K5lU1Q","expanded_url":"http://bit.ly/1lEY7Fn","display_url":"bit.ly/1lEY7Fn"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-07T16:47:23.000Z","text":"Our committee for veterinary medicines, #CVMP, meets next week. Highlights will be published next Friday: http://t.co/SVQ1K5lU1Q","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"441978428070576128","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"441897802327937024"}],"id":"441928683700629504","entities":{"hashtags":{},"mentions":[{"start":3,"end":19,"username":"eupatientsforum","id":"545343465"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-07T13:29:43.000Z","text":"RT @eupatientsforum: The application period for the EUPATI training course will open on Monday 10 March 2014 via the EUPATI website: http:/…","lang":"en","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"441928683700629504","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"441904738582687744"}],"id":"441928595037249536","entities":{"hashtags":{},"mentions":[{"start":3,"end":17,"username":"MHRAmedicines","id":"960436586"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-07T13:29:22.000Z","text":"RT @MHRAmedicines: Company-led drug recall: Thymoglobuline (Anti-thymocyte globulin – rabbit). Vials containing lyophilised pow... http://t…","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"441928595037249536","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"441904784975876096"}],"id":"441928572161499136","entities":{"hashtags":{},"mentions":[{"start":3,"end":8,"username":"Eu2P","id":"420241833"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-07T13:29:16.000Z","text":"RT @Eu2P: Looking for a course on public health impact of ADRs? Apply no later than March 30 for next certificate session. http://t.co/On3q…","lang":"en","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"441928572161499136","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","referenced_tweets":{},"id":"441927745770389504","entities":{"hashtags":[{"start":40,"end":45,"tag":"CVMP"}],"mentions":{},"urls":[{"start":97,"end":119,"url":"http://t.co/SVQ1K5lU1Q","expanded_url":"http://bit.ly/1lEY7Fn","display_url":"bit.ly/1lEY7Fn"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-07T13:25:59.000Z","text":"Our committee for veterinary medicines, #CVMP, is meeting next week. Highlights out next Friday: http://t.co/SVQ1K5lU1Q","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"441927745770389504","attachments":{"media_keys":{}}},{"source":"bitly bitlink","referenced_tweets":{},"id":"441912619054927872","entities":{"hashtags":[{"start":31,"end":40,"tag":"zolpidem"}],"mentions":{},"urls":[{"start":113,"end":135,"url":"http://t.co/U6HxyY7W39","expanded_url":"http://bit.ly/1gexY91","display_url":"bit.ly/1gexY91"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-07T12:25:53.000Z","text":"PRAC has recommended update of #zolpidem to minimise risk of impaired driving and mental alertness next morning: http://t.co/U6HxyY7W39","lang":"en","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"441912619054927872","attachments":{"media_keys":{}}},{"source":"bitly bitlink","referenced_tweets":{},"id":"441912105214943232","entities":{"hashtags":[{"start":21,"end":31,"tag":"diacerein"}],"mentions":{},"urls":[{"start":92,"end":114,"url":"http://t.co/BdfMVR4bOa","expanded_url":"http://bit.ly/P843cU","display_url":"bit.ly/P843cU"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-07T12:23:50.000Z","text":"PRAC has re-examined #diacerein and recommended that it remain available with restrictions: http://t.co/BdfMVR4bOa","lang":"en","public_metrics":{"retweet_count":6,"reply_count":1,"like_count":2,"quote_count":0},"conversation_id":"441912105214943232","attachments":{"media_keys":{}}},{"source":"bitly bitlink","referenced_tweets":{},"id":"441910072168693760","entities":{"hashtags":[{"start":35,"end":47,"tag":"domperidone"}],"mentions":{},"urls":[{"start":49,"end":71,"url":"http://t.co/rN8fqXcDeY","expanded_url":"http://bit.ly/1dyDGp0","display_url":"bit.ly/1dyDGp0"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-07T12:15:46.000Z","text":"PRAC recommends restricting use of #domperidone: http://t.co/rN8fqXcDeY","lang":"en","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"441910072168693760","attachments":{"media_keys":{}}},{"source":"bitly bitlink","referenced_tweets":{},"id":"441909836914380800","entities":{"hashtags":[{"start":25,"end":30,"tag":"PRAC"}],"mentions":{},"urls":[{"start":51,"end":73,"url":"http://t.co/XXc3FcbXqn","expanded_url":"http://bit.ly/1igyvtu","display_url":"bit.ly/1igyvtu"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-07T12:14:50.000Z","text":"We've just published the #PRAC meeting highlights: http://t.co/XXc3FcbXqn","lang":"en","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"441909836914380800","attachments":{"media_keys":{}}},{"source":"bitly bitlink","referenced_tweets":{},"id":"441909814038650880","entities":{"hashtags":[{"start":88,"end":92,"tag":"flu"}],"mentions":{},"urls":[{"start":113,"end":135,"url":"http://t.co/s4L6r9POZn","expanded_url":"http://bit.ly/1e8ZdBk","display_url":"bit.ly/1e8ZdBk"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-07T12:14:44.000Z","text":"Send your comments on our interim guidance on enhanced safety surveillance for seasonal #flu vaccines in the EU: http://t.co/s4L6r9POZn","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"441909814038650880","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","referenced_tweets":{},"id":"441887814486339584","entities":{"hashtags":[{"start":68,"end":84,"tag":"qualitybydesign"}],"mentions":[{"start":103,"end":110,"username":"US_FDA","id":"208120290"}],"urls":[{"start":112,"end":134,"url":"http://t.co/CJXrp8mBj6","expanded_url":"http://bit.ly/1g2QmFt","display_url":"bit.ly/1g2QmFt"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-07T10:47:19.000Z","text":"We're extending by 2 years our programme for parallel assessment of #qualitybydesign applications with @US_FDA: http://t.co/CJXrp8mBj6","lang":"en","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"441887814486339584","attachments":{"media_keys":{}}},{"source":"Twitter for iPhone","referenced_tweets":[{"type":"retweeted","id":"441633992207785984"}],"id":"441636000633470976","entities":{"hashtags":[{"start":127,"end":134,"tag":"mhraal"}],"mentions":[{"start":3,"end":13,"username":"MHRAgovuk","id":"330993102"},{"start":116,"end":126,"username":"RCPLondon","id":"1338487893279580167"}],"urls":{},"annotations":[{"start":51,"end":71,"probability":0.5548,"type":"Other","normalized_text":"Agency Annual Lecture"},{"start":80,"end":106,"probability":0.582,"type":"Organization","normalized_text":"Royal College of Physicians"},{"start":109,"end":114,"probability":0.8292,"type":"Place","normalized_text":"London"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-06T18:06:42.000Z","text":"RT @MHRAgovuk: Welcome to the live coverage of the Agency Annual Lecture at the Royal College of Physicians, London @RCPLondon #mhraal","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"441636000633470976","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"441623637901459456"}],"id":"441630061536739328","entities":{"hashtags":[{"start":111,"end":121,"tag":"Just1Bite"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":[{"start":88,"end":110,"url":"http://t.co/9HFK4gflQM","expanded_url":"http://goo.gl/KhHh9n","display_url":"goo.gl/KhHh9n"}],"annotations":[{"start":9,"end":24,"probability":0.6608,"type":"Other","normalized_text":"World Health Day"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-06T17:43:06.000Z","text":"RT @WHO: World Health Day 2014 posters are now available! Download and spread the word! http://t.co/9HFK4gflQM #Just1Bite http://t.co/QDNog…","lang":"en","public_metrics":{"retweet_count":183,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"441630061536739328","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"441616538039504896"}],"id":"441629804669190146","entities":{"hashtags":{},"mentions":[{"start":3,"end":12,"username":"FDAWomen","id":"65416742"}],"urls":{},"annotations":[{"start":14,"end":16,"probability":0.7612,"type":"Organization","normalized_text":"FDA"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-06T17:42:05.000Z","text":"RT @FDAWomen: FDA Public Hearing on demographic subpopulation data. Register &amp; submit commnets on  FDASIA Section 907 Action Plan http://t.…","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"441629804669190146","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"441612698045124609"}],"id":"441629516147216384","entities":{"hashtags":[{"start":67,"end":76,"tag":"vaccines"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":{},"annotations":[{"start":9,"end":15,"probability":0.9204,"type":"Person","normalized_text":"Dr Chan"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-06T17:40:56.000Z","text":"RT @WHO: Dr Chan: Ensuring uninterrupted supply of quality-assured #vaccines is central to improving performance of health systems","lang":"en","public_metrics":{"retweet_count":33,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"441629516147216384","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"441612686099374081"}],"id":"441629473948311552","entities":{"hashtags":[{"start":20,"end":24,"tag":"FDA"},{"start":32,"end":38,"tag":"Lilly"},{"start":40,"end":51,"tag":"Boehringer"},{"start":52,"end":61,"tag":"diabetes"},{"start":62,"end":67,"tag":"drug"}],"mentions":[{"start":3,"end":18,"username":"nakosbalamotis","id":"39364251"},{"start":119,"end":127,"username":"Reuters","id":"1652541"}],"urls":[{"start":92,"end":114,"url":"http://t.co/58uU8OzOP6","expanded_url":"http://reut.rs/1hKZWNQ","display_url":"reut.rs/1hKZWNQ"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-06T17:40:46.000Z","text":"RT @nakosbalamotis: #FDA spurns #Lilly, #Boehringer #diabetes #drug, cites factory problems http://t.co/58uU8OzOP6 via @reuters","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"441629473948311552","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"441605114928041984"}],"id":"441608984735522816","entities":{"hashtags":{},"mentions":[{"start":3,"end":11,"username":"FDACBER","id":"303777686"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-06T16:19:21.000Z","text":"RT @FDACBER: Public Workshop: Synergizing Efforts in Standards Development for Cellular Therapies &amp; Regenerative Medicine Products http://t…","lang":"en","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"441608984735522816","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"441602521300480000"}],"id":"441603061572964353","entities":{"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":62,"end":84,"url":"http://t.co/LzwIBJaBzL","expanded_url":"http://in.mobile.reuters.com/article/idINBREA242EA20140306?irpc=932","display_url":"in.mobile.reuters.com/article/idINBR…"}],"annotations":[{"start":58,"end":60,"probability":0.6204,"type":"Other","normalized_text":"HIV"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-06T15:55:49.000Z","text":"RT @GCessak: Gene therapy may offer 'functional' cure for HIV http://t.co/LzwIBJaBzL","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"441603061572964353","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"441602381764382720"}],"id":"441603015381094401","entities":{"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":69,"end":91,"url":"http://t.co/4hHMlD7SGM","expanded_url":"http://www.nature.com/news/gene-editing-method-tackles-hiv-in-first-clinical-test-1.14813","display_url":"nature.com/news/gene-edit…"}],"annotations":[{"start":41,"end":43,"probability":0.773,"type":"Other","normalized_text":"HIV"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-06T15:55:38.000Z","text":"RT @GCessak: Gene-editing method tackles HIV in first clinical test: http://t.co/4hHMlD7SGM","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"441603015381094401","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"441601288157925376"}],"id":"441602917225988096","entities":{"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":66,"end":88,"url":"http://t.co/BDB8JjirQu","expanded_url":"http://bit.ly/NVf00b","display_url":"bit.ly/NVf00b"},{"start":89,"end":111,"url":"http://t.co/X9wSv0i4xo","expanded_url":"https://twitter.com/EFPIA/status/441601288157925376/photo/1","display_url":"pic.twitter.com/X9wSv0i4xo"}],"annotations":[{"start":39,"end":41,"probability":0.7671,"type":"Other","normalized_text":"HIV"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-06T15:55:14.000Z","text":"RT @EFPIA: Gene-editing method tackles HIV in first clinical test http://t.co/BDB8JjirQu http://t.co/X9wSv0i4xo","lang":"en","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"441602917225988096","attachments":{"media_keys":["3_441601288162119680"]}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"441599734281949184"}],"id":"441600422042931200","entities":{"hashtags":[{"start":37,"end":42,"tag":"IGPA"},{"start":100,"end":109,"tag":"generics"},{"start":110,"end":126,"tag":"pharmaceuticals"},{"start":127,"end":134,"tag":"health"}],"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"}],"urls":[{"start":77,"end":99,"url":"http://t.co/93FPhrajow","expanded_url":"http://www.igpagenerics.com/","display_url":"igpagenerics.com"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-06T15:45:19.000Z","text":"RT @egagenerics: Do you know the new #IGPA website? Come in and take a look: http://t.co/93FPhrajow #generics #pharmaceuticals #health #ass…","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"441600422042931200","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"441599362129735680"}],"id":"441600393009979392","entities":{"hashtags":{},"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"},{"start":26,"end":36,"username":"URPLWMiPB","id":"556679074"},{"start":123,"end":130,"username":"US_FDA","id":"208120290"}],"urls":{},"annotations":[{"start":80,"end":121,"probability":0.4389,"type":"Organization","normalized_text":"United States Food And Drug Administration"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-06T15:45:12.000Z","text":"RT @URPLWMiPB: The Office @URPLWMiPB signed Confidentiality Commitment with the United States Food And Drug Administration @US_FDA http://t…","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"441600393009979392","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"441598109722746881"}],"id":"441598255248719872","entities":{"hashtags":{},"mentions":[{"start":3,"end":14,"username":"Berlaymont","id":"19003991"}],"urls":[{"start":57,"end":79,"url":"http://t.co/DTgV7SNS4R","expanded_url":"http://bit.ly/1l6oP6K","display_url":"bit.ly/1l6oP6K"}],"annotations":[{"start":53,"end":55,"probability":0.8095,"type":"Other","normalized_text":"HIV"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-06T15:36:43.000Z","text":"RT @Berlaymont: Second baby may have been cured from HIV http://t.co/DTgV7SNS4R","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"441598255248719872","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"441596071123247104"}],"id":"441597479122128896","entities":{"hashtags":[{"start":63,"end":67,"tag":"HIV"}],"mentions":[{"start":3,"end":18,"username":"nakosbalamotis","id":"39364251"},{"start":116,"end":124,"username":"Reuters","id":"1652541"}],"urls":[{"start":89,"end":111,"url":"http://t.co/opxRvpo9PG","expanded_url":"http://reut.rs/1gb6bWX","display_url":"reut.rs/1gb6bWX"}],"annotations":[{"start":69,"end":72,"probability":0.8917,"type":"Place","normalized_text":"U.S."}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-06T15:33:38.000Z","text":"RT @nakosbalamotis: Nine-month-old baby may have been cured of #HIV, U.S. scientists say http://t.co/opxRvpo9PG via @reuters","lang":"en","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"441597479122128896","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"441595332867395584"}],"id":"441597157364482048","entities":{"hashtags":[{"start":101,"end":110,"tag":"vaccines"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":{},"annotations":[{"start":9,"end":15,"probability":0.883,"type":"Person","normalized_text":"Dr Chan"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-06T15:32:21.000Z","text":"RT @WHO: Dr Chan: [In 1979] 5% of world’s children were protected from 6 killer diseases targeted by #vaccines. Today 83% are http://t.co/h…","lang":"en","public_metrics":{"retweet_count":71,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"441597157364482048","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"441590888222171137"}],"id":"441591109090045953","entities":{"hashtags":[{"start":74,"end":83,"tag":"vaccines"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":[{"start":117,"end":139,"url":"http://t.co/hIacQP2Zqt","expanded_url":"http://goo.gl/FX6JcT","display_url":"goo.gl/FX6JcT"}],"annotations":[{"start":9,"end":15,"probability":0.8643,"type":"Person","normalized_text":"Dr Chan"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-06T15:08:19.000Z","text":"RT @WHO: Dr Chan: Smallpox eradication was taken as proof of the power of #vaccines to permanently improve the world http://t.co/hIacQP2Zqt","lang":"en","public_metrics":{"retweet_count":55,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"441591109090045953","attachments":{"media_keys":{}}},{"source":"bitly bitlink","referenced_tweets":{},"id":"441587723791781888","entities":{"hashtags":[{"start":62,"end":78,"tag":"qualitybydesign"}],"mentions":[{"start":97,"end":104,"username":"US_FDA","id":"208120290"}],"urls":[{"start":106,"end":128,"url":"http://t.co/CJXrp8mBj6","expanded_url":"http://bit.ly/1g2QmFt","display_url":"bit.ly/1g2QmFt"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-06T14:54:52.000Z","text":"We've extended our pilot programme for parallel assessment of #qualitybydesign applications with @US_FDA: http://t.co/CJXrp8mBj6","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"441587723791781888","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"441585959571042304"}],"id":"441587188682457088","entities":{"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"},{"start":24,"end":34,"username":"URPLWMiPB","id":"556679074"},{"start":121,"end":128,"username":"US_FDA","id":"208120290"}],"urls":{},"annotations":[{"start":78,"end":119,"probability":0.4852,"type":"Organization","normalized_text":"United States Food And Drug Administration"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-06T14:52:44.000Z","text":"RT @GCessak: The Office @URPLWMiPB signed Confidentiality Commitment with the United States Food And Drug Administration @US_FDA http://t.c…","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"441587188682457088","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"441585080134537216"}],"id":"441587171422924800","entities":{"hashtags":[{"start":27,"end":37,"tag":"Alzheimer"},{"start":97,"end":104,"tag":"cancer"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":105,"end":127,"url":"http://t.co/ftnfgrf1ED","expanded_url":"http://wapo.st/MOE1t0","display_url":"wapo.st/MOE1t0"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-06T14:52:40.000Z","text":"RT @EFPIA: New study ranks #Alzheimer’s as third-leading cause of death, after heart disease and #cancer http://t.co/ftnfgrf1ED","lang":"en","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"441587171422924800","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"441561248933494785"}],"id":"441561350217940992","entities":{"hashtags":{},"mentions":[{"start":3,"end":17,"username":"MHRAmedicines","id":"960436586"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-06T13:10:04.000Z","text":"RT @MHRAmedicines: Class 2 Medicines Recall (action within 48 hours): Viread 245 mg Film-Coated Tablets - Gilead Sciences Limited... http:/…","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"441561350217940992","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"441544619093131264"}],"id":"441545155964063744","entities":{"hashtags":[{"start":121,"end":128,"tag":"mhraal"}],"mentions":[{"start":3,"end":13,"username":"MHRAgovuk","id":"330993102"},{"start":16,"end":23,"username":"US_FDA","id":"208120290"}],"urls":{},"annotations":[{"start":37,"end":46,"probability":0.6028,"type":"Person","normalized_text":"Dr Hamburg"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-06T12:05:43.000Z","text":"RT @MHRAgovuk: .@US_FDA Commissioner Dr Hamburg will talk about regulatory challenges presented by globalised healthcare #mhraal","lang":"en","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"441545155964063744","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"441544588608950272"}],"id":"441545142445821952","entities":{"hashtags":[{"start":22,"end":29,"tag":"mhraal"},{"start":123,"end":130,"tag":"mhraal"}],"mentions":[{"start":3,"end":13,"username":"MHRAgovuk","id":"330993102"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-06T12:05:40.000Z","text":"RT @MHRAgovuk: Follow #mhraal from 18:00 for tonight's Medicines and Healthcare Products Regulatory Agency Annual Lecture. #mhraal","lang":"en","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"441545142445821952","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"441539077075390464"}],"id":"441540745007484928","entities":{"hashtags":{},"mentions":[{"start":3,"end":13,"username":"MHRAgovuk","id":"330993102"}],"urls":{},"annotations":[{"start":22,"end":35,"probability":0.9934,"type":"Person","normalized_text":"Lynda Scammell"},{"start":38,"end":53,"probability":0.9966,"type":"Person","normalized_text":"Alastair Jeffrey"},{"start":59,"end":70,"probability":0.9952,"type":"Person","normalized_text":"Bruce Petrie"},{"start":90,"end":114,"probability":0.4272,"type":"Other","normalized_text":"Anti Illicit Trade Summit"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-06T11:48:11.000Z","text":"RT @MHRAgovuk: MHRA’s Lynda Scammell, Alastair Jeffrey and Bruce Petrie will speak at the Anti Illicit Trade Summit. Follow #bigdealscotlan…","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"441540745007484928","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"441538815253938176"}],"id":"441538935832207361","entities":{"hashtags":[{"start":111,"end":123,"tag":"socialmedia"},{"start":124,"end":131,"tag":"health"},{"start":132,"end":139,"tag":"europe"}],"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"},{"start":100,"end":110,"username":"edqm_news","id":"2242197968"}],"urls":[{"start":73,"end":95,"url":"http://t.co/6LnqtbgNOZ","expanded_url":"http://www.edqm.eu/en/EDQM-takes-its-first-steps-on-social-network-Twitter-1587.html?mbID=178&nc=7&e=am1hcmVjaGFsQGVnYWdlbmVyaWNzLmNvbQ%3D%3D","display_url":"edqm.eu/en/EDQM-takes-…"}],"annotations":[{"start":62,"end":68,"probability":0.6698,"type":"Product","normalized_text":"Twitter"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-06T11:41:00.000Z","text":"RT @egagenerics: EDQM takes its first steps on social network Twitter -  http://t.co/6LnqtbgNOZ via @edqm_news #socialmedia #health #europe","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"441538935832207361","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"441531196586348544"}],"id":"441532358219804672","entities":{"hashtags":[{"start":104,"end":109,"tag":"AIDS"},{"start":110,"end":114,"tag":"HIV"},{"start":115,"end":124,"tag":"Research"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":81,"end":103,"url":"http://t.co/2m87faFLvR","expanded_url":"http://nyti.ms/1cEjyhA","display_url":"nyti.ms/1cEjyhA"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-06T11:14:52.000Z","text":"RT @EFPIA: Injections Providing Protection Against AIDS in Monkeys, Studies Find http://t.co/2m87faFLvR #AIDS #HIV #Research","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"441532358219804672","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":{},"id":"441531974118019072","entities":{"hashtags":{},"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"urls":[{"start":114,"end":136,"url":"http://t.co/VW1WYawRFQ","expanded_url":"http://bit.ly/1ccbQjQ","display_url":"bit.ly/1ccbQjQ"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-06T11:13:20.000Z","text":"RT @INFARMED_IP: Voluntary recall of medicine Viread, 245mg, film-coated tablet - batch no. KFBPD, expiry 12/2017 http://t.co/VW1WYawRFQ","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"441531974118019072","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"441520974547009536"}],"id":"441531219420139521","entities":{"hashtags":[{"start":60,"end":65,"tag":"AIDS"}],"mentions":[{"start":3,"end":18,"username":"nakosbalamotis","id":"39364251"}],"urls":[{"start":91,"end":113,"url":"http://t.co/UTgtY7ND2Q","expanded_url":"http://nyti.ms/1dmYqjt","display_url":"nyti.ms/1dmYqjt"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-06T11:10:20.000Z","text":"RT @nakosbalamotis: Injections Providing Protection Against #AIDS in Monkeys, Studies Find http://t.co/UTgtY7ND2Q","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"441531219420139521","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"441519071880691712"}],"id":"441529637567737856","entities":{"hashtags":{},"mentions":[{"start":3,"end":19,"username":"EU_ScienceChief","id":"2743488442"}],"urls":[{"start":53,"end":75,"url":"http://t.co/d1UR7JdCKm","expanded_url":"http://www.theguardian.com/science/2014/mar/05/hiv-gene-therapy-gm-cells-trial-success","display_url":"theguardian.com/science/2014/m…"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-06T11:04:03.000Z","text":"RT @EU_ScienceChief: HIV gene therapy using GM cells http://t.co/d1UR7JdCKm","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"441529637567737856","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"441514514119655425"}],"id":"441528904256618496","entities":{"hashtags":[{"start":109,"end":114,"tag":"jobs"},{"start":115,"end":118,"tag":"eu"}],"mentions":[{"start":3,"end":17,"username":"karlosponders","id":"17485749"}],"urls":[{"start":86,"end":108,"url":"http://t.co/SCVoXID9Zw","expanded_url":"http://lnkd.in/dwMe_7x","display_url":"lnkd.in/dwMe_7x"}],"annotations":[{"start":23,"end":47,"probability":0.5758,"type":"Organization","normalized_text":"European Medicines Agency"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-06T11:01:08.000Z","text":"RT @karlosponders: The European Medicines Agency is looking to recruit a Data Analyst http://t.co/SCVoXID9Zw #jobs #eu","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"441528904256618496","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":{},"id":"441511772135387136","entities":{"hashtags":{},"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"urls":[{"start":114,"end":136,"url":"http://t.co/G0lwJMcz0t","expanded_url":"http://bit.ly/1gc0Y19","display_url":"bit.ly/1gc0Y19"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-06T09:53:04.000Z","text":"RT @URPLWMiPB: If you notice side effects, contact your doctor, pharmacist, or national medicines agency directly http://t.co/G0lwJMcz0t","lang":"en","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":1,"quote_count":0},"conversation_id":"441511772135387136","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":{},"id":"441511290918682624","entities":{"hashtags":{},"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"urls":[{"start":111,"end":133,"url":"http://t.co/WK4IvXoWuF","expanded_url":"http://bit.ly/1gc0QP0","display_url":"bit.ly/1gc0QP0"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-06T09:51:09.000Z","text":"RT @URPLWMiPB: New restriction of indication and recommendation for monitoring the safety of medicine Protelos http://t.co/WK4IvXoWuF","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":1},"conversation_id":"441511290918682624","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"441502585199931393"}],"id":"441510765250752512","entities":{"hashtags":[{"start":63,"end":78,"tag":"ClinicalTrials"}],"mentions":[{"start":3,"end":18,"username":"nakosbalamotis","id":"39364251"}],"urls":[{"start":101,"end":123,"url":"http://t.co/ZhLQaD1wIg","expanded_url":"http://www.medicalnewstoday.com/releases/273458.php#.Uxg7mWSMKl4.twitter","display_url":"medicalnewstoday.com/releases/27345…"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-06T09:49:03.000Z","text":"RT @nakosbalamotis: Study examines gap in federal oversight of #ClinicalTrials - Medical News Today: http://t.co/ZhLQaD1wIg","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"441510765250752512","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"441501800357957632"}],"id":"441510434152394752","entities":{"hashtags":[{"start":24,"end":28,"tag":"FDA"},{"start":80,"end":88,"tag":"twitter"}],"mentions":[{"start":3,"end":18,"username":"nakosbalamotis","id":"39364251"},{"start":98,"end":106,"username":"openFDA","id":"2227519598"}],"urls":[{"start":38,"end":60,"url":"http://t.co/3n2JSt3ZGN","expanded_url":"http://open.fda.gov/","display_url":"open.fda.gov"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-06T09:47:45.000Z","text":"RT @nakosbalamotis: New #FDA webpage (http://t.co/3n2JSt3ZGN). Follow their new #twitter account: @openFDA","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"441510434152394752","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"441501212001574913"}],"id":"441510362102628352","entities":{"hashtags":[{"start":12,"end":16,"tag":"eOJ"}],"mentions":[{"start":3,"end":10,"username":"EURLex","id":"294028805"},{"start":30,"end":37,"username":"EURLex","id":"294028805"}],"urls":[{"start":106,"end":128,"url":"http://t.co/gIa4ABk9EG","expanded_url":"http://new.eur-lex.europa.eu/oj/direct-access.html","display_url":"new.eur-lex.europa.eu/oj/direct-acce…"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-06T09:47:27.000Z","text":"RT @EURLex: #eOJ available on @EURLex same day it is published, usually before noon, after it is e-signed http://t.co/gIa4ABk9EG http://t.c…","lang":"en","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"441510362102628352","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"441498177720840192"}],"id":"441510200127008768","entities":{"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":62,"end":84,"url":"http://t.co/8pSGi1bFoO","expanded_url":"http://www.ema.europa.eu/docs/en_GB/document_library/Newsletter/2014/03/WC500162283.pdf","display_url":"ema.europa.eu/docs/en_GB/doc…"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-06T09:46:49.000Z","text":"RT @GCessak: EMA | Human medicines highlights - February 2014 http://t.co/8pSGi1bFoO","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"441510200127008768","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","referenced_tweets":{},"id":"441269031874490368","entities":{"hashtags":[{"start":123,"end":128,"tag":"data"}],"mentions":{},"urls":[{"start":99,"end":121,"url":"http://t.co/Oxib6u9rIA","expanded_url":"http://bit.ly/1ibWxu8","display_url":"bit.ly/1ibWxu8"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-05T17:48:30.000Z","text":"We've just published a new vacancy for a Data Analyst in our Business Data and Support Department: http://t.co/Oxib6u9rIA  #data","lang":"en","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"441269031874490368","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","referenced_tweets":{},"id":"441268612905463809","entities":{"hashtags":{},"mentions":{},"urls":[{"start":59,"end":81,"url":"http://t.co/WQancCVUZf","expanded_url":"http://bit.ly/1fxYYQt","display_url":"bit.ly/1fxYYQt"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-05T17:46:50.000Z","text":"We're recruiting a Legal Officer. Two weeks left to apply: http://t.co/WQancCVUZf","lang":"en","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"441268612905463809","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"441188949583613952"}],"id":"441222323438645248","entities":{"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":37,"end":59,"url":"http://t.co/F9oVeeCSVG","expanded_url":"http://bit.ly/1lysOfk","display_url":"bit.ly/1lysOfk"},{"start":60,"end":82,"url":"http://t.co/IXV5TzqJ93","expanded_url":"https://twitter.com/EFPIA/status/441188949583613952/photo/1","display_url":"pic.twitter.com/IXV5TzqJ93"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-05T14:42:54.000Z","text":"RT @EFPIA: Smart pills ‘set to boom’ http://t.co/F9oVeeCSVG http://t.co/IXV5TzqJ93","lang":"en","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"441222323438645248","attachments":{"media_keys":["3_441188949587808260"]}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"441161315298852864"}],"id":"441222066835292160","entities":{"hashtags":{},"mentions":[{"start":3,"end":14,"username":"eupatients","id":"465674067"}],"urls":[{"start":116,"end":138,"url":"http://t.co/M43CbQUEgg","expanded_url":"http://ow.ly/ucqJK","display_url":"ow.ly/ucqJK"}],"annotations":[{"start":95,"end":100,"probability":0.7204,"type":"Place","normalized_text":"Warsaw"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-05T14:41:52.000Z","text":"RT @eupatients: Looking for good examples of patient groups communicating with the public, for Warsaw presentation. http://t.co/M43CbQUEgg","lang":"en","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"441222066835292160","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"441190924341608448"}],"id":"441221957380747265","entities":{"hashtags":[{"start":22,"end":31,"tag":"diabetes"},{"start":41,"end":44,"tag":"EU"},{"start":93,"end":100,"tag":"speech"},{"start":102,"end":105,"tag":"EU"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":68,"end":77,"username":"EURACTIV","id":"14808226"},{"start":84,"end":92,"username":"borgton","id":"1605512862"}],"urls":[{"start":45,"end":67,"url":"http://t.co/rwlapd5bHe","expanded_url":"http://ow.ly/2EpSKN","display_url":"ow.ly/2EpSKN"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-05T14:41:26.000Z","text":"RT @EU_Health: Rising #diabetes curve in #EU http://t.co/rwlapd5bHe @EurActiv, read @borgton #speech: #EU action 2 address diabetes http://…","lang":"en","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"441221957380747265","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"441194944242655232"}],"id":"441221916448555009","entities":{"hashtags":[{"start":58,"end":62,"tag":"FDA"}],"mentions":[{"start":3,"end":19,"username":"FDAcdrhIndustry","id":"66367559"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-05T14:41:17.000Z","text":"RT @FDAcdrhIndustry: Demographic Data in Applications for #FDA Approval - Public Hearing 4/1/14 - Request for Comments http://t.co/6pumJwAN…","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"441221916448555009","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"441206652608323585"}],"id":"441220897534648320","entities":{"hashtags":{},"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"},{"start":20,"end":24,"username":"WHO","id":"14499829"}],"urls":[{"start":92,"end":114,"url":"http://t.co/JV9F1LpqXQ","expanded_url":"http://goo.gl/ULZXwu","display_url":"goo.gl/ULZXwu"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-05T14:37:14.000Z","text":"RT @Hep_Alliance: . @WHO Global policy report identifies govt strategies on viral hepatitis http://t.co/JV9F1LpqXQ 180 countries vaccinate …","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"441220897534648320","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"441211992854913025"}],"id":"441220701786476544","entities":{"hashtags":[{"start":127,"end":132,"tag":"STIs"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":[{"start":104,"end":126,"url":"http://t.co/3VnGNuGMQ6","expanded_url":"http://goo.gl/24X7j0","display_url":"goo.gl/24X7j0"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-05T14:36:27.000Z","text":"RT @WHO: Gonorrhoea is becoming increasingly resistant to the medicines currently available to treat it http://t.co/3VnGNuGMQ6 #STIs","lang":"en","public_metrics":{"retweet_count":108,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"441220701786476544","attachments":{"media_keys":{}}},{"source":"bitly bitlink","referenced_tweets":{},"id":"441182815305342976","entities":{"hashtags":{},"mentions":{},"urls":[{"start":71,"end":93,"url":"http://t.co/gRheJ2j2uB","expanded_url":"http://bit.ly/1fxYYQt","display_url":"bit.ly/1fxYYQt"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-05T12:05:54.000Z","text":"Two weeks left to apply to our vacancy for a Legal Officer at the EMA: http://t.co/gRheJ2j2uB","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"441182815305342976","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","referenced_tweets":{},"id":"441182360537546752","entities":{"hashtags":[{"start":70,"end":81,"tag":"vancomycin"}],"mentions":{},"urls":[{"start":92,"end":114,"url":"http://t.co/3kVFhAJbxz","expanded_url":"http://bit.ly/OWnpS8","display_url":"bit.ly/OWnpS8"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-05T12:04:06.000Z","text":"Comment on a draft Q&amp;A on expression / declaration of potency for #vancomycin products: http://t.co/3kVFhAJbxz","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"441182360537546752","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","referenced_tweets":{},"id":"441182130190577664","entities":{"hashtags":[{"start":84,"end":95,"tag":"fibrinogen"}],"mentions":{},"urls":[{"start":118,"end":140,"url":"http://t.co/VLnl3Tb3vb","expanded_url":"http://bit.ly/1mS70wH","display_url":"bit.ly/1mS70wH"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-05T12:03:11.000Z","text":"Send comments on our draft guideline on core summary of product characteristics for #fibrinogen-containing medicines: http://t.co/VLnl3Tb3vb","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"441182130190577664","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","referenced_tweets":{},"id":"441181910165770240","entities":{"hashtags":[{"start":17,"end":32,"tag":"EudraVigilance"}],"mentions":{},"urls":[{"start":73,"end":95,"url":"http://t.co/eOpWaoPlAT","expanded_url":"http://bit.ly/1f0OqJ2","display_url":"bit.ly/1f0OqJ2"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-05T12:02:18.000Z","text":"We are holding a #EudraVigilance information day at the EMA on 12 March: http://t.co/eOpWaoPlAT","lang":"en","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"441181910165770240","attachments":{"media_keys":{}}},{"source":"bitly bitlink","referenced_tweets":{},"id":"441172878139355136","entities":{"hashtags":[{"start":127,"end":132,"tag":"data"}],"mentions":{},"urls":[{"start":103,"end":125,"url":"http://t.co/3QRWDetdFl","expanded_url":"http://bit.ly/1ibWxu8","display_url":"bit.ly/1ibWxu8"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-05T11:26:25.000Z","text":"We're recruiting a Data Analyst to work in our newly established Business Data and Support Department: http://t.co/3QRWDetdFl  #data","lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":3,"quote_count":0},"conversation_id":"441172878139355136","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"440904665907994626"}],"id":"440904708186968065","entities":{"hashtags":[{"start":104,"end":111,"tag":"Pharma"},{"start":112,"end":117,"tag":"Jobs"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":81,"end":103,"url":"http://t.co/GLK5ycAX1v","expanded_url":"http://bit.ly/1n0lSG0","display_url":"bit.ly/1n0lSG0"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-04T17:40:48.000Z","text":"RT @EFPIA: JOB OPENING! EFPIA is looking for a Planning &amp; Operations Manager http://t.co/GLK5ycAX1v #Pharma #Jobs","lang":"en","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"440904708186968065","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"440900182998134784"}],"id":"440902096934957057","entities":{"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":84,"end":98,"username":"EU_Commission","id":"157981564"}],"urls":[{"start":61,"end":83,"url":"http://t.co/V48WuO4Yry","expanded_url":"http://bit.ly/1dmrZBr","display_url":"bit.ly/1dmrZBr"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-04T17:30:26.000Z","text":"RT @EFPIA: Indicators on life expectancy at birth and age 65 http://t.co/V48WuO4Yry @EU_Commission","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"440902096934957057","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"440898385608839168"}],"id":"440901466933694464","entities":{"hashtags":{},"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-04T17:27:55.000Z","text":"RT @euparkinsons: Zonisamide attenuates α-synuclein neurotoxicity by an aggregation-independent mechanism in a rat model of familial PD htt…","lang":"ro","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"440901466933694464","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"440892716428578816"}],"id":"440892790239948800","entities":{"hashtags":{},"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"}],"urls":[{"start":78,"end":100,"url":"http://t.co/CXVz4CcJyu","expanded_url":"http://orphandruganaut.wordpress.com/2014/03/04/orphan-drugs-fda-february-2014-products-receiving-approval/","display_url":"orphandruganaut.wordpress.com/2014/03/04/orp…"}],"annotations":[{"start":32,"end":34,"probability":0.6296,"type":"Organization","normalized_text":"FDA"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-04T16:53:27.000Z","text":"RT @DrugInfoAssn: Orphan Drugs: FDA February 2014 Products Receiving Approval http://t.co/CXVz4CcJyu","lang":"en","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"440892790239948800","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"440888358433468416"}],"id":"440888462758408192","entities":{"hashtags":[{"start":117,"end":121,"tag":"flu"}],"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"}],"urls":{},"annotations":[{"start":88,"end":89,"probability":0.875,"type":"Place","normalized_text":"US"},{"start":100,"end":105,"probability":0.9491,"type":"Place","normalized_text":"Europe"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-04T16:36:15.000Z","text":"RT @ECDC_Flu: Late start, no geographic pattern, A(H1)pdm09 virus less dominant than in US. More on Europe's 2013-14 #flu season: http://t.…","lang":"en","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"440888462758408192","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"440874513673515009"}],"id":"440876309422800896","entities":{"hashtags":[{"start":18,"end":28,"tag":"Parkinson"}],"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"urls":{},"annotations":[{"start":103,"end":125,"probability":0.4281,"type":"Organization","normalized_text":"University of Cambridge"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-04T15:47:57.000Z","text":"RT @euparkinsons: #Parkinson's &amp; impulsive control disorders: Volunteers sought 4 clinical trial @ the University of Cambridge - http://t.c…","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"440876309422800896","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"440871948780724224"}],"id":"440876114328977408","entities":{"hashtags":{},"mentions":[{"start":3,"end":18,"username":"nakosbalamotis","id":"39364251"}],"urls":[{"start":76,"end":98,"url":"http://t.co/JRk2DkB3mv","expanded_url":"http://www.pharmafile.com/news/182645/clinical-studies-still-not-being-published#.UxXxmPm7RJY.twitter","display_url":"pharmafile.com/news/182645/cl…"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-04T15:47:11.000Z","text":"RT @nakosbalamotis: Clinical studies still not being published | Pharmafile http://t.co/JRk2DkB3mv","lang":"en","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"440876114328977408","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":{},"id":"440876007118348288","entities":{"hashtags":[{"start":91,"end":95,"tag":"IGZ"},{"start":96,"end":110,"tag":"patientsafety"}],"mentions":[{"start":3,"end":9,"username":"Igznl","id":"1601603352"}],"urls":[{"start":111,"end":133,"url":"http://t.co/DXIyedne0o","expanded_url":"http://bit.ly/1c53daJ","display_url":"bit.ly/1c53daJ"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-04T15:46:45.000Z","text":"RT @igznl: Save the date: 19 June Dutch Healthcare Inspectorate patient safety conference. #IGZ #patientsafety http://t.co/DXIyedne0o","lang":"en","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"440876007118348288","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"440871149035978753"}],"id":"440875453545734145","entities":{"hashtags":[{"start":33,"end":46,"tag":"Transparency"},{"start":77,"end":92,"tag":"Pharmaceutical"}],"mentions":[{"start":3,"end":18,"username":"nakosbalamotis","id":"39364251"}],"urls":[{"start":103,"end":125,"url":"http://t.co/Uaj3Dg0iOH","expanded_url":"http://www.pharmexec.com/pharmexec/Noteworthy/The-Push-for-Transparency-Risks-Costs-and-Concerns/ArticleStandard/Article/detail/836439?ref=25#.UxXw1Xk8qCI.twitter","display_url":"pharmexec.com/pharmexec/Note…"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-04T15:44:33.000Z","text":"RT @nakosbalamotis: The Push for #Transparency: Risks, Costs, and Concerns - #Pharmaceutical Executive http://t.co/Uaj3Dg0iOH","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"440875453545734145","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":{},"id":"440875268266549248","entities":{"hashtags":{},"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"urls":[{"start":90,"end":112,"url":"http://t.co/Kg0TBIVKS7","expanded_url":"http://bit.ly/1c52N4b","display_url":"bit.ly/1c52N4b"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-04T15:43:49.000Z","text":"RT @URPLWMiPB: Regulatory information - fees for applications to the EMA from 1.04. 2014. http://t.co/Kg0TBIVKS7","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"440875268266549248","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"440867715222228992"}],"id":"440874971733438464","entities":{"hashtags":[{"start":112,"end":116,"tag":"HIV"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-04T15:42:38.000Z","text":"RT @WHO: Supplement to WHO 2013 consolidated guidelines on antiretroviral drugs use for treating and preventing #HIV infection http://t.co/…","lang":"en","public_metrics":{"retweet_count":51,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"440874971733438464","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"440864804924702721"}],"id":"440874636424011776","entities":{"hashtags":{},"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-04T15:41:19.000Z","text":"RT @FDAanimalhealth: Zoetis, et al.; Withdrawal of Approval of NADA for Combination Drug Medicated Feeds Containing an Arsenical Drug http:…","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"440874636424011776","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"440862322093858816"}],"id":"440862937411235841","entities":{"hashtags":[{"start":45,"end":51,"tag":"drugs"}],"mentions":[{"start":3,"end":18,"username":"nakosbalamotis","id":"39364251"},{"start":109,"end":121,"username":"MarketWatch","id":"624413"}],"urls":[{"start":82,"end":104,"url":"http://t.co/lgTZALj7Gm","expanded_url":"http://blogs.marketwatch.com/health-exchange/2014/02/28/winning-approval-for-new-drugs-may-get-harder-analyst-warns/","display_url":"blogs.marketwatch.com/health-exchang…"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-04T14:54:49.000Z","text":"RT @nakosbalamotis: Winning approval for new #drugs may get harder, analyst warns http://t.co/lgTZALj7Gm via @MarketWatch","lang":"en","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"440862937411235841","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"440862004207550465"}],"id":"440862736889954304","entities":{"hashtags":{},"mentions":[{"start":3,"end":13,"username":"MHRAgovuk","id":"330993102"},{"start":61,"end":74,"username":"NursingTimes","id":"15881875"}],"urls":[{"start":76,"end":98,"url":"http://t.co/B8MUR2Ptpv","expanded_url":"http://www.nursingtimes.net/nursing-practice/clinical-zones/childrens-nursing/call-to-report-drug-side-effects/5068511.article?blocktitle=News&contentID=4385","display_url":"nursingtimes.net/nursing-practi…"},{"start":99,"end":121,"url":"http://t.co/d6ttfmhPKh","expanded_url":"https://twitter.com/MHRAgovuk/status/440862004207550465/photo/1","display_url":"pic.twitter.com/d6ttfmhPKh"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-04T14:54:01.000Z","text":"RT @MHRAgovuk: Too few parents report drug side effects (via @NursingTimes) http://t.co/B8MUR2Ptpv http://t.co/d6ttfmhPKh","lang":"en","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"440862736889954304","attachments":{"media_keys":["3_440862004211744769"]}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"440861715731718144"}],"id":"440862630434312192","entities":{"hashtags":[{"start":19,"end":24,"tag":"EDQM"},{"start":80,"end":92,"tag":"proofreader"},{"start":117,"end":128,"tag":"employment"}],"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":[{"start":93,"end":115,"url":"http://t.co/E29jmTzUXC","expanded_url":"http://bit.ly/1mSaiAi","display_url":"bit.ly/1mSaiAi"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-04T14:53:36.000Z","text":"RT @edqm_news: The #EDQM is currently looking for a Scientific English-language #proofreader http://t.co/E29jmTzUXC  #employment","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"440862630434312192","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"440858897042006016"}],"id":"440859790110359553","entities":{"hashtags":{},"mentions":[{"start":3,"end":13,"username":"MHRApress","id":"330990243"},{"start":53,"end":66,"username":"standardnews","id":"38142380"}],"urls":[{"start":68,"end":90,"url":"http://t.co/h1ORudp8AV","expanded_url":"http://www.standard.co.uk/panewsfeeds/call-to-report-drug-sideeffects-9164279.html","display_url":"standard.co.uk/panewsfeeds/ca…"},{"start":91,"end":113,"url":"http://t.co/1wAkUpraEX","expanded_url":"https://twitter.com/MHRApress/status/440858897042006016/photo/1","display_url":"pic.twitter.com/1wAkUpraEX"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-04T14:42:19.000Z","text":"RT @MHRApress: Call to report drug side-effects (via @standardnews) http://t.co/h1ORudp8AV http://t.co/1wAkUpraEX","lang":"en","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"440859790110359553","attachments":{"media_keys":["3_440858897050394625"]}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"440857428544851968"}],"id":"440857506257338369","entities":{"hashtags":[{"start":29,"end":38,"tag":"Patients"},{"start":68,"end":81,"tag":"GlobalHealth"}],"mentions":[{"start":3,"end":11,"username":"EPHA_EU","id":"184756856"}],"urls":[{"start":108,"end":130,"url":"http://t.co/iLKDoPPjvd","expanded_url":"http://bit.ly/1hFP5of","display_url":"bit.ly/1hFP5of"}],"annotations":[{"start":97,"end":104,"probability":0.9575,"type":"Place","normalized_text":"Brussels"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-04T14:33:14.000Z","text":"RT @EPHA_EU: [Save the date] #Patients’ Needs Driving Innovation in #GlobalHealth (March 10th in Brussels): http://t.co/iLKDoPPjvd  RSVP by…","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"440857506257338369","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"440853842817609728"}],"id":"440856026712379392","entities":{"hashtags":[{"start":111,"end":131,"tag":"VeterinaryMedicines"}],"mentions":{},"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-04T14:27:22.000Z","text":"RT @IFAHEurope: We support adherence to global common standards &amp; promote a Global Regulatory Strategy for #VeterinaryMedicines: http://t.c…","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"440856026712379392","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":{},"id":"440855950401232896","entities":{"hashtags":[{"start":49,"end":56,"tag":"newjob"}],"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"urls":[{"start":26,"end":48,"url":"http://t.co/NxvS97DF6H","expanded_url":"http://bit.ly/1c4ONYd","display_url":"bit.ly/1c4ONYd"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-04T14:27:03.000Z","text":"RT @LV_MPA: GCP inspector http://t.co/NxvS97DF6H #newjob","lang":"ro","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"440855950401232896","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"440850297645461504"}],"id":"440855776014647296","entities":{"hashtags":[{"start":63,"end":71,"tag":"Vaccine"}],"mentions":[{"start":3,"end":12,"username":"FDA_MCMi","id":"1606025952"},{"start":15,"end":25,"username":"NIAIDNews","id":"59769395"}],"urls":{},"annotations":[{"start":107,"end":118,"probability":0.8776,"type":"Place","normalized_text":"Bethesda, MD"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-04T14:26:22.000Z","text":"RT @FDA_MCMi: .@NIAIDNews is live tweeting today at the Global #Vaccine and Immunization Research Forum in Bethesda, MD: http://t.co/Ijt8mn…","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"440855776014647296","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"440841937474846720"}],"id":"440842295739691009","entities":{"hashtags":[{"start":87,"end":95,"tag":"GPC2014"}],"mentions":[{"start":3,"end":14,"username":"IAPOtweets","id":"14682411"}],"urls":[{"start":64,"end":86,"url":"http://t.co/e7m0CCAd2L","expanded_url":"http://ow.ly/udxY3","display_url":"ow.ly/udxY3"},{"start":96,"end":118,"url":"http://t.co/ekDu0ol5pB","expanded_url":"http://ow.ly/udy5W","display_url":"ow.ly/udy5W"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-04T13:32:48.000Z","text":"RT @IAPOtweets: An introduction to Health Technology Assessment http://t.co/e7m0CCAd2L #GPC2014 http://t.co/ekDu0ol5pB","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"440842295739691009","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":{},"id":"440836485315846144","entities":{"hashtags":{},"mentions":[{"start":3,"end":14,"username":"sanidadgob","id":"232124120"},{"start":50,"end":65,"username":"Farmaindustria","id":"240204741"}],"urls":[{"start":113,"end":135,"url":"http://t.co/1XL6kEqgMw","expanded_url":"http://bit.ly/1g7c2wo","display_url":"bit.ly/1g7c2wo"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-04T13:09:43.000Z","text":"RT @sanidadgob: MSSSI and pharmaceutical industry @Farmaindustria agree to collaborate for benefit of patients - http://t.co/1XL6kEqgMw","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"440836485315846144","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"440833856392806400"}],"id":"440833980200652800","entities":{"hashtags":[{"start":17,"end":28,"tag":"didyouknow"},{"start":130,"end":137,"tag":"health"}],"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-04T12:59:45.000Z","text":"RT @egagenerics: #didyouknow a generic medicine provides the same quality, safety and efficacy as the original brand name product #health #…","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"440833980200652800","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"440824183279190016"}],"id":"440824270093295616","entities":{"hashtags":[{"start":106,"end":113,"tag":"Pharma"},{"start":114,"end":119,"tag":"Jobs"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":81,"end":103,"url":"http://t.co/GLK5ycAX1v","expanded_url":"http://bit.ly/1n0lSG0","display_url":"bit.ly/1n0lSG0"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-04T12:21:10.000Z","text":"RT @EFPIA: JOB OPENING! EFPIA is looking for a Planning &amp; Operations Manager http://t.co/GLK5ycAX1v   #Pharma #Jobs","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"440824270093295616","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","referenced_tweets":{},"id":"440822222471430144","entities":{"hashtags":[{"start":97,"end":106,"tag":"diabetes"}],"mentions":{},"urls":[{"start":108,"end":130,"url":"http://t.co/paRN7VYy6Q","expanded_url":"http://bit.ly/1cnfjfN","display_url":"bit.ly/1cnfjfN"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-04T12:13:02.000Z","text":"Comment now on our reflection paper on the way the indication is worded for medicines for type-2 #diabetes: http://t.co/paRN7VYy6Q","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"440822222471430144","attachments":{"media_keys":{}}},{"source":"bitly bitlink","referenced_tweets":{},"id":"440821930183368705","entities":{"hashtags":[{"start":74,"end":85,"tag":"vancomycin"}],"mentions":{},"urls":[{"start":120,"end":142,"url":"http://t.co/IbFp96WoCB","expanded_url":"http://bit.ly/OWnpS8","display_url":"bit.ly/OWnpS8"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-04T12:11:52.000Z","text":"We've released a draft Q&amp;A on expression / declaration of potency for #vancomycin products for public consultation: http://t.co/IbFp96WoCB","lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"440821930183368705","attachments":{"media_keys":{}}},{"source":"bitly bitlink","referenced_tweets":{},"id":"440821382788939776","entities":{"hashtags":[{"start":82,"end":93,"tag":"fibrinogen"}],"mentions":{},"urls":[{"start":116,"end":138,"url":"http://t.co/0gjP4JGxNi","expanded_url":"http://bit.ly/1mS70wH","display_url":"bit.ly/1mS70wH"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-04T12:09:42.000Z","text":"Consultation open on our guideline on core summary of product characteristics for #fibrinogen-containing medicines: http://t.co/0gjP4JGxNi","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"440821382788939776","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","referenced_tweets":{},"id":"440820569412354048","entities":{"hashtags":{},"mentions":{},"urls":[{"start":84,"end":106,"url":"http://t.co/YdXtxzNab3","expanded_url":"http://bit.ly/1cnLY4R","display_url":"bit.ly/1cnLY4R"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-04T12:06:28.000Z","text":"Companies: remember that our fees are increasing on 1 April in line with inflation: http://t.co/YdXtxzNab3","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"440820569412354048","attachments":{"media_keys":{}}},{"source":"bitly bitlink","referenced_tweets":{},"id":"440820100741218304","entities":{"hashtags":[{"start":9,"end":24,"tag":"EudraVigilance"}],"mentions":{},"urls":[{"start":70,"end":92,"url":"http://t.co/kLe3PZUZwn","expanded_url":"http://bit.ly/1f0OqJ2","display_url":"bit.ly/1f0OqJ2"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-04T12:04:36.000Z","text":"The 15th #EudraVigilance information day is taking place on 12 March: http://t.co/kLe3PZUZwn","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"440820100741218304","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"440813846761328640"}],"id":"440819386468024320","entities":{"hashtags":[{"start":59,"end":69,"tag":"influenza"}],"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"}],"urls":[{"start":95,"end":117,"url":"http://t.co/OraWfuIYx1","expanded_url":"http://bit.ly/1dWPkGS","display_url":"bit.ly/1dWPkGS"}],"annotations":[{"start":80,"end":85,"probability":0.9975,"type":"Place","normalized_text":"Europe"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-04T12:01:46.000Z","text":"RT @ECDC_Flu: ECDC's annual risk assessment of the ongoing #influenza season in Europe is out: http://t.co/OraWfuIYx1","lang":"en","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"440819386468024320","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"440803271276384256"}],"id":"440818782790230016","entities":{"hashtags":[{"start":13,"end":31,"tag":"Africanswinefever"},{"start":37,"end":40,"tag":"EU"},{"start":42,"end":47,"tag":"EFSA"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":[{"start":84,"end":106,"url":"http://t.co/ajJhk7Pchr","expanded_url":"http://bit.ly/1fEbnBT","display_url":"bit.ly/1fEbnBT"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-04T11:59:22.000Z","text":"RT @EFSA_EU: #Africanswinefever hits #EU: #EFSA assesses measures to prevent spread http://t.co/ajJhk7Pchr","lang":"en","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"440818782790230016","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":{},"id":"440818647876263936","entities":{"hashtags":{},"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"urls":[{"start":84,"end":106,"url":"http://t.co/T3WT3hVdtj","expanded_url":"http://bit.ly/1c4o5Pa","display_url":"bit.ly/1c4o5Pa"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-04T11:58:50.000Z","text":"RT @Aifa_ufficiale: Collaboration between the WHO and the Italian medicines agency: http://t.co/T3WT3hVdtj","lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"440818647876263936","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"440795682421489664"}],"id":"440817966410915840","entities":{"hashtags":{},"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"}],"urls":[{"start":109,"end":131,"url":"http://t.co/b4un4CjIv5","expanded_url":"http://www.malariajournal.com/content/12/1/395/abstract","display_url":"malariajournal.com/content/12/1/3…"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-04T11:56:07.000Z","text":"RT @EAHPtweet: CRIMALDDI: a prioritized research agenda to expedite the discovery of new anti-malarial drugs http://t.co/b4un4CjIv5 #malari…","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"440817966410915840","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"440795296792985600"}],"id":"440817865680510976","entities":{"hashtags":{},"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"}],"urls":[{"start":93,"end":115,"url":"http://t.co/zQ4Gvheag8","expanded_url":"http://www.medicalnewstoday.com/releases/273372.php#.UxWpK6CLVQk.twitter","display_url":"medicalnewstoday.com/releases/27337…"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-04T11:55:43.000Z","text":"RT @EAHPtweet: More powerful cancer treatments with fewer side effects - Medical News Today: http://t.co/zQ4Gvheag8","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"440817865680510976","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"440792450634752000"}],"id":"440817030930137088","entities":{"hashtags":[{"start":59,"end":68,"tag":"medicine"},{"start":101,"end":113,"tag":"prescribing"}],"mentions":[{"start":3,"end":13,"username":"HAIEurope","id":"3314634701"}],"urls":{},"annotations":[{"start":15,"end":16,"probability":0.8917,"type":"Place","normalized_text":"UK"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-04T11:52:24.000Z","text":"RT @HAIEurope: UK's drug regulator proposes pharma updates #medicine safety info online, but removes #prescribing info frm print ads http:/…","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"440817030930137088","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"440788775720206336"}],"id":"440788960198270976","entities":{"hashtags":{},"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"urls":{},"annotations":[{"start":15,"end":17,"probability":0.497,"type":"Organization","normalized_text":"EMA"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-04T10:00:52.000Z","text":"RT @URPLWMiPB: EMA reminds applicants and marketing-authorisation holders that adjusted fees will be coming into effect on 1.4.2014.\nhttp:/…","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"440788960198270976","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"440787342563880960"}],"id":"440787567391539200","entities":{"hashtags":[{"start":67,"end":79,"tag":"advertising"},{"start":97,"end":102,"tag":"drug"}],"mentions":[{"start":3,"end":13,"username":"HAIEurope","id":"3314634701"}],"urls":{},"annotations":[{"start":15,"end":27,"probability":0.3253,"type":"Organization","normalized_text":"Takeda pharma"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-04T09:55:20.000Z","text":"RT @HAIEurope: Takeda pharma admits promotional activities used in #advertising its hypertension #drug were “partially inappropriate”http:/…","lang":"en","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"440787567391539200","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"440784664463032321"}],"id":"440786371218014208","entities":{"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-04T09:50:34.000Z","text":"RT @GCessak: EMA | Regulatory information - adjusted fees for applications to European Medicines Agency from 1 April 2014 http://t.co/sQcGW…","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"440786371218014208","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":{},"id":"440786230012551168","entities":{"hashtags":{},"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"urls":[{"start":57,"end":79,"url":"http://t.co/497lQWgUiu","expanded_url":"http://bit.ly/1c43TNE","display_url":"bit.ly/1c43TNE"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-04T09:50:01.000Z","text":"RT @INFARMED_IP: Supply problem with the medicine Anapen http://t.co/497lQWgUiu","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"440786230012551168","attachments":{"media_keys":{}}},{"source":"bitly bitlink","referenced_tweets":{},"id":"440506315010756608","entities":{"hashtags":{},"mentions":{},"urls":[{"start":87,"end":109,"url":"http://t.co/cylHQTx5AP","expanded_url":"http://bit.ly/1cnLY4R","display_url":"bit.ly/1cnLY4R"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-03T15:17:44.000Z","text":"Companies should note that annual inflation-adjusted EMA fees will apply from 1 April: http://t.co/cylHQTx5AP","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"440506315010756608","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"440500456712704000"}],"id":"440503741218058240","entities":{"hashtags":[{"start":31,"end":39,"tag":"Medical"},{"start":40,"end":48,"tag":"Nursing"},{"start":55,"end":62,"tag":"Dental"},{"start":83,"end":92,"tag":"gr2014eu"},{"start":96,"end":103,"tag":"Athens"},{"start":112,"end":118,"tag":"EPSCO"}],"mentions":[{"start":3,"end":12,"username":"gr2014eu","id":"1397477076"},{"start":119,"end":129,"username":"EU_Health","id":"606325697"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-03T15:07:30.000Z","text":"RT @gr2014eu: Coming up: Chief #Medical #Nursing &amp; #Dental Officers' Mtg under #gr2014eu in #Athens Mar 4-5 #EPSCO @EU_Health http://t.co/a…","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"440503741218058240","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"440421419965767680"}],"id":"440451794624606208","entities":{"hashtags":[{"start":43,"end":50,"tag":"ELCC14"}],"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"urls":[{"start":82,"end":104,"url":"http://t.co/n5tX8hQbso","expanded_url":"http://ow.ly/uay3N","display_url":"ow.ly/uay3N"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-03T11:41:05.000Z","text":"RT @myESMO: Late registration deadline for #ELCC14 is 5 March 2014. Register now! http://t.co/n5tX8hQbso","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"440451794624606208","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"440422607028903936"}],"id":"440451669072314368","entities":{"hashtags":{},"mentions":[{"start":3,"end":19,"username":"ESEndocrinology","id":"221055586"}],"urls":{},"annotations":[{"start":113,"end":119,"probability":0.7897,"type":"Place","normalized_text":"Austria"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-03T11:40:35.000Z","text":"RT @ESEndocrinology: Registration now open for the ESE Summer School on Endocrinology, 3-7 August 2014, Bregenz, Austria. Find out more: ht…","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"440451669072314368","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"440427770120634368"}],"id":"440451416990441473","entities":{"hashtags":{},"mentions":[{"start":3,"end":17,"username":"MHRAmedicines","id":"960436586"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-03T11:39:35.000Z","text":"RT @MHRAmedicines: Company-led drug recalls: Company-led drug recall: Doribax® (doripenem) 500mg powder for solution for infusio... http://…","lang":"en","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"440451416990441473","attachments":{"media_keys":{}}},{"source":"bitly bitlink","referenced_tweets":{},"id":"440443433468317696","entities":{"hashtags":[{"start":104,"end":113,"tag":"diabetes"}],"mentions":{},"urls":[{"start":115,"end":137,"url":"http://t.co/CumfG4sDDx","expanded_url":"http://bit.ly/1cnfjfN","display_url":"bit.ly/1cnfjfN"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-03T11:07:52.000Z","text":"Send your comments on our reflection paper on the way the indication is worded for medicines for type 2 #diabetes: http://t.co/CumfG4sDDx","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"440443433468317696","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","referenced_tweets":{},"id":"440440945918484482","entities":{"hashtags":{},"mentions":{},"urls":[{"start":82,"end":104,"url":"http://t.co/k5bizRYhdW","expanded_url":"http://bit.ly/1fwhD4t","display_url":"bit.ly/1fwhD4t"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-03T10:57:59.000Z","text":"Our final guideline on process validation for finished products is now available: http://t.co/k5bizRYhdW","lang":"en","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"440440945918484482","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","referenced_tweets":{},"id":"440439354150748160","entities":{"hashtags":[{"start":60,"end":68,"tag":"trypsin"}],"mentions":{},"urls":[{"start":113,"end":135,"url":"http://t.co/9uHdmU8Zhv","expanded_url":"http://bit.ly/MBzF8y","display_url":"bit.ly/MBzF8y"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-03T10:51:39.000Z","text":"Comments invited on a draft guideline on the use of porcine #trypsin in the manufacture of biological medicines: http://t.co/9uHdmU8Zhv","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"440439354150748160","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","referenced_tweets":{},"id":"440436749261471745","entities":{"hashtags":[{"start":83,"end":96,"tag":"constipation"}],"mentions":{},"urls":[{"start":98,"end":120,"url":"http://t.co/GVWQQDmbOa","expanded_url":"http://bit.ly/1obj7R5","display_url":"bit.ly/1obj7R5"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-03T10:41:18.000Z","text":"Comment on our draft guideline on the evaluation of medicines for treating chronic #constipation: http://t.co/GVWQQDmbOa","lang":"en","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"440436749261471745","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","referenced_tweets":{},"id":"440436462102663169","entities":{"hashtags":[{"start":37,"end":54,"tag":"pharmacokinetics"},{"start":95,"end":101,"tag":"renal"}],"mentions":{},"urls":[{"start":112,"end":134,"url":"http://t.co/KzAXVcroBm","expanded_url":"http://bit.ly/1hZfaS0","display_url":"bit.ly/1hZfaS0"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-03T10:40:10.000Z","text":"We've published a draft guideline on #pharmacokinetics of medicines in patients with decreased #renal function: http://t.co/KzAXVcroBm","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"440436462102663169","attachments":{"media_keys":{}}},{"source":"bitly bitlink","referenced_tweets":{},"id":"440420327244718080","entities":{"hashtags":[{"start":32,"end":49,"tag":"pharmacokinetics"},{"start":54,"end":71,"tag":"pharmacodynamics"}],"mentions":{},"urls":[{"start":115,"end":137,"url":"http://t.co/2YDNq69VhV","expanded_url":"http://bit.ly/1pE8ObL","display_url":"bit.ly/1pE8ObL"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-03-03T09:36:03.000Z","text":"Comment on our concept paper on #pharmacokinetics and #pharmacodynamics in development of antibacterial medicines: http://t.co/2YDNq69VhV","lang":"en","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"440420327244718080","attachments":{"media_keys":{}}},{"source":"Twitter for iPhone","referenced_tweets":[{"type":"retweeted","id":"439456932999340033"}],"id":"439479534724087808","entities":{"hashtags":[{"start":18,"end":31,"tag":"rarediseases"},{"start":124,"end":131,"tag":"eahp14"}],"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"}],"urls":[{"start":101,"end":123,"url":"http://t.co/FLvest0sYt","expanded_url":"http://bit.ly/MBBulH","display_url":"bit.ly/MBBulH"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-28T19:17:40.000Z","text":"RT @EAHPtweet: If #rarediseases is your interest dont miss the orphan drugs workshop at our Congress http://t.co/FLvest0sYt #eahp14 http://…","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"439479534724087808","attachments":{"media_keys":{}}},{"source":"bitly bitlink","referenced_tweets":{},"id":"439452713722839041","entities":{"hashtags":[{"start":50,"end":58,"tag":"trypsin"}],"mentions":{},"urls":[{"start":109,"end":131,"url":"http://t.co/GNIHxdzjRQ","expanded_url":"http://bit.ly/MBzF8y","display_url":"bit.ly/MBzF8y"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-28T17:31:06.000Z","text":"We've published a guideline on the use of porcine #trypsin in the manufacture of human biological medicines: http://t.co/GNIHxdzjRQ","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"439452713722839041","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"439440652133490688"}],"id":"439440855834050560","entities":{"hashtags":{},"mentions":[{"start":3,"end":18,"username":"USPharmacopeia","id":"47953929"}],"urls":[{"start":85,"end":107,"url":"http://t.co/2qqQMBiDfk","expanded_url":"http://www.fda.gov/NewsEvents/Testimony/ucm387449.htm#.UxC8e7JwEZg.twitter","display_url":"fda.gov/NewsEvents/Tes…"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-28T16:43:59.000Z","text":"RT @USPharmacopeia: In the news: \"Counterfeit Drugs: Fighting Illegal Supply Chains\" http://t.co/2qqQMBiDfk","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"439440855834050560","attachments":{"media_keys":{}}},{"source":"bitly bitlink","referenced_tweets":{},"id":"439438699638845440","entities":{"hashtags":[{"start":50,"end":67,"tag":"pharmacokinetics"},{"start":72,"end":89,"tag":"pharmacodynamics"}],"mentions":{},"urls":[{"start":118,"end":140,"url":"http://t.co/2YDNq69VhV","expanded_url":"http://bit.ly/1pE8ObL","display_url":"bit.ly/1pE8ObL"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-28T16:35:25.000Z","text":"Send us your comments on our proposed revision to #pharmacokinetics and #pharmacodynamics in antibacterial medicines: http://t.co/2YDNq69VhV","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"439438699638845440","attachments":{"media_keys":{}}},{"source":"bitly bitlink","referenced_tweets":{},"id":"439438029229686784","entities":{"hashtags":[{"start":42,"end":59,"tag":"pharmacokinetics"},{"start":100,"end":106,"tag":"renal"}],"mentions":{},"urls":[{"start":117,"end":139,"url":"http://t.co/qzLSZPyFJr","expanded_url":"http://bit.ly/1hZfaS0","display_url":"bit.ly/1hZfaS0"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-28T16:32:45.000Z","text":"Consultation now open on our guideline on #pharmacokinetics of medicines in patients with decreased #renal function: http://t.co/qzLSZPyFJr","lang":"en","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"439438029229686784","attachments":{"media_keys":{}}},{"source":"bitly bitlink","referenced_tweets":{},"id":"439436739435065345","entities":{"hashtags":{},"mentions":{},"urls":[{"start":96,"end":118,"url":"http://t.co/nMNVkeiU26","expanded_url":"http://bit.ly/1fwhD4t","display_url":"bit.ly/1fwhD4t"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-28T16:27:37.000Z","text":"We've published the final version of our guideline on process validation for finished products: http://t.co/nMNVkeiU26","lang":"en","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":3,"quote_count":0},"conversation_id":"439436739435065345","attachments":{"media_keys":{}}},{"source":"bitly bitlink","referenced_tweets":{},"id":"439436232184299520","entities":{"hashtags":[{"start":83,"end":96,"tag":"constipation"}],"mentions":{},"urls":[{"start":115,"end":137,"url":"http://t.co/kgX3KMpL3D","expanded_url":"http://bit.ly/1obj7R5","display_url":"bit.ly/1obj7R5"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-28T16:25:36.000Z","text":"We've released a guideline on evaluation of medicines for the treatment of chronic #constipation for consultation: http://t.co/kgX3KMpL3D","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"439436232184299520","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"439435756444987392"}],"id":"439435846090248192","entities":{"hashtags":[{"start":90,"end":102,"tag":"raredisease"}],"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"},{"start":49,"end":59,"username":"EAHPtweet","id":"203357203"}],"urls":[{"start":108,"end":130,"url":"http://t.co/k5CsdMdoVq","expanded_url":"http://bit.ly/1fwh2Qa","display_url":"bit.ly/1fwh2Qa"}],"annotations":[{"start":15,"end":33,"probability":0.8193,"type":"Person","normalized_text":"Dr Roberto Frontini"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-28T16:24:04.000Z","text":"RT @EAHPtweet: Dr Roberto Frontini, President of @eahptweet : All countries should have a #raredisease plan http://t.co/k5CsdMdoVq http://t…","lang":"en","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"439435846090248192","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"439435669379616768"}],"id":"439435829786976257","entities":{"hashtags":[{"start":79,"end":90,"tag":"Innovation"},{"start":108,"end":117,"tag":"EUIC2014"}],"mentions":[{"start":3,"end":17,"username":"EU_Commission","id":"157981564"}],"urls":[{"start":118,"end":140,"url":"http://t.co/maf3WxMgJn","expanded_url":"http://bit.ly/1fOswgs","display_url":"bit.ly/1fOswgs"}],"annotations":[{"start":66,"end":71,"probability":0.8977,"type":"Place","normalized_text":"Europe"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-28T16:24:00.000Z","text":"RT @EU_Commission: Join the scientists,researchers&amp; innovators of Europe @ #Innovation Convention 2014! #EUIC2014 http://t.co/maf3WxMgJn ht…","lang":"en","public_metrics":{"retweet_count":75,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"439435829786976257","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"439428536135589888"}],"id":"439429623106252800","entities":{"hashtags":{},"mentions":[{"start":3,"end":15,"username":"Europarl_EN","id":"36329597"},{"start":21,"end":36,"username":"rarediseaseday","id":"19982434"}],"urls":[{"start":116,"end":138,"url":"http://t.co/ZtHdRrdWzz","expanded_url":"http://bit.ly/1fwc7P6","display_url":"bit.ly/1fwc7P6"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-28T15:59:21.000Z","text":"RT @Europarl_EN: Its @rarediseaseday +6000 rare diseases may affect 30 million EU citizens. Events in your country: http://t.co/ZtHdRrdWzz …","lang":"en","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"439429623106252800","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"439423469609295872"}],"id":"439423570666868736","entities":{"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":97,"end":112,"username":"rarediseaseday","id":"19982434"}],"urls":[{"start":73,"end":95,"url":"http://t.co/gFs5YwnxdT","expanded_url":"http://bit.ly/1k4fyvo","display_url":"bit.ly/1k4fyvo"}],"annotations":[{"start":37,"end":66,"probability":0.8945,"type":"Other","normalized_text":"International Rare Disease Day"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-28T15:35:18.000Z","text":"RT @EFPIA: 21 ways to participate in International Rare Disease Day 2014 http://t.co/gFs5YwnxdT  @rarediseaseday","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"439423570666868736","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"439422346295013376"}],"id":"439423206798397440","entities":{"hashtags":[{"start":57,"end":66,"tag":"Diabetes"},{"start":111,"end":122,"tag":"bluefriday"}],"mentions":[{"start":3,"end":18,"username":"IntDiabetesFed","id":"38393473"}],"urls":[{"start":88,"end":110,"url":"http://t.co/V6sTrGIfFm","expanded_url":"http://www.idf.org/diabetesvoice","display_url":"idf.org/diabetesvoice"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-28T15:33:51.000Z","text":"RT @IntDiabetesFed: Out now! Enjoy the latest edition of #Diabetes Voice this weekend.  http://t.co/V6sTrGIfFm #bluefriday","lang":"en","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"439423206798397440","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"439421659150548992"}],"id":"439421752230543360","entities":{"hashtags":[{"start":88,"end":103,"tag":"RareDiseaseDay"},{"start":104,"end":113,"tag":"EUHealth"},{"start":114,"end":125,"tag":"3DPrinting"},{"start":126,"end":139,"tag":"PharmaSummit"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":74,"end":87,"username":"TheEconomist","id":"5988062"}],"urls":[{"start":50,"end":72,"url":"http://t.co/0PN1Y8tkoB","expanded_url":"http://bit.ly/1fYjJ86","display_url":"bit.ly/1fYjJ86"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-28T15:28:04.000Z","text":"RT @EFPIA: Happy Friday! Efpia's Newletter is OUT http://t.co/0PN1Y8tkoB  @TheEconomist #RareDiseaseDay #EUHealth #3DPrinting #PharmaSummit","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"439421752230543360","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"439421368023912448"}],"id":"439421566682931200","entities":{"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":78,"end":100,"url":"http://t.co/ovyMqnK8Nm","expanded_url":"http://bit.ly/1kvpiPs","display_url":"bit.ly/1kvpiPs"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-28T15:27:20.000Z","text":"RT @EFPIA: Study identifies possible new target for future brain cancer drugs http://t.co/ovyMqnK8Nm","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"439421566682931200","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"439413912287850496"}],"id":"439414211878608896","entities":{"hashtags":[{"start":100,"end":115,"tag":"RareDiseaseDay"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":85,"end":99,"username":"EU_Commission","id":"157981564"}],"urls":[{"start":116,"end":138,"url":"http://t.co/wRIdkmBP27","expanded_url":"http://bit.ly/1eFJbhI","display_url":"bit.ly/1eFJbhI"}],"annotations":[{"start":58,"end":63,"probability":0.9909,"type":"Place","normalized_text":"Europe"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-28T14:58:06.000Z","text":"RT @EFPIA: Rare Disease Day 2014: Joining together across Europe for better care via @EU_Commission #RareDiseaseDay http://t.co/wRIdkmBP27","lang":"en","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"439414211878608896","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"439411461920923649"}],"id":"439414038284750848","entities":{"hashtags":[{"start":38,"end":50,"tag":"RareDisease"}],"mentions":[{"start":3,"end":18,"username":"rarediseaseday","id":"19982434"},{"start":29,"end":33,"username":"NIH","id":"15134240"}],"urls":[{"start":65,"end":87,"url":"http://t.co/ClRHGDTrkS","expanded_url":"http://ow.ly/u6icI","display_url":"ow.ly/u6icI"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-28T14:57:25.000Z","text":"RT @rarediseaseday: Join the @NIH for #RareDisease Day. Live now http://t.co/ClRHGDTrkS","lang":"en","public_metrics":{"retweet_count":37,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"439414038284750848","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"439409535217057792"}],"id":"439410987285110784","entities":{"hashtags":{},"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"urls":{},"annotations":[{"start":52,"end":81,"probability":0.4804,"type":"Other","normalized_text":"Burden of Communicable Disease"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-28T14:45:17.000Z","text":"RT @ECDC_EU: In coming months ECDC will publish the Burden of Communicable Disease study report &amp; launch webtool to calculate #diseaseburde…","lang":"en","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"439410987285110784","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"439399644637188096"}],"id":"439410580898971650","entities":{"hashtags":[{"start":14,"end":21,"tag":"hcsmeu"}],"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"urls":{},"annotations":[{"start":62,"end":63,"probability":0.532,"type":"Organization","normalized_text":"OD"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-28T14:43:41.000Z","text":"RT @eurordis: #hcsmeu EU orphan designations on the increase; OD regulation has adequate incentives and recognition is growing","lang":"en","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"439410580898971650","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"439398828090097664"}],"id":"439410557180207104","entities":{"hashtags":[{"start":17,"end":23,"tag":"RDD14"},{"start":24,"end":36,"tag":"RareDisease"},{"start":75,"end":84,"tag":"citizens"}],"mentions":[{"start":3,"end":15,"username":"CPME_EUROPA","id":"440810430"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-28T14:43:35.000Z","text":"RT @CPME_EUROPA: #RDD14 #RareDisease Day moment to raise awareness amongst #citizens &amp; decision-makers on rare diseases &amp; their impact on #…","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"439410557180207104","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"439398775111831552"}],"id":"439410513450389504","entities":{"hashtags":[{"start":47,"end":51,"tag":"FDA"}],"mentions":[{"start":3,"end":12,"username":"FDA_MCMi","id":"1606025952"}],"urls":[{"start":113,"end":135,"url":"http://t.co/Z5GVUeEuXm","expanded_url":"http://ht.ly/u69BU","display_url":"ht.ly/u69BU"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-28T14:43:24.000Z","text":"RT @FDA_MCMi: Webcast available live today for #FDA Vaccines and Related Biological Products Advisory Committee: http://t.co/Z5GVUeEuXm","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"439410513450389504","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"439398313214099456"}],"id":"439410424539521024","entities":{"hashtags":[{"start":26,"end":39,"tag":"RareDiseases"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-28T14:43:03.000Z","text":"RT @EFPIA: Check out this #RareDiseases infographic by @scripnews -&gt; http://t.co/rlYkEaKPkQ","lang":"en","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"439410424539521024","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"439395823026446336"}],"id":"439410206528012288","entities":{"hashtags":[{"start":14,"end":21,"tag":"hcsmeu"},{"start":22,"end":34,"tag":"raredisease"}],"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-28T14:42:11.000Z","text":"RT @eurordis: #hcsmeu #raredisease patients are experts on their own diseases - industry needs to involve them","lang":"en","public_metrics":{"retweet_count":32,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"439410206528012288","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"439392555806257152"}],"id":"439410079235059712","entities":{"hashtags":[{"start":12,"end":21,"tag":"FDAVoice"},{"start":95,"end":110,"tag":"RareDiseaseDay"}],"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"urls":[{"start":72,"end":94,"url":"http://t.co/lhVDAIsHCu","expanded_url":"http://go.usa.gov/KqS9","display_url":"go.usa.gov/KqS9"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-28T14:41:41.000Z","text":"RT @US_FDA: #FDAVoice: Rare Diseases in Children Pose Unique Challenges http://t.co/lhVDAIsHCu #RareDiseaseDay","lang":"en","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"439410079235059712","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"439370753264611328"}],"id":"439370838077607936","entities":{"hashtags":[{"start":25,"end":38,"tag":"rarediseases"},{"start":81,"end":84,"tag":"EU"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"urls":[{"start":102,"end":124,"url":"http://t.co/C6PUXQe4yy","expanded_url":"http://bit.ly/MxOV6q","display_url":"bit.ly/MxOV6q"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-28T12:05:45.000Z","text":"RT @EU_Health: 6000-8000 #rarediseases affecting between 30-40 million people in #EU. How do we help? http://t.co/C6PUXQe4yy #RareDiseaseDa…","lang":"en","public_metrics":{"retweet_count":17,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"439370838077607936","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","referenced_tweets":{},"id":"439370545327792128","entities":{"hashtags":[{"start":14,"end":32,"tag":"pharmacovigilance"}],"mentions":{},"urls":[{"start":90,"end":112,"url":"http://t.co/4Hre5XG2aC","expanded_url":"http://bit.ly/1d0iBDp","display_url":"bit.ly/1d0iBDp"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-28T12:04:35.000Z","text":"Now out: good #pharmacovigilance practice guideline module on risk-minimisation measures: http://t.co/4Hre5XG2aC","lang":"en","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"439370545327792128","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","referenced_tweets":{},"id":"439370438213652480","entities":{"hashtags":[{"start":53,"end":68,"tag":"bioequivalence"},{"start":82,"end":92,"tag":"sunitinib"}],"mentions":{},"urls":[{"start":94,"end":116,"url":"http://t.co/OTozfYxqpx","expanded_url":"http://bit.ly/1bcBnsu","display_url":"bit.ly/1bcBnsu"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-28T12:04:10.000Z","text":"Last chance to comment on our draft product-specific #bioequivalence guidance for #sunitinib: http://t.co/OTozfYxqpx","lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"439370438213652480","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"439369999854354432"}],"id":"439370303714918400","entities":{"hashtags":[{"start":95,"end":98,"tag":"EU"}],"mentions":[{"start":3,"end":11,"username":"borgton","id":"1605512862"}],"urls":[{"start":108,"end":130,"url":"http://t.co/JaMziQx5n8","expanded_url":"http://bit.ly/MxOV6q","display_url":"bit.ly/MxOV6q"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-28T12:03:38.000Z","text":"RT @borgton: Today: spare a special thought for patients with rare diseases in their struggle; #EU can help http://t.co/JaMziQx5n8 #raredis…","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"439370303714918400","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"439369822389141504"}],"id":"439370244646522880","entities":{"hashtags":{},"mentions":[{"start":3,"end":11,"username":"borgton","id":"1605512862"}],"urls":[{"start":107,"end":129,"url":"http://t.co/JaMziQx5n8","expanded_url":"http://bit.ly/MxOV6q","display_url":"bit.ly/MxOV6q"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-28T12:03:24.000Z","text":"RT @borgton: World Rare Diseases day today: need to beef up EU co-ordination so that no one is left behind http://t.co/JaMziQx5n8 #raredise…","lang":"en","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"439370244646522880","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","referenced_tweets":{},"id":"439369935668936704","entities":{"hashtags":[{"start":4,"end":22,"tag":"pharmacovigilance"},{"start":36,"end":41,"tag":"PRAC"}],"mentions":{},"urls":[{"start":113,"end":135,"url":"http://t.co/Uep4ZHWccW","expanded_url":"http://bit.ly/1fvANas","display_url":"bit.ly/1fvANas"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-28T12:02:10.000Z","text":"Our #pharmacovigilance committee's (#PRAC) next meeting is next week. We're publishing the highlights on Friday: http://t.co/Uep4ZHWccW","lang":"en","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":1,"quote_count":0},"conversation_id":"439369935668936704","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":{},"id":"439363759308812288","entities":{"hashtags":{},"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"},{"start":115,"end":131,"username":"redaccionmedica","id":"229001251"},{"start":132,"end":138,"username":"sefh_","id":"914462377"}],"urls":[{"start":88,"end":110,"url":"http://t.co/ee8Jt9Ap0E","expanded_url":"http://bit.ly/1jF5PMA","display_url":"bit.ly/1jF5PMA"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-28T11:37:37.000Z","text":"RT @EAHPtweet: Increasing safety in dispensing and administrating medicines in hospital http://t.co/ee8Jt9Ap0E via @redaccionmedica @sefh_","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"439363759308812288","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"439362639508946945"}],"id":"439363448561213440","entities":{"hashtags":[{"start":72,"end":81,"tag":"Pharmacy"}],"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"},{"start":30,"end":40,"username":"EAHPtweet","id":"203357203"}],"urls":[{"start":93,"end":115,"url":"http://t.co/ChleANeFpg","expanded_url":"http://ejhp.bmj.com/content/21/2.toc","display_url":"ejhp.bmj.com/content/21/2.t…"},{"start":116,"end":138,"url":"http://t.co/80mBeh7sOE","expanded_url":"http://twitpic.com/dww6du","display_url":"twitpic.com/dww6du"}],"annotations":[{"start":43,"end":70,"probability":0.4936,"type":"Other","normalized_text":"European Journal of Hospital"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-28T11:36:23.000Z","text":"RT @EAHPtweet: New edition of @EAHPtweet's European Journal of Hospital #Pharmacy now online http://t.co/ChleANeFpg http://t.co/80mBeh7sOE","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"439363448561213440","attachments":{"media_keys":{}}},{"source":"bitly bitlink","referenced_tweets":{},"id":"439350322503626752","entities":{"hashtags":[{"start":23,"end":41,"tag":"pharmacovigilance"}],"mentions":{},"urls":[{"start":99,"end":121,"url":"http://t.co/4Hre5XG2aC","expanded_url":"http://bit.ly/1d0iBDp","display_url":"bit.ly/1d0iBDp"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-28T10:44:14.000Z","text":"We've published a good #pharmacovigilance practice guideline module on risk-minimisation measures: http://t.co/4Hre5XG2aC","lang":"en","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"439350322503626752","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"439346315315916800"}],"id":"439346446413103106","entities":{"hashtags":[{"start":62,"end":73,"tag":"EUAgencies"}],"mentions":[{"start":3,"end":10,"username":"EURLex","id":"294028805"}],"urls":[{"start":75,"end":97,"url":"http://t.co/TnJPlzl7bN","expanded_url":"http://owl.li/u5LSw","display_url":"owl.li/u5LSw"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-28T10:28:50.000Z","text":"RT @EURLex: Latest figures on the revenues and expenditure of #EUAgencies: http://t.co/TnJPlzl7bN","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"439346446413103106","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"439343381102477312"}],"id":"439344090304770048","entities":{"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":88,"end":104,"username":"ThePharmaLetter","id":"71542880"}],"urls":[{"start":105,"end":127,"url":"http://t.co/nvCfymNXZQ","expanded_url":"http://bit.ly/1fvxfPF","display_url":"bit.ly/1fvxfPF"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-28T10:19:28.000Z","text":"RT @EFPIA: Which place for orphan drugs in the strategy of pharma companies and payers? @ThePharmaLetter http://t.co/nvCfymNXZQ #OrphanDrug…","lang":"en","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"439344090304770048","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"439339803633782784"}],"id":"439343775706791938","entities":{"hashtags":[{"start":29,"end":41,"tag":"RareDisease"}],"mentions":[{"start":3,"end":18,"username":"rarediseaseday","id":"19982434"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-28T10:18:13.000Z","text":"RT @rarediseaseday: Today is #RareDisease Day, the day to put rare diseases in the spotlight! Show your solidarity today! http://t.co/L36cE…","lang":"en","public_metrics":{"retweet_count":276,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"439343775706791938","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"439339801805082624"}],"id":"439343759499997184","entities":{"hashtags":[{"start":23,"end":35,"tag":"RareDisease"}],"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"urls":[{"start":116,"end":138,"url":"http://t.co/bale13QdZb","expanded_url":"http://thndr.it/1iPSEdF","display_url":"thndr.it/1iPSEdF"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-28T10:18:09.000Z","text":"RT @eurordis: Today is #RareDisease Day, the day to put rare diseases in the spotlight! Show your solidarity today! http://t.co/bale13QdZb","lang":"en","public_metrics":{"retweet_count":26,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"439343759499997184","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"439339478709440512"}],"id":"439339651892252672","entities":{"hashtags":[{"start":27,"end":39,"tag":"RareDisease"}],"mentions":[{"start":3,"end":16,"username":"ArthritisDay","id":"302074272"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-28T10:01:50.000Z","text":"RT @ArthritisDay: Today is #RareDisease Day, the day to put rare diseases in the spotlight! Show your solidarity today! http://t.co/OlA1yqW…","lang":"en","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"439339651892252672","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"439337644192198656"}],"id":"439339049351118848","entities":{"hashtags":[{"start":117,"end":130,"tag":"rarediseases"}],"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"},{"start":46,"end":60,"username":"EU_Commission","id":"157981564"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-28T09:59:26.000Z","text":"RT @EAHPtweet: Nice summary of activities the @EU_Commission is carrying out to promote improved care in the area of #rarediseases http://t…","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"439339049351118848","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"439336315419521026"}],"id":"439337760156311552","entities":{"hashtags":[{"start":19,"end":34,"tag":"RareDiseaseDay"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":35,"end":57,"url":"http://t.co/uTZaqEyKp4","expanded_url":"http://bit.ly/1buvbHf","display_url":"bit.ly/1buvbHf"},{"start":58,"end":80,"url":"http://t.co/Mdvi1e0zWX","expanded_url":"https://twitter.com/EFPIA/status/439336315419521026/photo/1","display_url":"pic.twitter.com/Mdvi1e0zWX"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-28T09:54:19.000Z","text":"RT @EFPIA: WATCH - #RareDiseaseDay http://t.co/uTZaqEyKp4 http://t.co/Mdvi1e0zWX","lang":"en","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"439337760156311552","attachments":{"media_keys":["3_439336315423715328"]}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"439331785520848896"}],"id":"439332743458357248","entities":{"hashtags":[{"start":37,"end":47,"tag":"Parkinson"},{"start":73,"end":91,"tag":"neurodegenerative"},{"start":107,"end":117,"tag":"Alzheimer"}],"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-28T09:34:23.000Z","text":"RT @euparkinsons: Fact: Did u know...#Parkinson's is the 2nd most common #neurodegenerative disease (after #Alzheimer’s disease) http://t.c…","lang":"en","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"439332743458357248","attachments":{"media_keys":{}}},{"source":"bitly bitlink","referenced_tweets":{},"id":"439328738048999424","entities":{"hashtags":[{"start":4,"end":22,"tag":"Pharmacovigilance"},{"start":50,"end":55,"tag":"PRAC"}],"mentions":{},"urls":[{"start":100,"end":122,"url":"http://t.co/Uep4ZHWccW","expanded_url":"http://bit.ly/1fvANas","display_url":"bit.ly/1fvANas"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-28T09:18:28.000Z","text":"Our #Pharmacovigilance Risk Assessment Committee (#PRAC) meets next week. Highlights out on Friday: http://t.co/Uep4ZHWccW","lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"439328738048999424","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","referenced_tweets":{},"id":"439328206563586048","entities":{"hashtags":[{"start":51,"end":66,"tag":"bioequivalence"},{"start":80,"end":90,"tag":"sunitinib"}],"mentions":{},"urls":[{"start":92,"end":114,"url":"http://t.co/OTozfYxqpx","expanded_url":"http://bit.ly/1bcBnsu","display_url":"bit.ly/1bcBnsu"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-28T09:16:21.000Z","text":"Last few days to comment on draft product-specific #bioequivalence guidance for #sunitinib: http://t.co/OTozfYxqpx","lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"439328206563586048","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"439327507805134848"}],"id":"439327622041198592","entities":{"hashtags":[{"start":30,"end":44,"tag":"diseaseburden"},{"start":65,"end":69,"tag":"STD"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"urls":{},"annotations":[{"start":48,"end":53,"probability":0.9939,"type":"Place","normalized_text":"Europe"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-28T09:14:02.000Z","text":"RT @ECDC_EU: More than 37% of #diseaseburden in Europe is due to #STD according to Burden of Communicable Disease Europe Study http://t.co/…","lang":"en","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"439327622041198592","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"439324310780788736"}],"id":"439327551132286976","entities":{"hashtags":[{"start":55,"end":69,"tag":"diseaseburden"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"urls":{},"annotations":[{"start":98,"end":99,"probability":0.5959,"type":"Place","normalized_text":"EU"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-28T09:13:45.000Z","text":"RT @ECDC_EU: Years of life lost account for 75% of the #diseaseburden of communicable diseases in EU according to BCoDe study http://t.co/T…","lang":"en","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"439327551132286976","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"439323009757634560"}],"id":"439327357598707712","entities":{"hashtags":[{"start":83,"end":95,"tag":"RareDisease"}],"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"},{"start":21,"end":31,"username":"EAHPtweet","id":"203357203"},{"start":46,"end":61,"username":"rarediseaseday","id":"19982434"}],"urls":[{"start":108,"end":130,"url":"http://t.co/QyjVnErumB","expanded_url":"http://bit.ly/1d4B51n","display_url":"bit.ly/1d4B51n"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-28T09:12:59.000Z","text":"RT @EAHPtweet: Today @EAHPtweet is supporting @rarediseaseday Find out more on the #RareDisease Day website http://t.co/QyjVnErumB http://t…","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"439327357598707712","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"439090960442863616"}],"id":"439099037158244352","entities":{"hashtags":{},"mentions":[{"start":3,"end":13,"username":"MHRApress","id":"330990243"}],"urls":[{"start":109,"end":131,"url":"http://t.co/Met3abisI5","expanded_url":"http://www.clinmed.rcpjournal.org/content/14/1/6.full.pdf+html","display_url":"clinmed.rcpjournal.org/content/14/1/6…"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-27T18:05:43.000Z","text":"RT @MHRApress: Good article on medicines and medical devices regulatory systems in Clinical Medicine journal http://t.co/Met3abisI5","lang":"en","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"439099037158244352","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","referenced_tweets":{},"id":"439098835600936960","entities":{"hashtags":{},"mentions":{},"urls":[{"start":99,"end":121,"url":"http://t.co/jT9Mpw3V5D","expanded_url":"http://bit.ly/1cjFONF","display_url":"bit.ly/1cjFONF"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-27T18:04:55.000Z","text":"This year's European rare disease leadership award was jointly received by our Executive Director: http://t.co/jT9Mpw3V5D","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"439098835600936960","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","referenced_tweets":{},"id":"439098569480736768","entities":{"hashtags":{},"mentions":{},"urls":[{"start":113,"end":135,"url":"http://t.co/HuKhuTijWg","expanded_url":"http://bit.ly/1aN4nXt","display_url":"bit.ly/1aN4nXt"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-27T18:03:51.000Z","text":"Last day to comment on reflection paper on data requirements for intravenous iron-based nano-colloidal products: http://t.co/HuKhuTijWg","lang":"en","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"439098569480736768","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"438720653341237248"}],"id":"439031231481925632","entities":{"hashtags":{},"mentions":[{"start":3,"end":14,"username":"eupatients","id":"465674067"}],"urls":[{"start":40,"end":62,"url":"http://t.co/1xRcQ4aA5P","expanded_url":"http://ow.ly/tUFZc","display_url":"ow.ly/tUFZc"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-27T13:36:17.000Z","text":"RT @eupatients: Chronic diseases summit http://t.co/1xRcQ4aA5P","lang":"en","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"439031231481925632","attachments":{"media_keys":{}}},{"source":"bitly bitlink","referenced_tweets":{},"id":"438984564196007936","entities":{"hashtags":{},"mentions":{},"urls":[{"start":116,"end":138,"url":"http://t.co/HuKhuTijWg","expanded_url":"http://bit.ly/1aN4nXt","display_url":"bit.ly/1aN4nXt"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-27T10:30:50.000Z","text":"Last chance to comment on reflection paper on data requirements for intravenous iron-based nano-colloidal products: http://t.co/HuKhuTijWg","lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"438984564196007936","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"438786390164537344"}],"id":"438984006198374400","entities":{"hashtags":[{"start":19,"end":23,"tag":"FDA"},{"start":24,"end":29,"tag":"CDER"},{"start":97,"end":101,"tag":"SES"}],"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-27T10:28:37.000Z","text":"RT @FDA_Drug_Info: #FDA #CDER is now hiring ORP Director w/ law degree and executive experience. #SES position located in MD. Thru 3/24. ht…","lang":"en","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"438984006198374400","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"438970515248918528"}],"id":"438982745872928768","entities":{"hashtags":{},"mentions":[{"start":3,"end":19,"username":"eupatientsforum","id":"545343465"}],"urls":[{"start":66,"end":88,"url":"http://t.co/ffpFy8q57f","expanded_url":"http://www.eu-patient.eu/Documents/Library/eNewsletter/2014/22_EPFnewsletter_27Feb14.pdf","display_url":"eu-patient.eu/Documents/Libr…"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-27T10:23:37.000Z","text":"RT @eupatientsforum: The February issue of our newsletter is out! http://t.co/ffpFy8q57f","lang":"en","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"438982745872928768","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"438973740446412800"}],"id":"438982630575706113","entities":{"hashtags":[{"start":102,"end":114,"tag":"RareDisease"}],"mentions":[{"start":3,"end":18,"username":"rarediseaseday","id":"19982434"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-27T10:23:09.000Z","text":"RT @rarediseaseday: Join Together for Better Care. Watch the video and share it with your friends for #RareDisease day http://t.co/l2TfhToc…","lang":"en","public_metrics":{"retweet_count":48,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"438982630575706113","attachments":{"media_keys":{}}},{"source":"bitly bitlink","referenced_tweets":{},"id":"438980976170266624","entities":{"hashtags":{},"mentions":{},"urls":[{"start":94,"end":116,"url":"http://t.co/jT9Mpw3V5D","expanded_url":"http://bit.ly/1cjFONF","display_url":"bit.ly/1cjFONF"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-27T10:16:35.000Z","text":"Our Executive Director jointly received the European rare diseases leadership award for 2014: http://t.co/jT9Mpw3V5D","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"438980976170266624","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"438724042359832576"}],"id":"438724698894245890","entities":{"hashtags":[{"start":40,"end":52,"tag":"RareDisease"}],"mentions":[{"start":3,"end":18,"username":"rarediseaseday","id":"19982434"}],"urls":[{"start":86,"end":108,"url":"http://t.co/mEMcibcjsd","expanded_url":"http://www.rarediseaseday.org/become-a-friend/","display_url":"rarediseaseday.org/become-a-frien…"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-26T17:18:14.000Z","text":"RT @rarediseaseday: Are you a friend of #RareDisease Day like these 201 other people?\nhttp://t.co/mEMcibcjsd","lang":"en","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"438724698894245890","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"438722240549748736"}],"id":"438723425612627968","entities":{"hashtags":{},"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"urls":[{"start":57,"end":79,"url":"http://t.co/EeYBXrgTLZ","expanded_url":"http://1.usa.gov/1cQbI7P","display_url":"1.usa.gov/1cQbI7P"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-26T17:13:10.000Z","text":"RT @FDAanimalhealth: New Paperwork Reduction Act Notices http://t.co/EeYBXrgTLZ","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"438723425612627968","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"438722173638037504"}],"id":"438723255428710400","entities":{"hashtags":[{"start":12,"end":21,"tag":"FDAVoice"}],"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"urls":[{"start":104,"end":126,"url":"http://t.co/VJk22YnMLK","expanded_url":"http://blogs.fda.gov/#sthash.E0c1JUMK.dpuf","display_url":"blogs.fda.gov/#sthash.E0c1JU…"}],"annotations":[{"start":23,"end":25,"probability":0.5604,"type":"Organization","normalized_text":"FDA"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-26T17:12:29.000Z","text":"RT @US_FDA: #FDAVoice: FDA Is Committed to Determining Sex Differences in How Drugs Work - See more at: http://t.co/VJk22YnMLK","lang":"en","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"438723255428710400","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"438721502460932098"}],"id":"438721725128142848","entities":{"hashtags":[{"start":18,"end":28,"tag":"Parkinson"},{"start":31,"end":41,"tag":"biomarker"},{"start":70,"end":79,"tag":"genetics"}],"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"urls":[{"start":81,"end":103,"url":"http://t.co/xFDuFLlExG","expanded_url":"http://bit.ly/1o5r2PJ","display_url":"bit.ly/1o5r2PJ"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-26T17:06:24.000Z","text":"RT @euparkinsons: #Parkinson’s #biomarker initiative expands study of #genetics: http://t.co/xFDuFLlExG","lang":"en","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"438721725128142848","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"438718220254466049"}],"id":"438721185543913473","entities":{"hashtags":[{"start":65,"end":69,"tag":"FDA"},{"start":70,"end":76,"tag":"GDUFA"}],"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"urls":[{"start":25,"end":47,"url":"http://t.co/oh1TiJHGqH","expanded_url":"http://1.usa.gov/1cQ775p","display_url":"1.usa.gov/1cQ775p"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-26T17:04:16.000Z","text":"RT @FDA_Drug_Info: Visit http://t.co/oh1TiJHGqH  for info on the #FDA #GDUFA Regulatory Science Initiatives Public Meeting. http://t.co/Q2W…","lang":"en","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"438721185543913473","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":{},"id":"438721117348691968","entities":{"hashtags":{},"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"urls":[{"start":105,"end":127,"url":"http://t.co/4fj4mf32F9","expanded_url":"http://bit.ly/1el2Tno","display_url":"bit.ly/1el2Tno"}],"annotations":[{"start":56,"end":103,"probability":0.3444,"type":"Organization","normalized_text":"Manufacturer Owens Technology Co., Ltd. Shenzhen"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-26T17:04:00.000Z","text":"RT @INFARMED_IP: CE conformity certificates withdrawn - Manufacturer Owens Technology Co., Ltd. Shenzhen http://t.co/4fj4mf32F9","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"438721117348691968","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"438701460248100864"}],"id":"438701616183918592","entities":{"hashtags":[{"start":72,"end":82,"tag":"influenza"},{"start":83,"end":91,"tag":"vaccine"}],"mentions":[{"start":3,"end":18,"username":"WHO_Europe_VPI","id":"561122363"},{"start":20,"end":24,"username":"WHO","id":"14499829"}],"urls":[{"start":93,"end":115,"url":"http://t.co/1fS2S9EYPu","expanded_url":"http://bit.ly/1mBkMAv","display_url":"bit.ly/1mBkMAv"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-26T15:46:30.000Z","text":"RT @WHO_Europe_VPI: @WHO recommends unchanged composition for next yr’s #influenza #vaccine: http://t.co/1fS2S9EYPu  Full report: http://t.…","lang":"en","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"438701616183918592","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"438698225533349888"}],"id":"438698567273021440","entities":{"hashtags":[{"start":25,"end":37,"tag":"SocialMedia"},{"start":47,"end":55,"tag":"Placebo"},{"start":56,"end":62,"tag":"Trial"}],"mentions":[{"start":3,"end":18,"username":"nakosbalamotis","id":"39364251"},{"start":91,"end":99,"username":"RAPSorg","id":"111425542"}],"urls":[{"start":64,"end":86,"url":"http://t.co/gDf7aN6gpA","expanded_url":"http://www.ask-cato.com/2014/02/will-social-media-kill-placebo-trial/","display_url":"ask-cato.com/2014/02/will-s…"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-26T15:34:23.000Z","text":"RT @nakosbalamotis: Will #SocialMedia Kill the #Placebo #Trial? http://t.co/gDf7aN6gpA via @RAPSorg","lang":"en","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"438698567273021440","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"438696712421789696"}],"id":"438698479024865281","entities":{"hashtags":[{"start":19,"end":23,"tag":"FDA"},{"start":33,"end":41,"tag":"Myalept"}],"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"urls":[{"start":75,"end":97,"url":"http://t.co/e1QE56wz2I","expanded_url":"http://1.usa.gov/1k8WD5U","display_url":"1.usa.gov/1k8WD5U"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-26T15:34:02.000Z","text":"RT @FDA_Drug_Info: #FDA approves #Myalept to treat rare metabolic disease. http://t.co/e1QE56wz2I","lang":"en","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"438698479024865281","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"438696140733554689"}],"id":"438698409974050817","entities":{"hashtags":[{"start":20,"end":24,"tag":"FDA"},{"start":39,"end":47,"tag":"Zohydro"}],"mentions":[{"start":3,"end":18,"username":"nakosbalamotis","id":"39364251"},{"start":100,"end":108,"username":"thehill","id":"1917731"}],"urls":[{"start":73,"end":95,"url":"http://t.co/E3yrNZjSS7","expanded_url":"http://thehill.com/blogs/regwatch/healthcare/199277-fda-approved-drug-faces-backlash#.Uw4HHwvKYLg.twitter","display_url":"thehill.com/blogs/regwatch…"}],"annotations":[{"start":65,"end":71,"probability":0.6673,"type":"Organization","normalized_text":"TheHill"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-26T15:33:46.000Z","text":"RT @nakosbalamotis: #FDA-approved drug #Zohydro faces backlash | TheHill http://t.co/E3yrNZjSS7 via @TheHill","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"438698409974050817","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"438696052779417600"}],"id":"438698293166899200","entities":{"hashtags":[{"start":105,"end":114,"tag":"melanoma"},{"start":115,"end":122,"tag":"cancer"}],"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"urls":[{"start":82,"end":104,"url":"http://t.co/p5tLhbD9Ys","expanded_url":"http://ow.ly/u1r6x","display_url":"ow.ly/u1r6x"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-26T15:33:18.000Z","text":"RT @myESMO: ESMOChannel: Inhibition of MEK to treat cancer: Focussing on melanoma http://t.co/p5tLhbD9Ys #melanoma #cancer","lang":"en","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"438698293166899200","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"438695798575222784"}],"id":"438697235682172928","entities":{"hashtags":{},"mentions":[{"start":3,"end":16,"username":"EFA_Patients","id":"1299643704"},{"start":56,"end":65,"username":"EMA_News","id":"116716199"}],"urls":{},"annotations":[{"start":18,"end":27,"probability":0.9803,"type":"Person","normalized_text":"Guido Rasi"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-26T15:29:06.000Z","text":"RT @EFA_Patients: Guido Rasi (Executive Director of the @EMA_News): need to involve additional expertise in benefit-risk evaluation: #patie…","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"438697235682172928","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"438695785434079232"}],"id":"438697202954031104","entities":{"hashtags":[{"start":20,"end":29,"tag":"Novartis"},{"start":38,"end":43,"tag":"Data"},{"start":75,"end":87,"tag":"Researchers"}],"mentions":[{"start":3,"end":18,"username":"nakosbalamotis","id":"39364251"}],"urls":[{"start":88,"end":110,"url":"http://t.co/rotsVR9xm4","expanded_url":"http://bloom.bg/1ek0hpW","display_url":"bloom.bg/1ek0hpW"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-26T15:28:58.000Z","text":"RT @nakosbalamotis: #Novartis to Open #Data on Newly Approved Medicines to #Researchers http://t.co/rotsVR9xm4 via @BloombergNews","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"438697202954031104","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":{},"id":"438693067185725440","entities":{"hashtags":{},"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"urls":[{"start":88,"end":110,"url":"http://t.co/M9VeDBlgTK","expanded_url":"http://bit.ly/OCxIKZ","display_url":"bit.ly/OCxIKZ"}],"annotations":[{"start":60,"end":86,"probability":0.4223,"type":"Organization","normalized_text":"Manufacturer Biolitec, Inc."}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-26T15:12:32.000Z","text":"RT @INFARMED_IP: Restriction to CE conformity certificate - Manufacturer Biolitec, Inc. http://t.co/M9VeDBlgTK","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"438693067185725440","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":{},"id":"438692911342178304","entities":{"hashtags":{},"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"urls":[{"start":82,"end":104,"url":"http://t.co/1GoaJrEBMq","expanded_url":"http://bit.ly/1ewasmE","display_url":"bit.ly/1ewasmE"}],"annotations":[{"start":68,"end":80,"probability":0.585,"type":"Person","normalized_text":"Pablo Ullrich"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-26T15:11:55.000Z","text":"RT @INFARMED_IP: CE conformity certificate suspended - Manufacturer Pablo Ullrich http://t.co/1GoaJrEBMq","lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"438692911342178304","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"438689382665846786"}],"id":"438689590673960960","entities":{"hashtags":{},"mentions":[{"start":3,"end":17,"username":"JeanGeorgesAE","id":"1502220312"},{"start":46,"end":55,"username":"EMA_News","id":"116716199"}],"urls":{},"annotations":[{"start":96,"end":105,"probability":0.9747,"type":"Person","normalized_text":"Guido Rasi"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-26T14:58:43.000Z","text":"RT @JeanGeorgesAE: Great to see commitment of @EMA_News to dialogue with patient organisations: Guido Rasi, EMA Executive Director addressi…","lang":"en","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"438689590673960960","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":{},"id":"438681804133117955","entities":{"hashtags":{},"mentions":[{"start":3,"end":18,"username":"Legemiddelinfo","id":"89806212"}],"urls":[{"start":67,"end":89,"url":"http://t.co/7U0i5Jetat","expanded_url":"http://bit.ly/OCoBd3","display_url":"bit.ly/OCoBd3"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-26T14:27:47.000Z","text":"RT @Legemiddelinfo: New studies of paracetamol usage in pregnancy: http://t.co/7U0i5Jetat","lang":"en","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"438681804133117955","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"438680238726184960"}],"id":"438681613334241281","entities":{"hashtags":[{"start":20,"end":29,"tag":"Novartis"}],"mentions":[{"start":3,"end":18,"username":"nakosbalamotis","id":"39364251"}],"urls":[{"start":112,"end":134,"url":"http://t.co/AVPq0JHOKp","expanded_url":"http://www.fiercebiotech.com/story/novartis-shutter-rd-site-june-global-reorganization-unfolds/2014-02-26?utm_campaign=AddThis&utm_medium=AddThis&utm_source=twitter#.Uw34UZ-2N7Y.twitter","display_url":"fiercebiotech.com/story/novartis…"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-26T14:27:01.000Z","text":"RT @nakosbalamotis: #Novartis to shutter R&amp;D site in June as global reorganization unfolds - FierceBiotech: http://t.co/AVPq0JHOKp","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"438681613334241281","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"438674064874692608"}],"id":"438681221854691328","entities":{"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":86,"end":108,"url":"http://t.co/x6ggNKaADu","expanded_url":"http://bit.ly/1cMWgcl","display_url":"bit.ly/1cMWgcl"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-26T14:25:28.000Z","text":"RT @EFPIA: Canada’s largest HIV treatment centre taps SAP, PHEMI for big data project http://t.co/x6ggNKaADu","lang":"ca","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"438681221854691328","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"438673381047939073"}],"id":"438680905365094400","entities":{"hashtags":[{"start":86,"end":92,"tag":"NSCLC"}],"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-26T14:24:12.000Z","text":"RT @myESMO: ESMO consensus recommendations for Early-stage non-small-cell lung cancer #NSCLC now available in Annals of Oncology  http://t.…","lang":"en","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"438680905365094400","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"438661103477075968"}],"id":"438680322247778304","entities":{"hashtags":[{"start":18,"end":22,"tag":"EMA"}],"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"},{"start":117,"end":126,"username":"EMA_News","id":"116716199"}],"urls":[{"start":94,"end":116,"url":"http://t.co/iVRWQJcNNg","expanded_url":"http://bit.ly/1o5qVDK","display_url":"bit.ly/1o5qVDK"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-26T14:21:53.000Z","text":"RT @euparkinsons: #EMA training session 4 patients &amp; consumers - presentations published: http://t.co/iVRWQJcNNg @EMA_News","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"438680322247778304","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"438661046417760256"}],"id":"438680270209056768","entities":{"hashtags":[{"start":108,"end":120,"tag":"raredisease"}],"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"urls":[{"start":49,"end":71,"url":"http://t.co/8nxXJezkKF","expanded_url":"http://www.eurordis.org/content/become-member","display_url":"eurordis.org/content/become…"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-26T14:21:41.000Z","text":"RT @eurordis: How to become a member of EURORDIS http://t.co/8nxXJezkKF\nJoin the movement that includes 614 #raredisease patient groups fro…","lang":"en","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"438680270209056768","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"438657712298020864"}],"id":"438679954025644032","entities":{"hashtags":[{"start":14,"end":24,"tag":"influenza"},{"start":27,"end":32,"tag":"H7N9"}],"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"}],"urls":[{"start":75,"end":97,"url":"http://t.co/YENUh5p822","expanded_url":"http://bit.ly/1mHadiO","display_url":"bit.ly/1mHadiO"},{"start":98,"end":120,"url":"http://t.co/9GktbQvRxB","expanded_url":"https://twitter.com/ECDC_Flu/status/438657712298020864/photo/1","display_url":"pic.twitter.com/9GktbQvRxB"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-26T14:20:25.000Z","text":"RT @ECDC_Flu: #influenza A(#H7N9): interactive map shows timeline of cases http://t.co/YENUh5p822 http://t.co/9GktbQvRxB","lang":"en","public_metrics":{"retweet_count":20,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"438679954025644032","attachments":{"media_keys":["3_438657712142811136"]}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"438630301645164544"}],"id":"438630557095047168","entities":{"hashtags":[{"start":27,"end":36,"tag":"vaccines"}],"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"urls":[{"start":114,"end":136,"url":"http://t.co/oBqnYA2LRT","expanded_url":"http://bit.ly/Hvac3world","display_url":"bit.ly/Hvac3world"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-26T11:04:08.000Z","text":"RT @innovationunion: First #vaccines against parasitic infections affecting the developing world are being tested http://t.co/oBqnYA2LRT #H…","lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"438630557095047168","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"438628277620838400"}],"id":"438628866622779392","entities":{"hashtags":[{"start":56,"end":66,"tag":"influenza"}],"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"},{"start":101,"end":109,"username":"ECDC_EU","id":"204752573"}],"urls":{},"annotations":[{"start":83,"end":87,"probability":0.9968,"type":"Place","normalized_text":"China"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-26T10:57:25.000Z","text":"RT @ECDC_Flu: No sign of sustained human-to-human avian #influenza transmission in China. See latest @ECDC_EU assessment: http://t.co/JkoDK…","lang":"en","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"438628866622779392","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","referenced_tweets":{},"id":"438626046074953728","entities":{"hashtags":[{"start":96,"end":111,"tag":"RareDiseaseDay"}],"mentions":{},"urls":[{"start":73,"end":95,"url":"http://t.co/jT9MpwkY7D","expanded_url":"http://bit.ly/1cjFONF","display_url":"bit.ly/1cjFONF"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-26T10:46:13.000Z","text":"Find out about our work in medicines for the treatment of rare diseases: http://t.co/jT9MpwkY7D #RareDiseaseDay","lang":"en","public_metrics":{"retweet_count":11,"reply_count":3,"like_count":1,"quote_count":0},"conversation_id":"438626046074953728","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"438622051876614144"}],"id":"438625236997902336","entities":{"hashtags":{},"mentions":[{"start":3,"end":19,"username":"ESEndocrinology","id":"221055586"}],"urls":{},"annotations":[{"start":21,"end":45,"probability":0.4714,"type":"Organization","normalized_text":"European Medicines Agency"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-26T10:43:00.000Z","text":"RT @ESEndocrinology: European Medicines Agency recommends that Protelos/Osseor remain available but with further restrictions http://t.co/O…","lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"438625236997902336","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"438600409259999232"}],"id":"438623987644792832","entities":{"hashtags":{},"mentions":[{"start":3,"end":17,"username":"JeanGeorgesAE","id":"1502220312"},{"start":33,"end":42,"username":"EMA_News","id":"116716199"}],"urls":{},"annotations":[{"start":44,"end":68,"probability":0.3496,"type":"Organization","normalized_text":"European Medicines Agency"}]},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-26T10:38:02.000Z","text":"RT @JeanGeorgesAE: Second day at @EMA_News: European Medicines Agency workshop on benefit/risk evaluation of new medicines","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"438623987644792832","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"438596484473552896"}],"id":"438623852344918016","entities":{"hashtags":[{"start":83,"end":98,"tag":"RareDiseaseDay"}],"mentions":[{"start":3,"end":19,"username":"Martinharvey100","id":"113148426"},{"start":47,"end":56,"username":"EMA_News","id":"116716199"}],"urls":[{"start":99,"end":121,"url":"http://t.co/PxcDTCxOpD","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/02/news_detail_002033.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-26T10:37:30.000Z","text":"RT @Martinharvey100: European Medicines Agency @EMA_News doing our part to support #RareDiseaseDay http://t.co/PxcDTCxOpD","lang":"en","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"438623852344918016","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":{},"id":"438364385091010560","entities":{"hashtags":{},"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"urls":[{"start":56,"end":78,"url":"http://t.co/ag1o9Tz7Qi","expanded_url":"http://bit.ly/1ljehnN","display_url":"bit.ly/1ljehnN"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-25T17:26:28.000Z","text":"RT @LV_MPA: Treatment with paracetamol during pregnancy http://t.co/ag1o9Tz7Qi","lang":"en","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"438364385091010560","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"retweeted","id":"438354040078868480"}],"id":"438354316681043968","entities":{"hashtags":[{"start":20,"end":25,"tag":"Drug"},{"start":68,"end":78,"tag":"addiction"}],"mentions":[{"start":3,"end":18,"username":"nakosbalamotis","id":"39364251"},{"start":116,"end":131,"username":"OutsourcPharma","id":"106451186"}],"urls":[{"start":89,"end":111,"url":"http://t.co/RMs9vRyeTz","expanded_url":"http://www.outsourcing-pharma.com/Clinical-Development/Drug-developers-turn-to-recreational-users-for-addiction-expertise?utm_source=AddThis&utm_medium=Twitter&utm_campaign=SocialMedia/#.UwyytS0WyLM.twitter","display_url":"outsourcing-pharma.com/Clinical-Devel…"}],"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-25T16:46:28.000Z","text":"RT @nakosbalamotis: #Drug developers turn to recreational users for #addiction expertise http://t.co/RMs9vRyeTz via @OutsourcPharma","lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"438354316681043968","attachments":{"media_keys":{}}},{"source":"TweetDeck","referenced_tweets":[{"type":"replied_to","id":"438341840572776448"}],"id":"438344026258149377","entities":{"hashtags":{},"mentions":[{"start":0,"end":8,"username":"CDeRede","id":"2254792730"},{"start":83,"end":97,"username":"EU_enterprise","id":"2562735307"},{"start":101,"end":111,"username":"EU_Health","id":"606325697"}],"urls":{},"annotations":{}},"author_id":"116716199","possibly_sensitive":false,"created_at":"2014-02-25T16:05:34.000Z","text":"@CDeRede No we don't because it falls outside of our remit. We suggest you contact @EU_enterprise or @EU_Health  for more information.","lang":"en","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"438341840572776448","attachments":{"media_keys":{}},"in_reply_to_user_id":"2254792730"}]
